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Abstract 
 
Cell death and bystander effect are crucial for both the efficacy of cancer therapy 
and the modulation of anti-tumour immune response. The „bystander effect‟ refers 
to a process whereby untreated cells exhibit either the deleterious or beneficial 
indirect effects as a result of signals received from nearby targeted cells. Various 
molecular players and pathways have been suggested to mediate the bystander 
effects, nevertheless to date it is not known which are the key molecules and 
cellular mechanisms underpinning cell death signal propagation. Several reports 
suggest the involvement of both nitric oxide (NO) and reactive nitrogen species 
(RNS) in mediating the bystander effect. Nevertheless their role in the process has 
not been totally defined since these molecules can either inhibit or sustain tumour 
progression. Additionally, the methods conventionally applied for NO tracking do 
neither necessarily reflect real-time NO production nor allow studies into intact 
three-dimensional tumour mass. 
 
The primary aim of this study was to investigate and characterize cell signals 
responsible for the bystander effect within the tumour microenvironment, paying 
particular attention to NO. To this purpose, we exploited intravital microscopy by 
taking advantage of the novel fluorecent probe for NO (CuFL) and the dorsal 
skinfold chamber model on living tumour-bearing mice subjected to 
photodynamic therapy (PDT). 
Notably, the PDT-triggered bystander effect was associated to the generation of 
very fast NO and Ca
2+ 
waves within the whole tumour mass, supported the 
hypothesis that constitutive NOS activity might be crucial for the beneficial 
spread of bystander response and death signals propagation. Additionally, we 
demonstrated that PDT triggered apoptosis in bystander cells, through gap 
junction intercellular communication.  
Finally, our results, provide the first direct evidence of NO involvement in 
bystander responses within a three-dimensional tumour mass, and strikingly 
corroborate the notion that connexin gap junction are instrumental for mediating 
bystander death signals propagation. 
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Riassunto 
 
La morte cellulare e l‟effetto bystander rappresentano degli elementi decisivi per 
l‟efficacia della terapia antitumorale nonchè per la modulazione della risposta 
immunitaria contro il cancro. Per “effetto bystander” si intende il processo per il 
quale le cellule non soggette a determinati trattamenti farmacologici subiscono 
indirettamente gli effetti terapeutici, siano essi positivi o negativi, risultanti dal 
trattamento esclusivo delle cellule vicine. Nonostante siano state proposte diverse 
molecole e vie di segnalazione coinvolte nell‟effetto bystander, i messaggeri 
molecolari essenziali ed i meccanismi che sottendono alla propagazione dei 
segnali di morte non sono ancora noti. Diversi studi suggeriscono un 
coinvolgimento dell‟ossido nitrico (NO) e delle specie reattive dell‟azoto (RNS) 
nell‟effetto bystander tuttavia, il loro ruolo nel processo non è tuttora totalmente 
chiaro, considerato che essi possono sia inibire che sostenere la progressione del 
tumore. Inoltre, i metodi tradizionalmente usati per lo studio dell‟ossido nitrico 
non riflettono necessariamente la produzione di NO in tempo reale nè consentono 
studi su complesse masse tumorali tridimensionali.  
 
L‟obiettivo principale di questo studio è stato quello di individuare e 
caratterizzare i segnali cellulari responsabili dell‟effetto bystander all‟interno del 
microambiente tumorale, rivolgendo particolare attenzione all‟NO. A questo 
scopo, abbiamo utilizzato delle tecniche di microscopia intravitale, avvalendoci di 
una nuova sonda fluorescente per l‟NO (CuFL) e del modello sperimentale delle 
camerette dorsali impiantate su topi affetti da tumore e sottoposti a terapia 
fotodinamica (PDT). 
Da questo studio è emerso che l‟effetto bystander indotto dalla terapia 
fotodinamica è associato alla generazione all‟interno della massa neoplastica di 
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molto rapide di segnali di NO e di Ca
2+
. Questi eventi avallano l‟ipotesi che 
l‟attività delle isoforme costitutive dell‟enzima NOS possa esercitare un ruolo 
cruciale nella diffusione delle risposte bystander e nella trasmissione dei segnali 
di morte. Questo lavoro inoltre ci ha consentito di dimostrare che la terapia 
fotodinamica è in grado di indurre l‟apoptosi delle cellule vicine non trattate 
(bystander) attraverso i meccanismi di comunicazione intercellulare mediati dalle 
giunzioni comunicanti. 
Infine, i risultati ottenuti hanno fornito la prima evidenza diretta della 
partecipazione dell‟NO all‟effetto bystander all‟interno di una massa tumorale 
tridimensionale e corroborano efficacemente l‟ipotesi che le giunzioni 
comunicanti formate da connesine siano essenziali per garantire la propagazione 
dei segnali di morte osservati nell‟effetto bystander. 
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Introduction 
Cancer represents the major public health problem for modern society. Despite 
major advances in conventional treatment, in the last 20 years the 5-year survival 
of many cancer patients has increased less than 10%. This poor clinical outcome 
illustrates an unmet clinical need for new therapeutic approaches, providing an 
effective long-lasting protection against disease recurrence. Since cell growth and 
cell death are two strictly regulated biological events that ultimately depend on the 
establishment of networks among neighbouring cells, the understanding of the 
molecular mechanisms underpinning intercellular communication within a tumour 
mass may represent a promising opportunity for the development of a successful 
cancer therapy.  
 
Cellular communication, gap junctions and their implication in cancer biology 
Cells do not live in isolation, but they receive and process a stream of information 
from the outside environment, thanks to a plethora of receptors capable of sensing 
mechanical, thermal and electrical stimuli. Moreover, cells can also receive other 
biological stimuli externally released, such as hormones, growth factors and 
cytokines, through which they indirectly establish connections to other cells. 
Additionally, cells may communicate directly each other through pathways 
requiring cell-cell contact. Direct communication among neighbouring cells is 
mainly mediated by gap junctions. Gap junctions (GJ) are intercellular membrane 
channels that typically gather in groups of 10 to 10,000, so-called plaques, at the 
plasma membrane surface. They arise from interaction of two opposing 
hemichannels, in turn consisting of six connexin proteins. Connexins are present 
in a wide variety of organisms. In humans, more than twenty connexin species 
have been characterized. They 
all share a similar structure of 
four membrane-spanning 
domains, two extracellular 
loops, one cytoplasmic loop, 
one cytosolic N-terminal tail, 
and one C-terminal region. 
The flux of molecules through 
these channels is called the 
gap junctional intercellular 
communication (GJIC) and 
includes the passive diffusion 
of ions, such as sodium, 
potassium and calcium and 
hydrophilic molecules (MW 
<1 kDa), such as metabolites 
Figure1. Basic structure of the gap junction. Each 
intercellular gap junction channel is formed by the pairing 
of connexon hemichannels, located in the lateral plasma 
membrane of adjacent cells. Each connexon in turn is made 
up of six connexins. 
(https://www.landesbioscience.com/curie/chapter/852/) 
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(e.g. ADP/ATP), nutrients (e.g. glucose), and second messengers (e.g. 
cAMP/cGMP, IP3), resulting in the metabolic and electric coupling of cells 
(Alexander and Goldberg 2003). As numerous physiological processes are 
mediated by regulatory molecules that are exchanged via gap junctions, GJIC is 
considered a key mechanism in the control of virtually all aspects of the cellular 
life cycle (Vinken, Vanhaecke et al. 2006). The functional importance of gap 
junctions is widespread, with these channel proteins being expressed in nearly all 
excitable and non-excitable tissues of the body. For example, in excitable tissues, 
the establishment of direct electrical circuits is essential for cardiac muscle 
synchronization and neural networks. Although not molecularly defined, 
collective information suggests that connexins in non-excitable tissues play key 
roles in development, differentiation, metabolic homeostasis and growth control. 
One of the major differences between rat liver cancer and normal cells resides in 
the resistance to ion diffusion from cell to cell. Indeed, while the cells of healthy 
liver form a functional continuum, the cells of cancerous tissue behave like 
isolated functional units (Loewenstein and Kanno 1967). Connexin function is 
tighly regulated at the level of transcription, translation, processing, gating and 
protein/channel turnover. Phosphorylation of multiple serines, threonines and 
tyrosines, predominantly in the cytoplasmic tail, appears to contribute to the 
orchestration of these various regulatory steps for several connexin types (King 
and Bertram 2005). Moreover, connexin channels gating, which occurs within 
milliseconds, is triggered by a number of factors, including transmembrane 
voltage (voltage gating), and H
+
 and Ca
2+
 ions (chemical gating). Numerous 
reports described variation in connexin expression according to different phase of 
cell cycle, thus claiming an important role in controlling cell growth. Moreover, 
during the last few years, most attention has been paid to unravelling GJ 
involvement in programmed cell death (Vinken, Vanhaecke et al. 2006). 
Apoptotic cell death is generally associated with drastic alterations in Ca
2+
 
concentration, which is frequently exchanged via gap junctions, thus spreading the 
death wave from cell to cell (Contreras, Sanchez et al. 2004). Furthermore, 
inositol triphosphate (IP3), even if not sufﬁcient for the spread of apoptosis – 
since it needs to team up with other factors to become a fully pro-apoptotic 
messenger – is a key necessary messenger for communicating apoptotic cell death 
via gap junctions (Decrock, Krysko et al. 2012). Additionally, different evidence 
supports the claim that connexins fulfil tumour suppression functions and, as 
tumour suppressor genes, their expression or function must also be abrogated to 
allow carcinogenic progression. First, connexins and/or gap junctions are typically 
downregulated in cell lines that are derived from various tumour types 
(Loewenstein and Kanno 1967). Second, rodent or human solid tissue tumours 
often lack gap junctions and exhibit reduced connexin levels. Intriguingly, 
numerous studies have demonstrated that human cancers are deficient in GJ either 
as a result of a downregulated expression of connexins, altered trafficking to the 
cell membrane or the inability to form functional junctions. Immunohistochemical 
analysis of primary excised human tumours revealed, indeed, downregulation of 
connexin expression in several cancer types, including lung, renal, endometrial 
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and breast carcinomas, gliomas, cervical and prostate carcinomas (King and 
Bertram 2005). Third, reagents and oncogenes that promote either tumour onset or 
progression frequently inhibit gap junction channel function and/or reduce 
connexin expression. Fourth, differential or subtractive gene profiling, as well as 
gene knockdown studies, have identified connexins as potential tumour 
suppressors. Fifth, ectopic reintroduction of connexins into tumour cells reduces 
cell proliferation and tumour growth, and partially re-differentiates transformed 
cells. Last, some connexin-knockout mice, as well as mice expressing reduced or 
dominant-negative connexins, have an increased incidence of tumour onset when 
challenged with a carcinogen. In addition to these lines of evidence linking 
connexins to cancer, other correlative studies have shown that retinoids and 
carotenoids might be involved in cancer prevention by upregulating connexins 
and GJIC through their nuclear retinoic acid receptor (RAR) (Chung, Choi et al. 
2010). 
Noteworthy, a recent study demonstrated that reduced expression of Cx43 in the 
cytoplasm of human colorectal tumours is associated with significantly poorer 
clinical outcome, thus suggesting that Cx43 could serve as prognostic biomarker 
to predict disease outcome (Sirnes, Bruun et al. 2012). Moreover, connexins 
expression and GJ networks may assume clinical relevance since their 
overexpression enhance the extent of tumour cell death, by allowing the transfer 
of toxic metabolites among neighbouring cells, thus assuring the so-called 
“bystander effect” of antitumour therapy by either pro-drugs (Mesnil, Piccoli et al. 
1996) or other chemotherapeutic agents (Garcia-Rodriguez, Perez-Torras et al. 
2011).  
 
Cancer therapy and the bystander effect 
The „bystander effect‟ refers to a process whereby untreated cells exhibit either 
the deleterious or beneficial indirect effects as a result of signals received from 
nearby targeted cells. Most frequently, directly irradiated cells forward damaging 
signals to non-irradiated cells thereby inducing a response similar to that of 
irradiated ones (Baskar 2010). Despite radiation-induced bystander effects have 
become established in the radiobiology vocabulary as a bona fide radiation 
response, there is still no consensus on the precise definition of the radiation-
induced bystander effect itself, which currently encompasses a number of distinct 
signalling-mediated events (Blyth and Sykes 2011). Notwithstanding, the 
bystander effect has been observed in response to a range of different insults 
including ultraviolet radiation, photodynamic therapy, heat and chemotherapy 
agents and is thought to involve direct cell–cell interactions through gap 
junctional intercellular communication (GJIC), requiring expression and surface 
location of connexin proteins (McMasters, Saylors et al. 1998; Garcia-Rodriguez, 
Perez-Torras et al. 2011). The hypothesis of metabolic cooperation to explain the 
bystander effect was supported by the transfer of toxic derivatives within the 
archetypal gene therapy model based on the herpes simplex virus-thymidine 
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kinase (HSV-TK) expression. TK/GCV system is probably the best documented 
example of a therapy that benefits from a bystander effect mediated by the traffic 
of phosphate derivatives through gap junctions. In this therapy, infact, cells are 
transfected with the HSV-TK gene and are thus incubated with the non-toxic 
agent ganciclovir (GCV), which is converted to a toxic analogue that diffuses and 
kills neighbouring cells, even if they were not transfected with HSV-TK (Mesnil 
and Yamasaki 2000). In this context, the bystander effect involved direct cell–cell 
communication through GJIC and required expression and surface location of 
Cx43 gap junctions (McMasters, Saylors et al. 1998). Moreover, a more recent 
study demonstrated that Cx26 participates in the gap junction–mediated bystander 
cytoxic effect of gemcitabine, providing evidence that upregulation of Cx26 
improves gemcitabine anticancer efficacy on human pancreatic tumour cells 
(Garcia-Rodriguez, Perez-Torras et al. 2011). Surprisingly, a key characteristic of 
the radiation-induced bystander responses, in contrast to direct irradiation effects, 
is the a typical dose–response relationship.  
 
Figure2. Key aspects of radiation-induced bystander responses. Typical dose response curves 
for direct (a) and bystander (b) responses are shown, highlighting the commonly observed 
saturation of response for bystander effect (Prise and O'Sullivan 2009). 
 
Instead of an increased response with increasing radiation dose, in fact, the 
bystander response becomes saturated at relatively low doses (typically less than 1 
Gy). This saturation means that, above a sort of dose threshold level, no additional 
effect occurs, therefore not every nearby cell is engaged in the bystander effect. It 
has also been suggested that bystander effect might be triggered in a binary mode 
as a simple on–off response, whose probability increases with radiation dose. It 
should be emphasized, however, that bystander responses can have a significant 
role even after high doses (>10 Gy). Interestingly, in many models after low-dose 
exposure bystander responses are almost equally effective as the direct response, 
suggesting that at least under some conditions bystander responses could 
predominate in overall effectiveness. From a molecular point of view, radiation-
induced bystander response is based on two main mechanisms of action, which 
involve both directly contacting cells via gap junctions and not physically 
connected cells through the release of soluble factors.  
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Figure3. Key pathways affecting bystander signals. Cells respond to direct radiation (red cell) 
by producing bystander responses through two key routes. One involves direct cell–cell 
communication through gap junctions and the second release of cytokine signals into the 
extracellular matrix. Not all cells respond (for example, the blue cell). In vivo, macrophages may 
be important mediators, which in response to radiation-induced tissue damage release bystander 
signals that affect non-irradiated cells (yellow cells). Some of the key pathways and mechanisms 
are now being elucidated, with roles for cytokine-mediated signalling, signal transduction through 
MAPKs and nuclear factor-κB (NF-κB) alongside the production of reactive oxygen and nitrogen 
species. COX2, cyclooxygenase 2; DR5, death receptor 5 (also known as TNFRSF10B); IL, 
interleukin; JNK, Jun N terminal kinase; NO, nitric oxide; NOS2, NO synthase 2; ROS, reactive 
oxygen species; TGFα, transforming growth factor-β; TGFβR, TGFβreceptor; TNFα, tumour 
necrosis factor-α; TRAIL, TNF-related apoptosis inducing ligand (Prise and O'Sullivan 2009).  
 
These factors, preferentially transferred through extracellular medium from 
irradiated to non-irradiated cells, include lipid peroxide products, inosine 
nucleotides and cytokines such as tumour necrosis factor-α (TNFα). Moreover, 
reactive oxygen species (ROS), such as superoxide radicals, are vividly involved 
in bystander cell signals (Prise and O'Sullivan 2009). Several reports have shown 
a key role for cytokines, including interleukin 6 (IL-6), IL-8, transforming growth 
factor-β1 (TGFβ1) and TNFα, as well as ROS and reactive nitrogen species 
(RNS), relating the bystander-mediated signalling to inflammatory responses. For 
example, recent studies have shown that macrophages, which are key mediators of 
the inflammatory response and distinctive components of tumour 
microenvironment (Balkwill and Mantovani 2012), produce persistent levels of 
oxidative stress mediators after radiation exposure under bystander conditions, 
due to the activation of cyclooxygenase 2 (COX2) and inducible nitric oxide (NO) 
synthase (iNOS). Khan et al. found that pre-injection of rat with either superoxide 
dismutase (SOD) or the NOS inhibitor L-NAME led to a reduced response in the 
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non-irradiated shielded lung areas, indicating the involvement of ROS and NO in 
irradiation-induced bystander DNA damage, which is reported to be accompanied 
by waves of macrophage activation and production of cytokines, including IL-1α, 
IL-1β, IL-6, TNFα and TGFβ, lasting up to 16 weeks after irradiation (Khan, Van 
Dyk et al. 2003). Furthermore, a growing number of findings support the 
importance of NO in intercellular signal transduction pathways initiated by 
ionizing radiation. Irradiation with helium ions of individual glioblastoma cells 
and subsequent co-culture with non-irradiated cells in the presence of either a 
NOS inhibitor or anti-TGFβ1 antibody demonstrated that both TGFβ1 and NO 
were released independently from irradiated cells and induced a burst of free 
radicals and DNA damage in neighbouring cells. Additionally, stimulation of NO 
release influenced the increase in TGFβ1 production and, inversely, TGFβ1 
stimulated the accumulation of iNOS, demonstrating a positive feedback between 
these two pathways (Shao, Folkard et al. 2008; Shao, Prise et al. 2008). 
 
Tumour microenvironment heterogeneity and antitumour immunity 
Since the last decade it became generally accepted that tumour mass are not only a 
collection of relatively homogenous cancer cells, but they rather form a sort of 
crowded organ composed of different cell populations, sustaining inflammation. 
Inflammation has indeed been extensively associated to cancer and the mediators 
and cellular effectors of inflammation are considered important constituents of the 
tumour microenvironment (Mantovani, Allavena et al. 2008; Grivennikov, Greten 
et al. 2010). The connection between cancer and inflammation dates back to 1863, 
when Rudolf Virchow noted leucocytes in neoplastic tissues, suggesting that the 
“lymphoreticular infiltrate” reflected the origin of cancer at sites of chronic 
inflammation (Balkwill and Mantovani 2001). Moreover, smouldering 
inflammation increases the risk of developing many types of cancer, including 
bladder, cervical, gastric, intestinal, oesophageal, ovarian, prostate and thyroid 
cancer (Porta, Riboldi et al. 2011), thus representing one of the novel additional 
hallmarks of cancers, namely sustaining proliferative signalling, evading growth 
suppressors, resisting cell death, enabling replicative immortality, inducing 
angiogenesis, activating invasion and metastasis, reprogramming energy 
metabolism, and evading immune destruction (Hanahan and Weinberg 2011). As 
a result of chronic inflammation, tumour microenviroment harbours different 
corrupted resident or purposely recruited cells which exert conflicting functions 
establishing a peculiar cytokine milieu. However, the stromal components of 
tumour microenvironment can be classified into three general classes: angiogenic 
vascular cells, cancer-associated fibroblastic cells and infiltrating immune cells 
(Hanahan and Coussens 2012). 
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Figure4. Tumour microenvironment heterogeneity. Tumour microenviroment is a dynamic 
niche where vascular, immune and fibroblastic cells cluster. Infiltrating immune cells can include 
multiple cell types that provide both pro- and anti-tumour support. The vascular endothelial 
networks differ in regard to the vessel‟s tissue of origin and require accumulation of immature 
pericytes. Finally, cancer-associated fibroblasts drive tissue remodelling enhancing tumour 
invasiveness (Junttila and de Sauvage 2013). 
 
Angiogenic vascular cells, accumulated within the neoplastic lesion thanks to pro-
angiogenic factors – primarily vascular endothelial growth factor (VEGF) – 
secretion by tumour itself, restore the oxygen and nutrients supply to cancer cells, 
which would not otherwise survive in hypoxic conditions. Nonetheless, 
endothelial cells as well as pericytes – the mural cells of blood microvessels 
involved in endothelial cell stimulation and guidance, endothelial stabilization and 
maturation – arrange themselves in a pathological anarchic manner, thus 
facilitating dissemination of cancer cells from primary tumour (Raza, Franklin et 
al. 2010). Cancer-associated fibroblasts (CAFs), differently from normal 
fibroblasts, which typically suppress tumour formation, show pro-tumourigenic 
properties, since they enhance tissue remodelling, by increasing expression of 
proteolytic enzymes, such as matrix metalloproteinases, and extracellular matrix 
deposition (Junttila and de Sauvage 2013). Moreover CAFs secrete distinctive 
factors as the stromal cell-derived factor 1 (SDF1), VEGF, the platelet-derived 
growth factor (PDGF), and the hepatocyte growth factor (HGF), promoting 
immune cell recruitment at tumour site (Polanska and Orimo 2013). Notably, the 
different number, type and location of tumour infiltrating immune cells reflect 
peculiar biological aspects of individual cancers. Interestingly, large studies have 
proven that tumour immune infiltrate patterns and subsets in colorectal cancer are 
significant prognostic biomarkers (Ogino, Nosho et al. 2009; Nosho, Baba et al. 
2010) thus paving the way for the clinical introduction of a novel parameter, the 
so-called “immunoscore”. This new index supports cancer staging and identifies 
patients with high-risk of tumour recurrence, thus facilitating clinical decision-
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making including rational stratification of patients who would benefit the most 
from adjuvant therapy. The “immunoscore” looks at the immune cell density, 
calculated by numerical quantification of two lymphocyte populations, cytotoxic 
and memory T cells both at the tumour core and the invasive margin (Galon, 
Pages et al. 2012). Tumour-infiltrating immune cells include however cell subsets 
belonging to both the adaptive and the innate immune compartments. 
Interestingly, very recent studies demonstrated the existence of peculiar organized 
tertiary lymphoid structures (TLS) within the tumours, consisting of segregated B 
and T cells, in the presence of high endothelial venule-like vasculature structures 
(Goc, Germain et al. 2013). Besides conventional B cells and αβ TCR–expressing 
CD8
+
 and CD4
+
 T cells crowding to the primary neoplastic lesion, natural killer 
(NK) cells, γδ T cells and natural killer T (NKT) cells are present within the 
tumour microenvironment. The role of these innate lymphocyte subsets in 
modulating immune response in cancer settings has not yet clearly elucidated, 
since they seem to either promote or suppress T cell activation depending on the 
cytokine milieu (Gajewski, Schreiber et al. 2013). Moreover, among myeloid cell 
populations observed at tumour site, there are both terminally differentiated cells, 
as dendritic cells (DCs), macrophages and granulocytes, and immature myeloid 
cells, named as myeloid-derived suppressor cells (MDSCs), which are generated 
from bone marrow as a consequence of a cancer-induced abnormal myelopoieis 
(Gabrilovich, Ostrand-Rosenberg et al. 2012). Nonetheless, DCs in tumour-
bearing hosts do not adequately stimulate an effective immune response because 
of the down-regulated expression of the MHC class II and co-stimulatory 
molecules CD80 and CD86, thus favouring tumour immune evasion (Gabrilovich 
2004). Macrophages flocked to the tumour, the so-called tumour associated 
macrophages (TAMs), generally show peculiar characteristics, typical of those 
macrophages exhibiting an M2 phenotype. 
While M1 or „classically activated‟ macrophages  stimulated by IFNγ and 
bacterial products and expressing high levels of IL-12 and low levels of IL-10  
are tumouricidal, M2 or „alternatively activated‟ macrophages  activated by IL-4, 
IL-10, IL-13 and glucocorticoid hormones and secreting high levels of IL-10 and 
low levels of IL-12  favour tumour progression (Mantovani, Sozzani et al. 2002). 
M2 macrophages display, infact, poor antigen presenting capacity, promote 
angiogenesis and lymphangiogenesis, sustain tissue remodelling, tumour invasion 
and metastasis, and suppress anti-tumoural adaptive immunity (Galdiero, 
Garlanda et al. 2013). Similarly to macrophages, tumour-associated granulocytes, 
which are prominently neutrophils, have been shown to shift from an antitumoural 
„N1‟ phenotype to a pro-tumoural „N2‟ phenotype after TGF-β exposure, which is 
frequently secreted by cancer cells. Whilst N1 TANs showed high expression of 
immunoactivating cytokines and chemokines, low levels of arginase, and high 
capability of killing tumour cells in vitro, N2 TANs exhibit pro-tumoural 
properties (Fridlender, Sun et al. 2009). Finally, MDSCs include direct 
progenitors of DCs, macrophages and granulocytes and exploit multiple redundant 
mechanisms to influence both innate and adaptive immune responses. First, 
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MDSCs induce the activation and expansion of regulatory T cells (Treg) 
population by promoting antigen-specific natural Treg clonal expansion and naive 
CD4
+
 T cell conversion into induced Treg cells. The second immunomodulating 
mechanism is based on nutrients depletion required by lymphocytes, i.e. L-
cysteine sequestration and L-arginine depletion through arginase-1 (ARG1) 
dependent consumption, which cause TCR δ-chain down-regulation and the 
proliferative arrest of antigen-activated T cells. Moreover, MDSCs interfere with 
lymphocyte trafficking and viability, by expressing at the plasma membrane 
ADAM17 (disintegrin and metalloproteinase domain-containing protein 17), 
which cleaves key proteins for T cell recirculation to lymph nodes, and galectin-9 
(GAL-9), which induce T cell apoptosis. Finally, MDSCs produce ROS, NO and 
other RNS, thus sustaining oxidative stress within tumour microenvironment, by 
the synergistic activity of ARG1, iNOS and NADPH oxydase enzymes 
(Gabrilovich, Ostrand-Rosenberg et al. 2012). 
 
 
 
Figure5. Mechanisms of MDSC-dependent inhibition of T cell activation and proliferation. 
Myeloid-derived suppressor cells (MDSCs) can inhibit efficient antitumour T cell responses 
through a number of mechanisms. a) Tumour-associated MDSCs induce the development of 
regulatory T (Treg) cells or expand existing Treg cell populations. b) Tumour-associated myeloid 
cells deprive T cells of amino acids that are essential for their growth and differentiation. c) 
Tumour-associated myeloid cells release oxidizing molecules, such as hydrogen peroxide (H2O2) 
and peroxynitrite (ONOO–) which cause nitration and nitrosylation of components of the T cell 
receptor (TCR) signalling complex, and the loss of the TCR δ-chain, thereby inhibiting T cell 
activation through the TCR. d) Tumour-associated myeloid cells can also interfere with T cell 
migration and viability through ADAM17  and GAL9 expression. (Gabrilovich, Ostrand-
Rosenberg et al. 2012). 
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The dual role of nitric oxide in cancer biology 
Nitric oxide (NO) is a lipophilic, highly diffusible, and short-lived physiological 
messenger (Lancaster 1997), which modulates a variety of important biological 
process. In particular, low NO concentration acts as a physiological signal 
transducer in many physiological processes, such as blood flow regulation, 
smooth muscle relaxation, iron homeostasis, platelet reactivity and 
neurotransmission. Conversely, high NO concentrations serve as a cytotoxic 
defensive mechanism against pathogens and, perhaps, tumours (Mocellin, Bronte 
et al. 2007). Several investigators have reported the expression of iNOS by 
malignant cells or within the tumour rmicroenvironment, both at mRNA and 
protein level. In breast carcinoma, an initial study suggested that iNOS activity 
was higher in less differentiated tumours and detected predominantly in TAMs 
(Thomsen, Miles et al. 1995). Subsequently, other reports demonstrated that iNOS 
was also expressed by breast carcinoma cells and positively correlated with 
tumour stage (Thomsen, Miles et al. 1995; Reveneau, Arnould et al. 1999) and 
microvessel density (Zhang, He et al. 2011). In addition to breast cancer, iNOS is 
markedly expressed in approximately 60% of human colon adenomas and in 
20%–25% of colon carcinomas, while the expression is either low or absent in the 
surrounding normal tissues. Similar results were obtained for human ovarian 
cancer and melanoma. Other cancers that express iNOS are head and neck, 
esophagus, lung, prostate, bladder and pancreatic carcinomas, brain tumours, 
Kaposi‟s sarcoma, mesothelioma, and hematological malignancies. Moreover, the 
endothelial NOS isoform (eNOS) has been found in both endothelial and tumour 
cells of breast carcinomas, and the neuronal NOS isoform (nNOS) has been 
detected in some oligodendroglioma and neuroblastoma cell lines. However, the 
role of NO in cancer biology has not been clearly elucidated yet, since various 
studies have shown that NO may either promote or inhibit tumour progression and 
metastasis. The net effect of NO in tumours seems to depend on the activity and 
localization of NOS isoforms, concentration and duration of NO exposure, 
cellular sensitivity and hypoxia/re-oxygenation process within tumour 
microenvironment (Fukumura, Kashiwagi et al. 2006). In general, high 
concentrations of NO and RNS can arrest cell cycle (cytostatic effect) or induce 
cell death, whereas low concentrations may protect cells from apoptosis. Infact, 
generation of high levels of NO/RNS is a very effective tool to induce cell death, 
and macrophages use it as a major weapon in their arsenal against invading 
pathogens and tumour cells (Weigert and Brune 2008). High levels of NO/RNS 
post-translationally modify death-related target proteins, as the death receptors of 
the TNFα superfamily, and block respiration in target cells by affecting the 
mitochondrial respiratory chain and its outer membrane permeability and thus 
leading to the release of cytochrome c and apoptosis initiation (Leon, Jeannin et 
al. 2008). Moreover, high NO concentrations, oxidizing and/or deaminating the 
DNA bases, result in DNA breaks, DNA base modifications or DNA cross-links, 
which cause mutations that may either activate oncogenes or deactivate tumour 
suppressor genes. In addition, NO/RNS-driven protein modifications such as S-
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nitrosylation or nitration may inhibit proteins belonging to the DNA repair 
systems, driving to genomic instability (Lechner, Lirk et al. 2005). Importantly, 
DNA damages that cannot be repaired, cause apoptosis induction, by the 
activation of DNA-damage-sensing proteins (e.g., p53, PARP, DNA-PK, BRCA1, 
ATM) (Norbury and Zhivotovsky 2004). However, NO has been demonstrated to 
inhibit programmed cell death in endothelial cells and some liver cancer cell lines, 
mainly through S-nitrosylation of the active-site cysteine of caspases (Dimmeler, 
Haendeler et al. 1997), thus perpetuating mutations and consequently sustaining 
transformation (Torok, Higuchi et al. 2002; Muntane, De la Rosa et al. 2013). On 
the other hand, NO may induce apoptosis either via downregulation of the anti 
apoptotic protein survivin, as observed in human lung carcinoma cells (Chao, Kuo 
et al. 2004), or upregulation of Fas expression, as shown in ovarian carcinoma cell 
lines, through the specific inactivation of the transcription repressor yin-yang-1, 
which binds to the silencer region of the Fas promoter (Garban and Bonavida 
2001). Besides enhancing citotoxicity, NO plays a role in angiogenesis and 
metastasis since several reports showed a positive correlation between NOS 
expression/activity in tumour tissues and lymphatic metastasis in head and neck, 
thyroid, breast, stomach, gallbladder cancers (Fukumura, Kashiwagi et al. 2006; 
Lahdenranta, Hagendoorn et al. 2009) and melanoma (Massi, De Nisi et al. 2009). 
 
 
Figure6. Mechanisms of action of NO on tumour cells. NO can induce both tumour progression 
and metastasis (green) and tumour regression and inhibition of metastasis (brown) depending on 
the dose and duration of NO exposure and on cellular sensitivity to NO. NO promotes tumour 
progression and metastasis by direct induction of tumour-cell proliferation, migration and 
invasion, and indirectly through the expression of angiogenic and lymphangiogenic factors in 
tumour cells. On the other hand, the cytotoxic effects of NO that are typically induced by high 
doses promote DNA damage, gene mutation and tumour-cell death, which result in tumour 
regression and inhibition of metastasis (Fukumura, Kashiwagi et al. 2006). 
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As under physiologic conditions, NO maintains blood flow by dilatation of 
arterial vessels, promotes perivascular cell recruitment and vessel remodelling and 
maturation within tumours (Fukumura, Kashiwagi et al. 2006). NO exposure of 
A-431 squamous carcinoma cells and MDA-MB-231 breast cancer cells was, 
infact, able to induce VEGF-C expression, which mediates lymphangiogenesis 
and metastasis (Franchi, Massi et al. 2006). However, NO may also inhibit the 
aggregation of platelets through a cGMP-dependent mechanism, preventing 
aggregates formation with tumour cells, which may facilitate their adhesion to 
vascular endothelial cells and haematogeneous dissemination (Mehta 1984). 
Finally, as previously mentioned, NO/RNS can suppress tumour-specific adaptive 
immunity through several mechanisms. One mechanism involves the inhibition of 
phosphorylation, and thereby the activation of important signalling proteins in the 
IL-2-receptor pathway (including Janus activated kinase 1 (JAK1), JAK3, 
STAT5, extracellular-signal-regulated kinase (ERK) and AKT) in T cells 
(Bingisser, Tilbrook et al. 1998). Additionally, NO promotes tumour 
immunosuppression, by affecting the stability of IL-2 encoding mRNA and the 
release of IL-2 by activated human T cells (Macphail, Gibney et al. 2003). 
Finally, NO/RNS may dampen antitumour immunity through post-translational 
modifications of key proteins for T cell activation, such as CD8 and TCR complex 
α/β chains molecules (Nagaraj, Gupta et al. 2007), and T lymphocyte recruitment 
to the tumour site, such as the chemokine CCL2 (Molon, Ugel et al. 2011).  
Thus, interfering with NO/RNS production within tumour microenvironment may 
represent a promising successful strategy to implement the efficacy of antitumour 
therapy alone or, even better, in combination with conventional chemotherapy, 
radiotherapy, photodynamic therapy and immunotherapy approaches. 
 
Structure and function of NOS enzymes  
The enzymes responsible for the generation of endogenous NO through L-
arginine oxidation in mammals are known as NO synthases (NOS). Three quite 
distinct isoforms of NOS have been identified. These isoforms are referred by the 
most common nomenclature: nNOS (also known as Type I, NOS-I and NOS-1) 
being the first isoform found and predominating in neuronal tissue; iNOS (also 
known as Type II, NOS-II and NOS-2), which is inducible in a wide range of cells 
and tissues, primarily in macrophages; and eNOS (alsoknown as Type III, NOS-
III and NOS-3) predominantly found in endothelial cells. nNOS synthesizes NO 
in a neuron in response to glutamate while iNOS produces NO in a macrophage 
following its induction by cytokines and microbial products; eNOS generates NO 
in a vascular endothelial cell in response to acetylcholine (Knowles and Moncada 
1994). These different enzymes are products of different genes, with different 
localization, regulation, catalytic properties and inhibitor sensitivity, and with 51-
57% homology between the human isoforms, suggesting the existence of a 
common ancestral NOS gene. The nNOS gene appears to be an intron-containing 
gene of at least 20 kb, and is unequivocally localized to a single position on 
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human chromosome 12 (Hall, Antoniou et al. 1994). The iNOS gene maps to 
chromosome 17 (Charles, Palmer et al. 1993), whereas eNOS gene is located on 
chromosome 7 (Janssens, Shimouchi et al. 1992). Whilst both nNOS and eNOS 
are commonly considered constitutive enzymes, since they are permanent cell and 
tissue constituents, even if expressed at low levels, iNOS remain virtually not 
expressed unless induced by endotoxins, such as lipopolysaccharides (LPS), or 
inflammatory cytokines such as IFN-γ and TNF-α (Alderton, Cooper et al. 2001). 
All NOS enzymes are usually referred to as `dimeric' in their active form, even if 
they require calmodulins (CaMs), thus forming tetramers of two NOS monomers 
associated with two CaMs (Crane, Arvai et al. 1998). Nevertheless, only nNOS 
and eNOS activity is considered calmodulin/Ca
2+ 
dependent, having a much 
higher Ca
2+ 
requirement than iNOS. Infact, for half-maximal activity NOS 
purified from cells other than macrophages requires Ca
2+
 concentrations of 200-
400 nM, which exceed the 70-100 nM levels in resting cells (Cheung 1980). In 
contrast, CaM associates with iNOS at Ca
2+
 concentrations in the range of 39 nM, 
therefore even in cells whose Ca
2+
 remains at the resting level (Cho, Xie et al. 
1992). All NOS isoforms exhibit a bidomain structure with an N-terminal 
oxygenase domain containing binding sites for haem and (6R)-5,6,7,8-
tetrahydrobiopterin (BH4) cofactors, and a C-terminal reductase domain contains 
binding sites for NADPH and for FAD and FMN cofactors (Crane, Arvai et al. 
1997). CaM binding at its binding site located between the two NOS domains, 
increases the rate of electron transfer from NADPH to the reductase domain and 
triggers electron transfer from the reductase domain to the haem centre (Matsuda 
and Iyanagi 1999). CaM effect is however only kinetic, rather than 
thermodynamic, since CaM-Ca
2+ 
binding has little effect on redox potential of the 
flavins (Noble, Munro et al. 1999).  
 
 
 
Figure8. Structure of nitric oxide isoforms. NH2(N) and COOH(C) termini are indicated. 
Homology in amino acid sequences are depicted: open boxes, homologous regions; hatched boxes, 
homologous in neuronal (nNOS) and endothelial nitric oxide synthase (eNOS); solid boxes, 
isoform-specific sequences. For eNOS, regions involved in acylation and binding of substrates and 
cofactors are indicated, as well as the oxygenase and reductase domain and the direction of the 
intramolecular electron flow. Arg, arginine; BH4, tetrahydrobiopterin; CaM, calmodulin; FMN, 
flavin mononucleotide; FAD, flavin adenine dinucleotide (Govers and Rabelink 2001). 
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Noteworthy, the reason why NOS monomer is not active resides in a peculiar 
electron flow, which requires that the reductase domain of one polypeptide chain 
donates its electrons to the oxygenase domain of the other (Siddhanta, Wu et al. 
1996). NOS dimerization involves a large interface in the oxygenase domain, 
including the BH4 binding site, which contributes to structure the active-site 
pocket (Crane, Rosenfeld et al. 1999). Moreover, BH4, together with haem and L-
arginine, promotes and/or stabilizes the active dimer of all three isoforms.  
 
 
 
Figure9. Scheme depicting electron flow in NOS dimers. Electron flow starts from NADPH to 
flavins FAD and FMN of the reductase domain, which transfer the electrons to the iron of the 
heam in the oxygenase domain. BH4 and Calmodulin (CAM) contribute to stabilize the active  
dimer (Munzel, Daiber et al. 2005). 
 
NOS catalyze the oxidative conversion of L-arginine to L-citrulline and NO by 
requiring NADPH and O2 as substrates. This reaction has been divided into two 
major mono-oxygenation steps, which produce N
ω
-hydroxy-L-arginine as 
intermediate (Stuehr, Kwon et al. 1991) 
The first step of the reaction (monooxygenase I) is  reported as follows: 
L-arginine + NADPH + H
+ 
+ O2 → N
ω
-hydroxy-L-arginine + NADP
+ 
+H2O 
Then the second step (monooxygenase II) is stated as:  
N
ω
-hydroxy-L-arginine + 0.5 NADPH+0.5 H
+ 
+ O2→ 
 Citrulline + 0.5 NADP
+ 
+H2O + •NO 
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The essential role of FAD and FMN 
cofactors in the reductase domain is to 
accept two electrons from NADPH and 
pass them on to a one-electron acceptor 
haem domain by forming stable 
semiquinone radical intermediates. 
Electron flow between the two flavins has 
been suggested to be the control point 
where CaM acts, since electron transfer 
from FAD to FMN is slow in the absence 
of CaM/Ca
2+ 
(Matsuda and Iyanagi 1999). 
The monooxygenase II step involves the 
reduction of  haem ferric to ferrous ion and 
O2 binding. This form of the enzyme then 
reacts with N
ω
-hydroxy-L-arginine to form 
its radical and a haem-peroxy complex. 
The N
ω
-hydroxy-L-arginine radical and the peroxy complex then react with each 
other in a 'radical rebound' mechanism to generate citrulline and NO, and to re-
generate the ferric haem iron (Alderton, Cooper et al. 2001). Interestingly, NOS 
activity does not only yield NO, since in the presence of superoxide dismutase 
(SOD), peroxynitrite (ONOO
-
) and other RNS are detected (Schmidt, Hofmann et 
al. 1996). When superoxide (O2•
−
) is not efficiently removed by the scavenging 
enzyme SOD accumulating at high concentrations, NO and superoxide 
spontaneously combine within few cell diameters, thus yielding peroxynitrite 
(Huie and Padmaja 1993). Physiologically, NO is efficiently removed by reacting 
with oxyhemoglobin to form  nitrate, which prevents nitrogen dioxide formation. 
Nonetheless, under pro-inflammatory conditions, simultaneous production of 
superoxide and NO can be strongly activated, thus increasing peroxynitrite 
formation by a 1,000,000-fold (Pacher, Beckman et al. 2007).  
 
 
Figure11. The interplay of nitric oxide, superoxide, peroxynitrite, and nitrogen dioxide. 
When nitric oxide and superoxide are both present, they may also react with nitrogen dioxide to 
form N2O3 and peroxynitrate. Peroxynitrate decomposes to give nitrite and oxygen, while N2O3 
can react with thiols to give nitrosothiols or with hydroxide anion to give nitrite (Pacher, Beckman 
et al. 2007).  
Figure10. NO synhtesis  reaction steps 
(Knowles and Moncada 1994). 
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Although the half-life of peroxynitrite is short (~10–20 ms), peroxynitrite can 
rapidly diffuse to nearby cells (Denicola, Souza et al. 1998) and significantly 
modify critical biomolecules. The most common reaction occurs under 
peroxynitrite exposure include cystein oxidation (Radi, Beckman et al. 1991), 
tyrosine nitration (Greenacre and Ischiropoulos 2001), tryptophan, methionine, 
and histidine oxidation on proteins (Alvarez and Radi 2003), beyond lipid 
peroxidation in membranes (Radi, Beckman et al. 1991) and lipoproteins and 
oxidation of both nucleobases and sugar-phosphate backbone on nucleic acids 
(Burney, Caulfield et al. 1999). 
 
Calcium signalling in cancer 
Regulation of constitutive NOS activity is not the main function of calcium ions, 
since Ca
2+ 
is a ubiquitous intracellular signal which modulates a plethora of  
cellular processes. The key to this pleiotropic role is the complex spatiotemporal 
organization of the intracellular Ca
2+ 
rise evoked by extracellular agonists, which 
allows selected effectors to be recruited and specific actions to be initiated 
(Rizzuto and Pozzan 2006). Resting cells show indeed cytosolic free Ca
2+ 
concentration of 100 nM, but they may be activated when this level rises to 
roughly 1 µM. Ca
2+
 signalling is required for fertilization, cell proliferation and 
differentiation, transcription factor activation and apoptosis modulation (Berridge, 
Lipp et al. 2000). Since its versatile activity, it is conceivable that Ca
2+ 
mediated 
signalling pathways play important roles in cancer initiation, tumour formation, 
tumour progression, metastasis, invasion and angiogenesis (Parkash and Asotra 
2010). Ca
2+ 
signalling pathways are, infact, remodelled or deregulated in cancer 
because of the altered expression of key molecules of the so-called Ca
2+
 signalling 
toolkit, which includes receptors and messengers able to generate Ca
2+
 signals by 
using both external and internal sources of Ca
2+ 
ions. The Ca
2+
 toolkit includes 
environmental sensors and Ca
2+ 
mobilizing messengers that are generated when 
stimuli bind to cell surface receptors, and other second messengers modulating 
Ca
2+ 
concentration in intracellular stores (Berridge, Lipp et al. 2000). External 
Ca
2+
 entry is mediated by different families of Ca
2+ 
channels localized on plasma 
membrane, which are defined by the way they are activated. Among these, there 
are voltage-operated channels (VOCs), activated by membrane depolarization; 
receptor-operated channels (ROCs), which open in response to the binding of an 
extracellular ligand, usually transmitters such as glutamate, ATP or acetylcholine; 
store-operated channels (SOCs) (Roderick and Cook 2008), which open in 
response to the depletion of internal Ca
2+
 stores, as the (STIM)/Ora1-mediated 
store-operated Ca
2+
 channels and, finally, the second messenger-operated 
channels (SMOCs), as the permeable transient receptor potential channels TRPCs 
(Berridge, Bootman et al. 2003). 
Ca
2+ 
release from intracellular stores is mainly mediated by the activation of the 
inositol 1,4,5-trisphosphate receptors (InsP3Rs) and ryanodinereceptors (RYR), 
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localized on the endoplasmic reticulum (ER). These two channels are regulated by 
several factors that involve phospholipase C (PLC) activation, but the most 
important is Ca
2+ 
itself, which triggers the so-called Ca
2+
-induced-Ca
2+
-release 
(CICR) from intracellular stores. CICR is responsible for intercellular Ca
2+
 signal 
spreading and for the generation of Ca
2+
 waves capable of coordinating the 
activity of many neighbouring cells (Robb-Gaspers and Thomas 1995; Parkash 
and Asotra 2010). Once Ca
2+ 
has carried out its signalling functions, it is rapidly 
removed from the cytoplasm to return intracellular Ca
2+
 concentration to pre-
stimulation levels by various pumps and exchangers, localized both on plasma 
membrane and ER. These signal terminators include plasma membrane-localized 
Ca
2+
 ATPases (PMCA) and plasma membrane exchangers as the Na
+–Ca2+ 
exchanger (NCX) on cell surface, and the sarco-endoplasmic reticulum ATPases 
(SERCA) on ER. Moreover also mitochondria, through the mitochondrial calcium 
uniporter (MCU) (De Stefani, Raffaello et al. 2011) and Golgi apparatus and 
lysosomes, contribute to maintain intracellular Ca
2+ 
homeostatic levels, through 
the secretory pathway Ca
2+
ATPases (SPCA) (Monteith, Davis et al. 2012; Feng 
and Rao 2013). Interestingly, many recent reports demonstrated deregulation of at 
least one of these Ca
2+ 
signalling toolkit components in human tumour samples, 
thus providing additional evidence for the critical roles of Ca
2+ 
ions in cell 
integrity and function maintenance. The most dysregulated channels identified in 
human tumours are TRPM8, ORAI1 and TRPV6 which are upregulated in 
prostate, breast and colon cancers; SERCA2 is downregulated in lung, colon and 
thyroid tumours and PMCA, whose isoforms are deregulated in breast, lung colon 
and oral neoplasia (Lee, Davis et al. 2011). 
Moreover, ORAI1 and TRPM7 are reported to be overexpressed in human breast 
cancer where they promote tumour cell migration, invasion and metastasis (Chen, 
Chen et al. 2013) and SPCA1 and SPCA2 are upregulated in breast cancer, where 
they accumulate at plasma membrane thus activating ORAI1 and the downstream 
activation of the transcription factor NFAT (Feng, Grice et al. 2010; Grice, Vetter 
et al. 2010). This altered expression or activity of Ca
2+ 
channels and pumps could 
either cause or promote cancers through modulation of Ca
2+
 concentrations in 
cytoplasm, ER, and mitochondria as well as spatio-temporal nature of Ca
2+ 
signalling (Berridge, Bootman et al. 2003). Either the overexpression of proteins 
such as IP3R channels, which can cause an increase in Ca
2+
 leakage from the ER 
thus reducing theCa
2+
 content of the ER Ca
2+ 
stores, or the reduced sequestration 
of Ca
2+
 as a consequence of lower levels of SERCA2 could lead to decrease in the 
apoptotic rates. Therefore, Ca
2+ 
release from the ER and its uptake and 
accumulation into mitochondria play a pivotal role in triggering apoptotic signals, 
and one of the mechanisms through which overexpression of antiapoptotic 
proteins (or ablation of proapoptotic ones) counteracts cell death is the reduction 
in the amount of available Ca
2+ 
in the ER (Rizzuto, Pinton et al. 2003).  
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Figure12. The Ca
2+
 signalosome. In response to a change in their environment, intracellular Ca
2+ 
levels increase and induce changes in cell physiology. Ca
2+
 signals are generated as a result of 
influx from the extracellular space through channels located at the plasma membrane (receptor-
operated channels (ROCs), voltage-operated channels (VOCs), second-messenger-operated 
channels (SMOCs) and store-operated channels (SOCs)) or via release from intracellular stores, 
predominantly through inositol 1,4,5- trisphosphate receptors (InsP3Rs) or ryanodine receptors 
(RyRs). Ca
2+
 channels and pumps are also functionally expressed in lysosomes and the Golgi. Ca
2+
 
signals return to pre-stimulated levels through the concerted action of cytosolic Ca
2+
 buffer 
proteins (CaBPs), mitochondria, ATP-dependent pumps on the intracellular Ca
2+
 stores (SERCA) 
and plasma membrane (PMCA), as well as through the Na
+–Ca2+ exchanger (NCX). Ca2+ is stored 
within the endoplasmic reticulum bound to the low-affinity, high-capacity Ca
2+
 storage protein 
calreticulin (CRT). DAG, diacylglycerol; GPCR, G-protein coupled receptor; PIP2, 
phosphatidylinositol bisphosphate; PLC, phospholipase C; RTK, receptor tyrosine kinase; VDAC, 
voltage-dependent anion channel (Roderick and Cook 2008). 
 
Notwithstanding, among the calcium-related proteins that are altered in cancer 
microenvironment, another family, the S100 proteins, have recently drawn 
oncoimmunologists attention. S100 family comprises more than 25 different 
members, requiring calcium-induced dimer and oligomer formation for their 
functional activity. In addition to acting intracellularly, where they are involved in 
the activation of specific biochemical pathways modulatingcell proliferation, 
survival, differentiation and motility (Santamaria-Kisiel, Rintala-Dempsey et al. 
2006), S100 proteins can be extracellularly secreted, by the activation of protein 
kinase C (Rammes, Roth et al. 1997), and act as chemo-attractants by actively 
promoting phagocyte migration (Ryckman, Vandal et al. 2003). Additionally, 
S100A8 and S100A9 are presumed to bind to the pathogen-recognition receptors 
(PRRs), including the toll-like receptor 4 (TLR4), the formyl-methionine 
receptors, and the receptor for advanced glycation end-products (RAGE); the 
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evidence that S100A9 is also apotent activator of various neutrophil functions, 
such as degranulation and phagocytosis, further support the S100 protein role as a 
danger-associated molecular patterns (DAMP) (Simard, Girard et al. 2010). Since 
their involvement in chronic inflammation, S100A8 and S100A9 have been also 
implicated in tumour development and progression (Gebhardt, Nemeth et al. 
2006) and are currently being explored in the clinic as potential diagnostic 
markers or therapeutic targets, as enhanced expression of S100A8/A9 is 
associated with poor prognosis (Arai, Takano et al. 2008). Although the 
S100A8/A9 molecular function in growing tumours remains uncertain, the 
increased S100 protein expression in tumour-infiltrating myeloid cells in many 
epithelial tumours (Gebhardt, Nemeth et al. 2006; Salama, Malone et al. 2008) 
suggested that these proteins contributed to the activation and accumulation of 
MDSCs during the induction of tumour-immune tolerance (Sinha, Okoro et al. 
2008), and to the inhibition of DC and macrophage differentiation (Cheng, Corzo 
et al. 2008). Moreover, S100A8/A9 binding to the RAGE receptor on colon 
tumour cells stimulates NF-kB signalling and activates the transcription of genes 
such as CXCL1 (GROa/KC), CCL2 (MCP-1), CCL5 (RANTES), and CCL7 
(MCP-3) whose expression strongly promotes tumour growth, migration, 
invasion, and metastatic progression (Lukanidin and Sleeman 2012). Finally, 
recent reports showed that S100A8 and S100A9 induce the secretion of several 
pro-inflammatory cytokines, including IL-6, TNFα, and IL-1β by stimulating the 
production of ROS in human PBMCs, which, in turn, activate the transcription 
factor NF-kB, leading to cytokine secretion and expression and activation of the 
NLRP3 inflammasome (Simard, Cesaro et al. 2013). Inflammasomes, which are 
multiprotein complexes operating as activation platforms for caspase-1, may have 
contrasting roles in tumourigenesis since they positively affect cell-autonomous 
death pathways and anticancer immunosurveillance, but they also stimulate 
autocrine or paracrine processes that favour carcinogenic inflammation, tumour 
growth, metastasis and angiogenesis (Zitvogel, Kepp et al. 2012). Therefore, 
intracellular Ca
2+
 pumps and channels, but also extracellular calcium-activated 
proteins, as S100, may play crucial role in tumour progression and antitumour 
immunity, and require further investigation representing potential effective targets 
for novel successful therapeutic approaches. 
 
Photodynamic therapy and antitumour immunity 
The increasing incidence of cancer and the insistent need for the development of 
more effective therapies with minimal side effects have prompted studies to find 
alternative new treatments. Among new therapies, photodynamic therapy (PDT) 
appears as a promising modality in cancer treatment with the lowest rates of side 
effects. PDT involves two individually non-toxic components that are combined 
to induce cellular and tissue effects in an oxygen-dependent manner. The first 
component of PDT is a photosensitizer (PS), a systemically (intravenously) or 
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topically administered light-sensitive molecule that, after a specific time interval 
for distribution, localizes more or less specifically to neoplastic tissue (Dolmans, 
Fukumura et al. 2003). The mechanisms by which the PS selectively accumulates 
in tumours are complex and not fully understood. It is presumably because of the 
lack of lymphatic drainage and the high vascular permeability of the agents across 
a favourable leaky vasculature, as well as their affinity for proliferating 
endothelium within the tumour stroma. Moreover, the presence of TAMs and the 
acidic pH of tumour stroma promote the selective uptake of PS by cancer cells 
(Dougherty, Gomer et al. 1998). The second component of the PDT is light of a 
specific wavelength, which locally activates the PS. PS activation induces 
photochemical and photophysical phenomena, marked by the energy transfer to 
the nearby oxygen, locally generating ROS, as singlet oxygen, hydroxyl radical, 
and superoxide anions (Portilho, Cavalcanti et al. 2013). More specifically, 
following the absorption of light (photons), one of the two electrons with opposite 
spins in the low energy molecular orbital (this is known as singlet state) of the 
ground state PS is boosted into a high-energy orbital keeping its spin (first excited 
singlet state). This is a short-lived (nanoseconds) species and can lose its energy 
by emitting light (fluorescence) or by internal conversion into heat. Alternatively, 
this excited singlet state PS may also undergo the process known as intersystem 
crossing whereby the spin of the excited electron inverts to form the relatively 
long-lived (microseconds) excited triplet-state that has electron spins parallel. The 
long lifetime of the PS triplet state is explained by the fact that the loss of energy 
by emission of light (phosphorescence) is a „„spinforbidden‟‟process as the PS 
would move directly from a triplet to a singlet state. Additionally, the excited 
triplet state PS can induce chemical changes in a neighbouring molecule via two 
main pathways, called type-I and type-II photochemical reaction. Firstly, in a 
type-I reaction, activated triplet state PS can react directly with other adjacent 
molecules and transfer a proton or an electron to form a radical anion or radical 
cation, respectively, which may further react with molecular oxygen or NO
-
 to 
produce ROS and RNS, respectively. Alternatively, in a type-II reaction, the 
triplet PS can transfer its energy directly to molecular oxygen (itself a triplet in the 
ground state), to form excited state singlet oxygen (Plaetzer, Krammer et al. 
2009). 
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Figure13. Graphical illustration of the photophysical and photochemical mechanisms of PDT 
Both type-I and type-II reactions can occur simultaneously, and the ratio between 
these processes depends on the type of PS used, the concentration of substrate and 
oxygen (Castano, Demidova et al. 2004). As a result of these photoreactions, 
cellular organelles and membranes are subjected to a so-called photodamage, 
whose extent and cytotoxicity depends on several independent factors: the type of 
PS, its extracellular and intracellular localization, the total dose administered, the 
total light exposure dose (the total energy of exposed light across a sectional area 
of irradiated spot, expressed in J/cm
2
), the light fluence rate (the radiant energy 
incident per second across a sectional area of irradiated spot, expressed in 
W/cm
2
), the oxygenation state of the tissue and the time between the 
administration of the drug and light exposure (Dolmans, Fukumura et al. 2003). 
However, the anti-cancer effects of PDT are thought to occur at two different 
levels: direct lethal effects on tumour cells and vascular impairment that limits 
blood supply to the region (Dougherty, Gomer et al. 1998). The direct PDT effects 
on tumour cells  result in activation of both apoptosis, which may occur via either 
extrinsic or intrinsic pathway, and necrosis (Castano, Demidova et al. 2005). 
Crucial determinants for the type of cell death after PDT are cell type, subcellular 
localization of the PS, and the light dose applied. In general, lower doses are 
reported to induce apoptosis, while higher doses lead to necrosis (Plaetzer, 
Kiesslich et al. 2002). Nevertheless, several studies reported the induction of 
apoptosis after PDT, through the involvement of the death receptor FAS and its 
ligand FASL and subsequent activation of caspase-8 activation (Ahmad, Gupta et 
al. 2000; Yokota, Ikeda et al. 2000; Ali, Chee et al. 2002). However, also loss of 
mitochondrial membrane potential and structural integrity were demonstrated to 
be involved in apoptosis induction upon PDT via cytochrome c release and 
caspase-9 activation (Kim, Luo et al. 1999; Grebenova, Kuzelova et al. 2003; 
Almeida, Manadas et al. 2004). Notably, the targets of PDT also include the 
microvasculature of the tumour bed, as well as normal microvasculature, and the 
inflammatory and immune host system. Singlet oxygen causes, infact, 
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microvascular acute injury and blood vessel blockage in tumour, enhancing 
apoptosis of tumour cells because of the reduction of blood supply, besides tissue 
oxygen consumption (Portilho, Cavalcanti et al. 2013). Moreover, since PDT 
response involves apoptosis induction and microvasculature alteration, it has been 
suggested that the intrinsic level of tumour NO may be a determinant in the 
response to PDT, enhancing apoptosis, reducing ischaemia-reperfusion injury and 
impairing immune response (Reeves, Reed et al. 2009). However the NO role in 
PDT is still a matter of debate since different studies have shown conflicting 
results. On one hand, tumours generating low levels of NO are reported to be 
much more sensitive to PDT than those containing high levels of NO, and the 
administration of the NOS inhibitor with PDT treatment, enhanced tumour 
regression (Korbelik, Parkins et al. 2000), while pre-incubation of cells with NO 
donors or L-arginine decreased cell death induced by photosensitization (Gomes, 
Almeida et al. 2002). On the other hand, NO positively participates in the events 
associated with PDT-mediated tumour destruction, particularly in the vascular 
response. High NO levels may, infact, maintain vessel dilation during PDT 
treatment, resulting in increased tumour oxygenation, thereby enhancing the 
oxygen-dependent generation of phototoxic damage, thus promoting tumour 
regression (Korbelik, Parkins et al. 2000). Moreover, NO participate in 
modulating antitumour immunity upon PDT treatment (Kawczyk-Krupka, Czuba 
et al. 2011). PDT may play, infact, a significant role in modulating antitumour 
immune response, which may be both immunostimulatory and 
immunosuppressive (Castano, Mroz et al. 2006). Several reports demonstrated 
that PDT induces the upregulation and extracellular release from necrotic tumour 
cells of the heat shock protein Hsp70 that, once induced in stress conditions, 
remains intracellular to chaperone unfolded protein and prevent cell death. 
Extracellular HSP70 binds to high-affinity receptors expressed on the surface of  
antigen presenting cells (APC), thus promoting DCs activation and maturation, 
which allow cross-presentation of antigen cargo of HSP70 by the APCs to CD8
+
 
cytotoxic T cells (Todryk, Melcher et al. 1999).  
Additionally, other studies demonstrated that PDT promotes overexpression of 
HSP family members, such as HSP47and HSP60 (Hanlon, Adams et al. 2001; 
Verrico, Haylett et al. 2001). Moreover, many reports showed increased serum 
levels of inflammatory cytokines, such as IL-6, IL1β, IL-10 and IL-8, and local 
recruitment of neutrophils, mast cell and monocytes after PDT, thus enhancing 
antitumour immunity (Castano, Mroz et al. 2006). Conversely, PDT was also 
reported to induce cell death mainly in activated lymphocytes (Jiang, Granville et 
al. 2002). 
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Figure14. Photodynamic therapy induces activation of antigen-specific T cells. When light 
(hν) is delivered to a photosensitizer (PS)-loaded tumour it induces both apoptotic and necrotic cell 
death. These cells are phagocytosed by dendritic cells (DCs) that have accumulated owing to the 
acute inflammatory response triggered by photodynamic therapy (PDT). DCs mature after 
stimulation by cytokines, which are released at the site of inflammation, and home to the regional 
lymph nodes where they present antigens to the T lymphocytes. Activated T lymphocytes become 
effector T cells and, attracted by chemokines, migrate to the tumour and kill the tumour cells 
(Castano, Mroz et al. 2006). 
 
Notably, PDT induce nuclear translocation of the transcription factor NFκB, thus 
promoting inflammatory cytokines secretion (Ryter and Gomer 1993). Since its 
immunomodulating properties, PDT was also tested in combinatorial settings with 
microbial adjuvant (Korbelik, Sun et al. 2001), exogenous cytokines 
administration (Golab, Wilczynski et al. 2000) and adoptive cell therapy (ACT) 
with immature DCs (Jalili, Makowski et al. 2004; Saji, Song et al. 2006), showing 
very promising results. Notwithstanding, to date PDT is not widely employed, 
particularly in countries with well-developed infrastructure for cancer care. 
However, starting from the 1980s, Photofrin
®
, a hematoporphyrin derivative, has 
achieved regulatory approval in North and South America, Europe and Asia for 
treatment of tumours in almost all anatomic sites. Amino levulonic acid (ALA) 
has been commercially formulated for topical, oral or intravenous introduction for 
treatment of deeper-seated lesions of the head and neck, lung or esophagus in 
North and South America, Europe and Asia. Foscan
®
, a chlorine-based PS, is 
approved in Europe, South America and Asia for squamous cell cancers of the 
head and neck that have failed prior therapy. Thanks to the development of novel 
optic fibers that may be used to drive light to tumours of the cavities, many 
clinical trials are running for clinical translation of PDT to successful treatment of 
pulmonary, gastrointestinal and genitouninary tract tumours (Allison 2014).  
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Aim of the study 
 
Cell death and the bystander effect are crucial for both the efficacy of cancer 
therapy and the modulation of anti-tumour immune response. Photodynamic 
therapy (PDT), a form of therapy based on light-sensitive compounds, which are 
not toxic unless locally photoactivated, provides the opportunity to investigate 
intercellular communication networks among bystander cells. Although various 
mediators and pathways have been suggested to mediate cell–cell communication 
and death signals propagation, to date it is not known which are the key molecules 
and crucial cellular mechanisms involved for the paucity of studies focusing on 
the three-dimensional tumour mass. Among the molecules reported to be 
involved, nitric oxide (NO) and reactive nitrogen species (RNS) appear to be 
instrumental for cancer therapy success. In fact, NO and RNS act as a double 
edged sword in cancer biology: depending on the location, amount, and duration 
of release, in fact, NO can either kill or sustain proliferation of tumour cells. So 
far, few methods such as chemiluminescence and spectroscopy have been applied 
for NO tracking, however they suffer from low spatial resolution and, in some 
cases, require complicated instrumentation.  
Therefore, the primary aim of this study was to investigate and characterize the 
cell signals responsible for bystander effect occurring upon PDT within the intact 
tumour microenvironment, paying particular attention to NO. To this purpose a 
focal PDT approach focused on one single cell was exploited on tumour-bearing 
mice in which dorsal skinfold window chambers were surgically implanted. 
Intravital microscopy on tumour-bearing mice allows to image clearly individual 
cells, including tumour, stromal and immune cells, disclosing in real time the 
dynamics of cell communication after PDT. Instrumental for the study was the 
setting of a valuable tool to dynamically monitor in real-time intracellular NO by 
fluorescence microscopy on live animals and cell cultures. Since nitric oxide 
synthase (NOS) enzymes activity may be modulated by intracellular calcium 
concentration depending on the specific NOS isoform involved, to characterize 
deeper the molecular mechanisms triggered by PDT intracellular calcium level 
variations were also investigated. Moreover, the involvement of gap junctions and 
connexins in PDT bystander effect was evaluated. 
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Materials and methods 
 
Animals and surgical procedures for intravital microscopy 
Adult male BALB/c (27-30 grams) mice were purchased from Charles River 
Laboratories (Calco, Italy). All mice were maintained under specific pathogen-
free conditions in the animal facilities of the Venetian Institute of Molecular 
Medicine, and experiments were performed according to state guidelines and 
approved by the local ethics committee. Dorsal skinfold window chambers 
(DSWC) were surgically implanted into the backs of mice as follows and entire 
implantation procedure was conducted within a laminar flow hood to preserve a 
sterile field. Mice were anesthetized with Ketamine/Xylazine i.p. at a dose of 
80mg/kg Ketamine and 5mg/kg Xylazine and maintained at 38° C on a steel 
heating plate. Both chamber pieces containing a round window were placed on the 
mouse dorsal skin, tightened together by the appropriate screws and finally 
sutured to the skin by non-absorbable monofilament sutures. An area of 10 mm 
diameter circle of cutaneous tissue was carefully cut away from the skin fold 
inside the DSWC window, exposing the blood vessels of the subcutaneous tissue 
adjacent to the striated muscles of the opposing skin fold by ophthalmic scissors. 
Then, a 12-mm round glass coverslip was placed in the chamber to cover the 
exposed tissue and secured with a snap C-ring. A more detailed procedure can be 
found in (Huang, Shan et al. 1999; Roberts and Lin 2004). After surgery mice 
were treated twice a day for 3 days with Tramadol i.m. at a dose of 10mg/kg/die 
and finally tumour cells were dropped within the chamber. Therefore, the C-ring 
and glass cover slip was temporarily removed from the chamber and the single 
cell suspension was injected s.c. into the opposing fold of skin. Mice were 
checked daily for general health as well as for vessel formation/tumour 
progression and chamber-skin interaction. At day 5-7 of tumour growth, the 
tumour-bearing mouse was anesthetized with ketamine/xylazine (80mg/kg and 
5mg/kg) and prepared for PDT treatment and intravital microscopy. 
Cell culture and tumour injection  
C26GM mouse colon carcinoma cell line was derived from C26 colon carcinoma 
(H-2
d
) genetically modified to release GM-CSF. Briefly, GM-CSF cDNA 
obtained by RT-PCR from ConA-stimulated murine blasts was cloned into the 
LXSN retroviral vector, and used to infect C26 cells, as previously described 
(Bronte, Serafini et al. 2003). C26GM cells were grown in DMEM (Invitrogen), 
supplemented with 2mM L-glutamine, 10mM HEPES, 50µM 2-Mercaptoethanol, 
150U/mL streptomycin, 200 U/mL penicillin, and 10% heat-inactivated FBS 
(Gibco). For tumour challenge, 0.5 x 10
6
 C26GM cells were labeled with 5µM 
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Carboxyfluorescein diacetate succinimidyl ester (CFDA-SE, Molecular Probes) 
and injected in a total volume of 20µl s.c. into the DSWC. For in vitro studies, 
1.5-2.0 x 10
5 
C26GM were plated on 12-mm round glass coverslips into 24-well 
culture plates. 
 
In vivo photodynamic therapy and intravital microscopy 
Aluminum phthalocyanine chloride (AlPC) (Sigma) was dissolved in dimethyl 
sulfoxide (Sigma) at 10mM and kept in the dark. Five days after tumour cell 
challenge, mice were anesthetized with Ketamine/Xylazine i.p. at a dose of 
80mg/kg Ketamine and 5mg/kg Xylazine and maintained at 38°C on a steel 
heating plate under an upright microscope with the window opening facing the 
objective lens. Then mice received an intratumoural microinjection of 20µM 
AlPC diluted in DMEM, by a glass micropipette and after one hour of incubation, 
subjected to focal PDT. For focal photosensitization, the output of a 671 solid 
state laser was injected into a permissive fibre optic cable (62.5μm core, 
Thorlabs), whose output was projected onto the specimen plane by an aspheric 
condenser lens (20mm effective focal length, Thorlabs) and the re−collimated 
beam was directed onto a dichromatic mirror (650 shortpass, Chroma) placed at 
45° just above the objective lens of the microscope. By carefully adjusting the 
position of the fiber in front of the aspheric lens we projected a sharp image of the 
illuminated fiber core (spot) onto the specimen focal plane selected by the 
(infinity corrected) objective lens. For focal PDT treatment, an irradiation time of 
60 sec was used to deliver 0.06mW/µm
2
 of light (Power = 5 mW centered on a 
circular area of 80µm
2
) from a 671 nm solid state laser, using a 40x water 
immersion objective (NA1.15, UApoN340, Olympus) connected to a microscope 
(BX51, Olympus) equipped with a spinning disk unit (DSU, Olympus). For 
intravital microscopy, tumour mass was incubated with AlPC 20µM and co-
loaded for 60 min with Fura-2 AM 30µM (Molecular Probes) by micro-injection 
with a glass micropipette. The incubation medium contained also pluronic F–127 
(0.01% w/v), and sulphinpyrazone (250µM) to prevent dye sequestration and 
secretion. AlPC-Fura-2 loaded tumour was alternately illuminated by light from a 
365 nm and 385 nm LEDs, directed onto the sample through a DM480HQ 
dichromatic mirror (Chroma) and fluorescence emission was selected at around 
510 nm using an interference filter (BA495-540HQ, Chroma). Images were 
recorded on a sCMOS camera (PCO.Edge) at a rate of 1 couple of frame per 
second, with 200ms exposure time/frame. Signals were measured as dye emission 
ratio changes, ∆R = R(t) − R(0), where t is time and R(t) is emission intensity 
excited at 360 nm divided by the intensity excited at 380 nm, and R(0) indicates 
pre−stimulus ratio. For NO detection, after one hour AlPC incubation, tumour was 
loaded with the fluorescent probe selective for NO, 2-{4,5-Bis[(6-(2-ethoxy-2-
oxoethoxy)-2-methylquinolin-8-ylamino)methyl]-6-hydoxy-3-oxo-3H-xanthen-9-
yl}benzoic acid FL (CuFL) (Lim, Xu et al. 2006) at the final concentration of 
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40 M (Strem Chemicals) and AlPC-CuFL loaded cells were excited by light from 
a collimated 470 nm LED (M470L2–C1, Thorlabs) for 200 ms. Signals were 
measured as relative changes of fluorescence emission intensity (ΔF/F0), where F0 
is prestimulus fluorescence, F is fluorescence at post–stimulus time t and ΔF = F – 
F0. 
In vitro PDT, ratiometric calcium imaging and NO imaging  
C26GM cell cultures were incubated with AlPC 10 µM and co-loaded with Fura-2 
AM 15 µM (Molecular Probes) for 60 min at 37° in DMEM containing pluronic 
F–127 (0.01%, w/v), and sulphinpyrazone (250 µM). For NO detection, after one 
hour of AlPC and Fura-2 incubation, cells were loaded with CuFL 20 µM for 20 
min at room temperature. C26GM cells were then transferred to the stage of an 
upright wide–field fluorescence microscope and continually superfused with an 
extracellular medium containing NaCl 150mM, KCl 5mM, MgCl2 1mM, Sodium 
Pyruvate 2mM, Hepes−NaOH 10mM, D−glucose 5mM (pH 7.2, 310 mOsm). 
When present, CaCl2 was added at the final concentration of 1mM. AlPC-Fura-2-
CuFL co-loaded C26GM cells were alternately illuminated by light from a 365 
nm and 385 nm LEDs for Fura-2 and 470 nm LED for CuFL. The same objective, 
filter settings and PDT parameter of in vivo PDT approach were used for in vitro 
experiments. Images were recorded at a rate of 1 couple of frame/second for Fura-
2 and 1frame/second for CuFL, (camera exposure time 50ms/frame). Experiments 
with EGTA (adjusted to pH 7.3 with NaOH), U73122 and Flufenamic Acid 
(FFA)(Sigma-Aldrich) were performed by adding the reagents in extracellular 
medium bath at room temperature. For NOS inhibition, L- NAME (Tocris) was 
diluted in culture medium, incubated overnight and cells were maintained in 
solution supplemented with the inhibitor for all steps of the experiments. 
Real-time live cell imaging of apoptosis 
AlPC incubated C26GM were loaded only with Fura 2 for focal PDT treatment, as 
previously described. After photosensitization, ,pSIVA-IANBD and Propidium 
Iodide (Imgenex) were added directly to the extracellular medium enriched with 
CaCl2 to the final concentration of 2.5 mM.. Cells were imaged by time lapse 
microscopy of the same field of view. pSIVA-IANBD fluorescence was excited 
by light from a collimated 470 nm LED (M470L2, Thorlabs), through a 
DM480HQ dichromatic mirror (Chroma) and fluorescence emission was selected 
at around 510 nm using an interference filter (BA495-540HQ, Chroma), whilst 
Propidium Iodide was illuminated by a 535 nm LED, through a DM560 
dichromatic mirror (Chroma), and fluorescence emission was collected by a 
590LPV2 emission filter. 
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Focal photostimulation with caged IP3 
For focal photostimulation with caged IP3, the output of a Transistor–Transistor 
Logic-controlled laser diode (10 mW, 375 nm; Power Technology,) was injected 
into a UV permissive fibre optic cable (multimode step index 0.22 N.A., 105 µm 
core, Thorlabs). Fibre output was projected onto the specimen plane by an 
aspheric condenser lens (20 mm effective focal length, Thorlabs) and the 
re−collimated beam was directed onto a dichromatic mirror (400 dclp, Chroma) 
placed at 45° just above the objective lens of the microscope. C26GM cells were 
loaded with 5µM caged IP3 AM, 10-µM Fura Red-AM, pluronic F–127 (0.01% 
w/v), and sulphinpyrazone (250µM) and incubated for 60 min at 37°. Then, cells 
were loaded with CuFL 20µM for 20 min at room temperature. Fura Red-AM and 
CuFL fluorescence was excited by a 470 LED, through a dichromatic mirror (400 
dclp, Chroma) and detected using a dichroic beam splitter 585 DCXR (Chroma) 
and an emission filter 660/50 nm and 535/30 nm, respectively. Cultures were 
observed with a 60x water immersion objective (N.A. 1.0, Fluor; Nikon), and 
emission was monitored with a sCMOS camera (PCO.Edge). 
qRT-PCR 
mRNA was extracted from C26GM cultured cells using RNAeasy kit (Qiagen). 
cDNA was obtained by reverse transcription of mRNA with random hexamers 
and ThermoScript RT-PCR system (Life technologies) according manufacturer 
instruction. qPCR was performed on cDNA to amplify Cx26, Cx30, Cx30.3, 
Cx40, Cx43, NOS1, NOS2 and NOS3 and was normalized to GAPDH expression. 
Amplification was carried out using SYBER Green (Applied Biosystems) on the 
ABI 7700 sequence detection system equipped with ABI Prism 7700 SDS 
software (Applied Biosystems) through the following amplification cycles: 
50°C: 2 min  
95°C: 10 min 
95°C: 15sec , 60°C: 1 min (40 cycles) 
For Real-Time PCR the following primers were used: 
Cx26f: 5‟−CGG AAG TTC ATG AAG GGA GAG AT −3‟ 
Cx26r: 5‟−GGT CTT TTG GAC TTT CCT GAG CA −3‟ 
Cx30f: 5‟− GTC ATC GGT GGC GTG AAC AAG CAC −3‟ 
Cx30r: 5‟− GAG CAG CAT GCA AAT CAC GGA TGC −3‟ 
Cx30.3f: 5‟− TCA AAC ATG GGC CCA ATG −3‟ 
Cx30.3r: 5‟− GGG AGT CAC AGA GCA AGC −3‟ 
Cx40f: 5‟− CTG TCC CCA CCC AGT CAA CT −3‟ 
Cx40r: 5‟− CCG TTT GTC ACT ATG GTA GC −3‟ 
Cx43f: 5‟− TAC CAC GCC ACC ACC GGC CCA −3‟ 
Cx43r: 5‟− GGC ATTTTGGCTGTCGTCAGGGAA −3‟ 
NOS1f: 5‟−TCA AAG CCA TCC AGC GCA TA −3‟ 
NOS1r: 5‟− TGG TAC CGG TTG TCA TCC CT −3‟ 
NOS2f: 5‟− GAC ATT ACG ACC CCT CCC AC −3‟ 
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NOS2r: 5‟− ACT CTG AGG GCT GAC ACA AG −3‟ 
NOS3f: 5‟− GGG AAA GCT GCA GGT ATT TG −3‟ 
NOS3r: 5‟− CTG TGA TGG CTG AAC GAA GA −3‟ 
GAPDHf: 5‟−ATG TGT CCG TCG TGG ATC TGA C−3‟ 
GAPDHr: 5‟−AGA CAA CCT GGT CCT CAG TGT AG−3‟ 
Connexin and NOS mRNA expression relative to GAPDH was performed using 
the ΔΔCT method . 
Electrophysiology and fluorescence imaging 
Vf2.1.Cl (Miller, Lin et al. 2012) was provided by Roger Y. Tsien (University of 
California, San Diego). For voltage imaging, C26GM cell cultures were incubated 
for 15 min at 37°C in extracellular medium (see above) supplemented with 
Vf2.1.Cl (200nM) and pluronic F–127 (0.1% w/v), thereafter cultures were 
continually superfused with extracellular medium. Vf2.1.Cl fluorescence was 
excited by light from a 470 nm LED (M470L2, Thorlabs) passing through a 
BP460–480 filter (Olympus) and directed onto the sample through a 515 dcxr 
dichromatic mirror (Chroma) while Vf2.1.Cl fluorescence emission was selected 
by an ET535/30M filter (Chroma). All fluorescence images were formed by a 60x 
water immersion objective (NA 1.0, Fluor, Nikon) and projected on a sCMOS 
camera (PCO.Edge) controlled by software developed in the laboratory. Image 
sequences of Vf2.1.Cl fluorescence were acquired continuously at 10 frames per 
second with 100 ms exposure time. To synchronize image acquisition and 
electrical recordings, we sampled the 5 V pulse (FVAL) that signals active 
exposure of the CCD camera Vf2.1.Cl signals were measured as relative changes 
of fluorescence emission intensity (ΔF/F0), where F0 is prestimulus fluorescence, 
F is fluorescence at time t and ΔF = F – F0 (Ceriani and Mammano 2013) 
Immunofluorescence and confocal microscopy 
C26GM cells, treated or not with AlPC, were fixed in 4% paraformaldehyde for 
20 min at room temperature, rinsed in phosphate buffered saline (PBS), and 
permeabilized with 0.1% Triton X–100, dissolved in bovine serum albumin 
(BSA) 1% solution and incubated with anti NOS (1:200, Santa Cruz), anti NOS2 
(1:200, Abcam), anti NOS3 (1:200, BD transduction laboratories), anti 
Cytochrome C (1:200, BD Pharmingen). The appropriate AlexaFluor488-
conjugated secondary antibodies were used. Nuclei were counterstained with 1 
μg/ml Hoechst 33258 and mounted with ProLong (Invitrogen). Images were 
acquired using a confocal microscope (TCS SP5, Leica) equipped with an oil–
immersion objective (63x HCX PL APO 1.25 N.A., Leica). Laser line intensities 
and detector gains were carefully adjusted to minimize signal bleed through 
outside the designated spectral windows. 
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Data analysis and statistics 
Images, acquired using software developed by Prof. Mammano‟s group, were 
analyzed based on Matlab platform (Release 14, MathWorks, Inc., Natick, MA, 
USA). Specific regions of interest (ROIs), corresponding to different cells located 
at different distance from the PDT-targeted cell, were drawn in order to measure, 
the amplitude, the rate of increase and area under the curve of the fluorescence 
traces of Fura-2 and CuFl signals per single cell. Specifically, amplitude was 
measured as maximal fluorescence variation in response to a specific stimulus,, 
whereas the rate of increase was estimated as the slope of the line tangent to each 
fluorescence trace in the linear range of amplitude response. Statistical 
comparisons of means for paired samples were made by one-way ANOVA test. 
p–values are indicated by letter p and p< 0.05 was selected as the criterion for 
statistical significance. The wave invaded area was computed as the field of view 
fraction where fluorescence levels exceeded an arbitrary threshold, corresponding 
to a 10% increase over the pre-stimulus values for both ratiometric Fura-2, and 
CuFL fluorescence changes. The rate of wave propagation was calculated as the 
slope of the line tangent to each wave invaded area curve in the linear range of 
increase. Statistical comparison between rate of wave propagation was performed 
by using Student‟s t test. In figures, asterisks were used as follows: * p≤0.05; 
**p≤0.01; *** p≤0.001. Pseudocolor images were generated using the hue-
saturation-value (HSV) visualization algorithm: hue was used to represent 
fluorescence changes; value (brightness) carried pixel intensity from a reference 
image that was either updated on a frame-by-frame basis or obtained as an 
average over a specified number of frames; saturation was set to 1.0. Frames so 
constructed were converted to ordinary RGB images by a single call to the Matlab 
library function hsv2rgb, and displayed. 
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Results 
Focal PDT triggers NO and Ca
2+
release within tumour microenvironment  
Radiation-induced bystander effects have become established in the radiobiology 
vocabulary as a bona fide radiation response, however key messengers and 
signalling pathways are only partially characterized. This lack of information 
reflects the paucity of studies focusing on the three-dimensional tumour mass. 
Several reports suggest the involvement of NO and RNS in bystander effects, 
even if no direct evidence of NO release after PDT has been published. 
Chemiluminescence and spectroscopy have been used for NO tracking, however 
these methods suffer from low spatial and temporal resolution and, in some cases, 
require complicated instrumentation.  
Small molecule–based fluorescent probes for NO, including o-
diaminonaphthalene (DAN), o-diaminofluoresceins (DAFs) and o-
diaminocyanines (DACs), are now commercially available, but their changes in 
fluorescence require reactions with oxidized NO products rather than NO itself, 
thus, their fluorescence-response does not necessarily reflect real-time NO 
production. For these reasons, we based our studies on CuFL, a Cu(II) 
fluorescein-based compound which reacts rapidly, is substantially more selective 
for NO compared to other potentially interfering molecules and can be utilized to 
visualize NO production in living cells by fluorescence imaging (Lim, Xu et al. 
2006).  
To single out the key mediators of bystander effects and to define the role of NO, 
dorsal skinfold window chambers (DSCW) were surgically implanted on BALB/c 
mice. Few days after recovery from surgery, 0.5 x 10
6 
C26GM colon carcinoma 
cells were injected into the DSCW. Owing to its GM-CSF secretion and 
aggressiveness (animals are killed by the tumour in less than 2 weeks), the 
C26GM colon carcinoma cell line is suitable for intravital microscopy on DSCW-
bearing mice, where it induces immune cell accumulation at tumour site. Five 
days after tumour challenge, the implanted tumour was co-loaded with the PS 
aluminum phtahlocyanine chloride (AlPC) and fluorescent indicators (CuFl, Fura-
2) by intra-tumour microinjection with a glass micropipettes (see Methods). Mice 
were transferred on the stage of an up-right spinning disk confocal microscope 
and AlPC was activated in a single cell of the tumour mass by focussing 670 nm 
laser light into an 80µm
2 
area (see Methods). We refer to this type of stimulation 
as focal PDT. NO produced by cells within the tumour was monitored by 
intravital microscopy of CuFl fluoresence emission, which raises rapidly when 
NO levels increase and binds irreversibly to this probe (Lim, Xu et al. 2006). As 
shown in Figure1, focal PDT ensued in CuFl increase not only in the irradiated 
but also in a vast population of sorrounding (and, by definition, bystander) cells 
within the tumour microenvironment.  
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Figure1. Focal PDT induces NO release within the tumour microenvironment.  
a. Representative false-color image showing CuFL fluorescence changes (ΔF/F0), encoded as 
shown by the color scale bar, obtained as maximal projection rendering of all frames recorded in  
C26GM tumour, transplanted into the DSWC and imaged for 4 min at one frame per second. After 
10 s of baseline recording, the PS was activated by a 60 s light step from a 670 nm laser focused 
on the white circled cell. (Scale bar, 50 μm.). b. NO fluorecence traces obtained by averaging 
signals within 20 regions of interest (ROIs) corresponding to individual bystander cells at different 
distance from the irradiated one.  
 
Since NOS activation may depend on intracellular Ca
2+
 concentration, which is 
known to modulate a plethora of cellular processes, we took advantage of the 
ratiometric Ca
2+
 indicator Fura-2 to measure intracellular Ca
2+
 level variations. 
Following focal PDT, we observed a rapid increase in intracellular Ca
2+
 
concentration (max ∆R = 40%). Also this type of signal was detected both in the 
irradiated and in bystander cells (Figure2). These data provide direct evidence 
that focal PDT induces NO production from irradiated as well as non-irradiated 
cells, which may release ions, cytokines and other second messengers establishing 
a signalling intercellular network responsible for bystander effects within the 
tissue. Our Fura-2 data suggest that Ca
2+ 
signalling may play an important role in 
these processes. 
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Figure2. Focal PDT induces intracellular Ca
2+
 transients within the tumour mass.  
a. Representative false-color image of Fura-2 fluorescence ratio changes (ΔR), encoded as shown 
by the color scale bar, obtained as maximal projection rendering of all frames recorded in C26GM 
tumour, transplanted into the DSWC. Images were acquired for 4 min at 2 frame per second. After 
30 s of baseline recording, the PS was activated by a 60 s light step from a 670 nm laser focused 
on the white circled cell. (Scale bar, 50 μm) b. Sample traces of Ca2+ responses obtained by 
averaging Fura-2 ratio signals within 20 randomly selected ROIs corresponding to individual 
bystander cells at different distance from the irradiated one.  
 
Bystander effects produced by focal PDT are sensitive to stimulus duration 
The analysis of bystander effects within the whole tumour mass is complicated by 
the presence of different cell populations and the difficulty of performing 
intravital microscopy experiments. In particular, Fura-2 excitation requires short 
wavelengths (360nm and 380nm light sources), which do not penetrate deep into 
the tissues. To circumvent these problems, we performed the same experiments on 
C26GM cancer cell monolayers grown on glass coverslips and co-loaded with 
Fura-2 and CuFL. We used a 3-wavelength sequential excitation protocol (360 
nm, 380 nm, 470 nm) to record both Ca
2+
 and NO signals from the same cell 
population and we analyzed signal correlation under these simplified in vitro 
conditions (Figure3 a, b, c). Analysis of Fura-2 fluorescence traces shows that 
focal PDT induced a rapid raise of intracellular Ca
2+ 
levels in the irradiated cell 
which propagated to all the cells in the field of view within 10 seconds. Of notice, 
this radial intercellular Ca
2+
 wave was followed by a slower wave of NO release 
that progressed from the irradiated cell to the bystander population. To quantify 
these phenomena, the wave invaded area was computed as the field of view 
fraction where fluorescence levels exceeded an arbitrary threshold (corresponding 
to a 10% increase over the pre-stimulus values). We measured this area for 
different values (15, 30 and 60 s) of the time interval during which the targeted 
cell was exposed to light from the 670 nm laser light (light step). Focal PDT 
evoked a Ca
2+
 wave that invaded the whole field of view (corresponding to an 
area of 60  10
3
 µm
2 
) for each one of these light steps (Figure3 a, b, c). As for 
NO, both the rate of area invasion and its extent varied with light step duration 
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(Figure3 d, e, f). Specifically, NO signals evoked by a 15 s light step invaded 
only 50% of bystander cells. With a 30 s step, the intercellular NO wave required 
20 seconds to reach 50% of its maximal invaded area (90%). Finally, a 60 s light 
step promoted a faster NO wave that invaded 50% of the cells within 12 s and 
thereafter propagated to all cells within the analyzed area (Figure3 g, h, i).  
 
Figure3. Focal PDT duration modulates the extent of bystander effects.  
a-c Representative false–color images of Fura-2 fluorescence ratio variations obtained as maximal 
projection rendering of all frames recorded in C26GM cells; laser light was focused on the white 
circled cell for 15 s (a), 30 s (b) and 60 s (c). d-f Maximal projection rendering of CuFL 
fluorescence variation during focal PDT for light steps of 15 s (d), 30 s (e) and 60 s (f); scale bar, 
50 μm. g-i The percentage of field of view invaded by Ca2+ (blue dots) and NO (red dots) 
intercellular waves is shown as function of time for light steps of 15 s (g), 30 s (h) and 60 s (i). 
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NO production is strictly dependent on the distance of bystander cells from the 
irradiated cell 
To maximize the number of NO-producing bystender cells within the field of 
view, for the rest of these experiments we used only 60 s light steps. We spatially 
averaged Fura-2 and CuFl fluorescence signals from regions of interest (ROIs) 
corresponding to individual cells generating families of 
time-dependent fluorescence traces. We then quantified 
both amplitude and rate of increase of Ca
2+
 and NO 
signals in response to focal PDT . Amplitude was 
measured as maximal fluorescence variation, whereas 
the rate of increase was estimated as the slope of the 
line tangent to each fluorescence trace in the linear 
range of amplitude response. We also quantified the the 
area under the trace, which depends on both the signal 
amplitude and the duration of the intracellular signal 
variation. Data analysis shows that intracellular Ca
2+
 concentration increased 
rapidly in bystander cells (Figure4 a) whereas NO production followed a slower 
time course (Figure4 b). For statistical comparison, we divided the field of view 
(total area 60  10
3
 µm
2
) into three concentric regions centred on the irradiated 
cell (Figure S1). The first region, r1, was a circle with a radius of 35µm; the 
second region, r2, was an annulus with an inner radius of 35µm and outer radius 
of 75µm; the third region, r3, was a larger annulus with inner radius of 75µm and 
outer radius of 120µm. In each region, we selected a number of cells proportional 
to the analyzed area (5, 18 and 35 cells respectively within r1, r2 and r3). We then 
pooled and analyzed data from three independent experiments. Amplitudes of 
Ca
2+ 
signals as well as the area under the trace increased at increasing distance 
from the irradiated cell, whereas the temporal rate of signal increase displayed an 
opposite trend (Figure4 c). In the case of NO, all three parameters decreased at 
increasing distance from the irradiated cell (Figure4 d). These data support the 
notion that bystander cells actively participate in the spreading of the PDT 
response, as intracellular Ca
2+
 concentration and NO production may be detected 
also at distant site from the targeted cell. The mechanism underpinning this 
crosstalk, however required further investigations. 
Figure S1. Scheme 
depicting the analyzed 
areas r1, r2, r3. 
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Figure4. NO release is strictly dependent on the distance from the targeted cell. 
Representative false–color images and sample traces of Fura-2 (a) and CuFL (b) fluorescence 
variations induced by 60 second-focal PDT, (30 sec baseline recording). Box plots showing 
distribution of amplitude, rate of increase and area under the trace of Ca
2+ 
(c) and NO (d) signals in 
cells located within the areas r1,r2 and r3. Data in (c) and (d) were pooled from three independent 
experiments. Asterisks indicate significant differences between data distributions *, p ≤ 0.05; **, 
p≤ 0.01; ***, p ≤ 0.001 (Anova test).  
 
NO signals evoked by PDT are likely due to constituive NOS  
The correlation between intracellular Ca
2+ 
transient and NO production evoked by 
PDT raised the hypothesis that NO might be the product of  NOS enzymes. Only 
constitutive NOS1 and NOS3 activity is considered calmodulin/Ca
2+ 
dependent. 
However several reports demonstrated NOS2 positivity in human tumour samples, 
including colon cancers. Therefore we performed mRNA analysis to identify the 
NOS isoforms expressed by the C26GM cell line. We detected low absolute 
mRNA levels of all three isoforms (particularly low in the case of NOS2) and the 
highest signal corresponded to NOS3 (Figure5 a). To corroborate these findings, 
NOS expression was tested at the protein level by confocal immunofluorescence 
imaging using an antibody that cross-reacts with all three isoforms (Figure5 b). 
Using specific antibodies for NOS2 and NOS3, we verified that the NOS3 signal, 
albeit weak, is clearly detectable (Figure5 c, d).  
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Figure5. C26GM cells show low levels of NOS. a. Total RNA was isolated from C26GM and 
qRT-PCR for NOS1, NOS2 and NOS3 content was performed. Data, reported as relative 
abundance, are normalized to NOS3. GAPDH was used as internal control. .Confocal images of 
C26GM colon carcinoma cells immunostained for total NOS protein (b), NOS2 (c) and NOS3 (d) 
(green fluorescence). Nuclei were counterstained with Hoechst (blue). (Scale bar, 25 µm) 
 
We further tested NOS involvement in PDT bystander responses using the cell-
permeable NOS inhibitor L-N
ω‑nitro‑L‑arginine methyl ester (L-NAME), a more 
soluble analogue of L-arginine. After overnight incubation with 1µM L-NAME, 
focal PDT was performed as described above. This inhibitor significantly reduced 
bystander NO release, which showed lower amplitudes and slower rate of signal 
increases (Figure6 a-h). In the presence of L-NAME, the NO wave was delayed 
with respect to the control, whereas the Ca
2+ 
wave was nearly unaffected (Figure6 
i). However Ca
2+ 
signal amplitude and rate of signal increase were reduced by 
treatment with L-NAME (Figure6 e, g), suggesting that a positive feedback 
mechanism links NO production to the increase of intracelluar Ca
2+
 levels 
promoted by PDT. In central neurons, NO has been recently demonstrated to 
directly activate ryanodine receptors (RyRs), which mediate Ca
2+ 
release from 
intracellular stores (Kakizawa, Yamazawa et al. 2012). Our results therefore 
suggest that NO increase following PDT in tumour cells may trigger a Nitric 
Oxide Induced Calcium release (NICR) mechanism similar to that involved in 
NO-induced neuronal cell death (Kakizawa, Yamazawa et al. 2012).  
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Figure6. PDT triggers NOS activation. Representative false–color images of Fura-2 and CuFL 
fluorescence variations, encoded as shown by the color scale bars, induced by focal PDT in either 
control (a, b) or L-NAME-treated (c, d) C26GM cells (scale bar, 50 μm). Ca2+ and NO signal 
amplitude (e, f) and rate of increase (g, h) in control or L-NAME-treated C26GM cells . Data were 
pooled from three independent experiments. Asterisks indicate significant differences between 
data distributions (*** p≤0.001, Anova test). i. Area invaded by Ca2+ and NO waves vs. time 
(mean ± s.d.) for C26GM cells incubated or not with L-NAME. Red asterisks indicate significant 
differences between the rates of NO wave propagation in control or L-NAME treated cells. (*** 
p≤0.001, Student‟s t test).  
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PDT-induced bystander effects trigger apoptosis via cytochrome c release 
Both Ca
2+ 
and NO are reported to be involved in the induction of apoptosis. 
Indeed, the loss of Ca
2+
 homeostasis may lead to cell injury as well as high levels 
of NO/RNS which, through modifications of death-related target proteins, mediate 
inhibition of cellular respiration, thus affecting mitochondrial membrane 
permeability, finally leading to cytochrome c release and initiation of apoptosis 
(Leon, Jeannin et al. 2008). PDT has been indeed demonstrated to trigger both 
apoptosis and necrosis. (Castano, Demidova et al. 2005). Thus, we performed 
focal PDT with AlPC and we evaluated the expression of specific apoptotic 
markers. In particular, we used pSIVA, an annexin-based, polarity sensitive probe 
for the spatiotemporal or kinetic analysis of apoptosis (Kim, Chen et al. 2010). In 
these experiments, we monitored only Ca
2+
 (with Fura-2) and not NO due to  the 
overlap between CuFL and Psiva fluorescence emission spectra. After focal PDT, 
we added pSIVA and propidium iodide (PI) to the extracellular medium. 
Fluorescence images were acquired every 30 min (1 frame for pSIVA and 1 frame 
for PI). The irradiated cell displayed a clearly detectable pSIVA signal afters 30 
min (data non shown). Within 1 hour following PDT, both pSIVA and PI signals 
were detected in the irradiated cell and its nearest neighbours; thereafter the 
signals propagated to more remotely located bystander cells (Figure7). By 4 
hours about 40% of cells has at least entered apoptotic cell death. No toxic effects 
were observed in control experiment, in which the PS AlPC was loaded but not 
photoactivated. These data demonstrate that unless photostimulated, the PS is not 
able to trigger any Ca
2+ 
wave (Figure7). As internal positive control of the 
staining, control cells were treated with staurosporine, a well known apoptosis 
inducer (20 µM, 2 hour incubation) after 4 hours of recording (Figure7 e). 
Altogether, these results support the notion that PDT promotes bystander cell 
death and suggest that these effects may contribute significantly to the efficacy of 
PDT in cancer treatment.  
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Figure7. Photosensitization induces an “apoptotic death-wave”. a. Representative false–color 
images of Fura-2 fluorescence ratio variation during focal PDT in AlPC-treated C26GM cells 
either non-photostimulated (ctrl) or photosensitized (PDT). Fura-2 fluorescence ratio variation is 
encoded as shown by the color scale bar. Time-lapse microscopy was used to monitor apoptosis by 
real-time detection of phosphatidylserine externalization in C26GM cells subjected (PDT) or not 
(ctrl) to focal PDT. Representative color-merged images of C26GM cells; propidium iodide 
fluorescence (red) and pSIVA fluorescence (green) at the indicated time (h, hours) following or 
not focal PDT. As an apoptosis positive-control, cells were incubated with Staurosporine  (e, 
upper image). Scale bars, 50 μm. 
 
Several studies of apoptotic cell death induced by PDT claimed the involvement 
of both the extrinsic or intrinsic pathway (Castano, Demidova et al. 2005). While 
the extrinsic pathway requires the binding of death receptor Fas to its ligand FasL 
and subsequent activation of caspase-8, the intrinsic pathway involves the loss of 
mitochondrial membrane potential, cytochrome c release and caspase-9 activation. 
To single out the prevailing pathway in the apoptotic process triggered by focal 
PDT, cells were maintained at 37°C and fixed at different time points following 
AlPC photoactivation. Immunofluorescence staining demonstrated that 
cytochrome c was released in the cytosol after 1 hour, from bystander cells within 
1 mm from the PDT target, as well as in those located 5-8 mm from it (Figure8). 
Control samples provided additional evidence of the PS safety unless 
photoactivated. 
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Figure8. PDT induced apoptosis via cytochrome c release. Confocal images of control and 
PDT-treated C26GM cells immunostained for cytochrome c (green fluorescence) and 
counterstained with the nuclear dye Hoechst (blue). a AlPC-loaded but not photosensitized cells 
(ctrl) were fixed at the indicated time points. Cytochrome c immunostaining of C26GM cells 
located within 1 mm (b) or 5-8 mm (c) from the PDT-targeted cell. (Scale bar, 25 µm). d. Graph 
depicting quantification of cytocrome c staining (mean of fluorescence intensty, n = 50 ROIs per 
field). Statistical analysis was performed using Student‟s t test.  
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NO release during PDT is partially dependent on extracellular Ca
2+
 
The notion that NO production from constitutive NOS is dependent on 
intracellular Ca
2+ 
concentration is generally accepted. However, it is not clear 
whether NOS activation is caused by Ca
2+
 release from intracellular stores or Ca
2+ 
influx through store-operated or other plasma membrane channels permeable to 
Ca
2+ 
ions. Studies with pulmonary artery endothelial cells showed that Ca
2+ 
release from internal stores has a small but significant effect on NO production 
after ATP stimulation (Wang, Shin et al. 1996). Conversely, another report 
suggested that store-operated Ca
2+ 
influx can activate NOS3 in endothelial cells, 
and NOS activity is more sensitive to Ca
2+
 entry through store-operated Ca
2+ 
channels than to Ca
2+
 release from intracellular stores (Lin, Fagan et al. 2000). To 
dissect the link between intracellular Ca
2+ 
increase and NO production in 
bystander responses triggered by PDT, we performed focal PDT experiments after 
removing Ca
2+ 
from the extracellular medium (using the Ca
2+ 
chelator EGTA, 100 
µM). To minimize the variability due to the difference in fluorescent probe cell 
loading, for each EGTA experiment, control recordings were acquired from 
different fields of view of the same C26GM monolayer before incubation in a 
nominally Ca
2+
 free medium supplemented with EGTA. As expected, both 
amplitude and rate of increase of intracellular Ca
2+ 
variations were significatly 
reduced (p<0.03 and p<10
-14
, respectively). Notably, analysis of NO fluorescence 
traces showed a dramatic reduction in both parameters (p<10
-14
). In the absence of 
extracelluar Ca
2+
, only 80% of cells were involved in NO wave propagation, 
which spread slower with respect to the control. A similar reduction affected also 
the Ca
2+
 wave, corroborating the hypothesis that NO production is partially 
dependent on Ca
2+ 
influx. Furthemore, we noted a remarkable difference when 
comparing the rate of propagation between Ca
2+ 
and NO waves in control versus 
EGTA. The control NO wave showed a 10 s delay with respect to the Ca
2+ 
wave, 
whereas in the EGTA experiment this delay was increased to 20 s (Figure9). The 
residual Ca
2+
 signal which persisted in the presence of EGTA suggests the 
involvement of additional Ca
2+ 
sources in the bystander responses evoked by 
PDT. Nevertheless, these data provide clear evidence that NO production by NOS 
during PDT may be, at least in part, dependent on Ca
2+ 
influx from the 
extracellular medium.  
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Figure9. NO synthesis during PDT is partially regulated by extracellular Ca
2+ 
influx. 
Representative false–color images of Fura-2 and CuFL fluorescence variations, encoded as shown 
by the color scale bars, induced by focal PDT in control (a, b) and EGTA incubated C26GM (c, d) 
(Scale bar, 50 μm). e-h, Ca2+ and NO signal amplitude (e, f) and rate of increase (g, h) in control 
and EGTA incubated C26GM cells. g, h. Data were pooled from three independent experiments. 
Asterisks indicate significant differences between data distributions (Anova test) i. Area invaded 
by Ca
2+
 and NO waves vs. time (mean ± s.d.) for C26GM cells incubated or not with EGTA. 
Asterisks indicate significant differences between Ca
2+ 
(blue asterisk) and NO (red asterisks) rates 
of wave propagation in control or EGTA incubated cells. (Student‟s t test). * p ≤ 0.05; ** p ≤ 0.01; 
*** p ≤ 0.001.  
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NO synthesis during PDT is modulated by Ca
2+ 
release from intracellular stores 
Experiments in Ca
2+
-free conditions showed that NO production during PDT was 
not totally abolished, although reduced and delayed. To investigate further the 
correlation between the observed intracellular Ca
2+ 
and NO waves, we performed 
a different sets of experiments. Firstly, we used the phospholipase C (PLC) 
inhibitor U73122. After activation, PLC hydrolyzes phosphatidyl inositol-4,5-
diphosphate (PIP2) subsequently producing diacylglycerol (DAG), which is 
known to activate protein kinase C (PKC), and IP3, that acting on its receptors 
(IP3R) on intracellular Ca
2+ 
stores, triggers Ca
2+
release (Berridge, Bootman et al. 
2003). Thus, we performed focal-PDT after 10 min incubation with U73122 (2.5 
µM). To minimize the variability due to the difference in fluorescent probe cell 
loading, control experiments were performed in different fields of view of the 
same C26GM samples, before U73122 incubation. Interestingly, PLC inhibition, 
significantly decreased both amplitude and rate of increase of intracellular Ca
2+ 
variations (p< 10
-14
). Noteworthy, analysis of NO fluorescence traces showed a 
remarkable reduction in both parameters (p<10
-14
). The variance in both Ca
2+ 
and 
NO signals induced by focal PDT resulted in delayed waves propagation which 
spread slower with respect to the control. (Figure10). 
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Figure10. NO production during PDT in modulated by Ca
2+
 release from intracellular 
stores. Representative false–color images of Fura-2 and CuFL fluorescence variations, encoded as 
shown by the color scale bars, induced by focal PDT in control (a, b) and U73122 treated C26GM 
cells (c, d) (Scale bar, 50 μm). e-h, Ca2+ and NO signal amplitude (e, f) and rate of increase (g, h) 
in control and U73122 incubated C26GM cells. g, h. Data were pooled from three independent 
experiments. Asterisks indicate significant differences between data distributions (Anova test). i. 
Area invaded by Ca
2+
 and NO waves vs. time (mean ± s.d.) for C26GM cells incubated or not with 
U73122. Asterisks indicate significant differences between Ca
2+ 
(blue asterisks) and NO (red 
asterisks) rates of wave propagation in control or U73122 treated cells. (Student‟s t test). ***  p ≤ 
0.001. 
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We then asked whether NO release during photosensitization could be mimicked 
by more “physiologic” processes not requiring the presence of the PS. In 
particular, we exploited the possibility to induce a cell-localized release of Ca
2+ 
and evaluate its effect on nearby cells. To this end, we set up the focal 
photostimulation of caged- inositol 1,4,5-trisphosphate (caged-IP3) in cultured 
C26GM cells, which were co-loaded with Fura-red and CuFL. Since the uncaging 
required UV-light exposure that was also necessary for Fura-2 excitation, we used 
an alternative Ca
2+ 
indicator (Fura-red) in combination with CuFL. Flash 
photolysis of caged-IP3 induced activation of its receptors (IP3R) on intracellular 
Ca
2+ 
stores in the UV-flashed C26GM cell, triggering Ca
2+ 
release (Figure11). 
Notably, when we performed 100 ms focal photostimulation of caged-IP3, we 
recorded a decrease of fura-red fluorescence emission (excited at 470 nm), 
indicative of a corresponding increase in the intracellular Ca
2+ 
concentration, and 
a simultaneous increase of CuFL fluorescence both in the UV-flashed cell and in 
nearby unirradiated cells. These findings suggest that photosensitization with 
AlPC might trigger NO release simply by promoting Ca
2+
 realease from 
intracellular stores in the irradiated cell, which then generates a Ca
2+ 
wave that 
propagates to surrounding cells and contributes to determine the therapeutic 
effects initiated by the PS. 
 
Figure11. Ca
2+ 
 leakage from intracellular store activate NO synthesis. a. Fura-red 
fluorescence variations (measured as ∆F/F0) of Ca
2+
 responses evoked by 100 ms focal 
photostimulation of the blue circled C26GM cell with caged IP3. b.Representative false–color 
images of CuFL fluorescence variations after IP3 uncaging encoded, as shown by the color scale 
bar (Scale bar, 50 μm). Fluorescence traces of Ca2+(c) and NO (d) responses induced by focal 
photostimulation with caged-IP3.  
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Gap junction intercellular communication mediates bystander effect and 
apoptosis 
The observed fast electrical coupling underpinning the Ca
2+
 and NO waves among 
bystander cells suggested the involvement of connexins and gap junctions in 
bystander response. Cx26 has been indeed reported to mediate bystander effect of 
gemcitabine (Garcia-Rodriguez, Perez-Torras et al. 2011) in human pancreatic 
tumours; while Cx43 has been demonstrated to be involved in bystander effect of 
HSV/tk-based cancer therapy in rat glioma cells (Sanson, Marcaud et al. 2002). 
Therefore, we assessed gap-junction contribution in the spread of the apoptotic 
death after PDT. To this aim, we performed focal PDT on C26GM cells after 15 
minute incubation with the gap junction blocker flufenamic acid (FFA) (100µM). 
After photosensititazion, FFA was removed, cells were carefully washed by 
perfusion and then imaged in the presence of pSIVA and PI to monitor apoptosis 
spreading. FFA incubation highly reduced the percentage (16%) of both late 
apoptotic (pSIVA-PI double positive cells) and early apoptotic cell (pSIVA 
positive, PI negative cells) with respect to the control cells (37%). These data 
strikingly demonstrate that connexin gap junctions are necessary for mediating 
bystander cell death (Figure12). 
 
 
Figure12. PDT bystander cell death is mediated by connexin gap junctions. a. Representative 
false–color images of Fura-2 fluorescence ratio variation, encoded as shown by the color scale bar, 
during focal PDT in control and FFA incubated C26GM cells. b-d Time-lapse microscopy was 
performed to monitor apoptosis by real-time detection of phosphatidylserine externalization in 
C26GM cells incubated (FFA) or not (ctrl) with FFA. Representative color-merged images of 
C26GM cells; propidium iodide fluorescence (red) and pSIVA fluorescence (green). The hours 
shown indicate the time after focal PDT. (Scale bar, 50 μm). 
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To unveil the contribution of gap junction intercellular communication in PDT 
bystander signals propagation, we performed focal PDT experiments after 15 
minute incubation with FFA (100µM). Under these conditions, we 
photosensitized the cell, located in the center of the field of view and analyzed the 
amplitude, rate of signal increase and extent of the Ca
2+
 and NO “death waves”. 
FFA incubation extremely reduced the amplitude and rate of increase of 
intracellular Ca
2+
 transients evoked by focal PDT (p<10
-14
). Noteworthy, gap 
junction blocking also dramatically decreased both the parameters of NO signals 
(p< 10
-14
). These data strongly supported our hypothesis concerning the tight 
correlation between the two analyzed waves. Strikingly, gap junction blocking 
provided additional evidence for the engagement of connexins in bystander effect. 
Our results depict a scenario where Ca
2+ 
signalling spread among juxtapposed 
cells via gap junctions, which allows the transfer from one cell to another of Ca
2+ 
and IP3. IP3 activates its receptors on intracellular stores, thus triggering Ca
2+ 
release, which in turn might be exchanged with the closest cells. This self-
amplifying circuit might not be necessary for the mere NO gas diffusion. Notably, 
the rates of both Ca
2+
and NO waves in FFA-treated cells showed a striking 
decrease with respect to control cells. Remarkably, the extent of NO wave during 
PDT was dramatically reduced in FFA-treated cells since it involved only 30% of 
cells in 60 seconds (Figure13). 
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Figure13. PDT bystander effect is dependent on GJIC. Representative false–color images of 
Fura-2 and CuFL fluorescence variations, encoded as shown by the color scale bars, induced by 
focal PDT in control (a, b) or  FFA incubated C26GM cells (c, d) (Scale bar, 50 μm). Ca2+ and NO 
signal amplitude (e, f) and rate of increase (g, h) in control or FFA incubated C26GM cells. Data 
were pooled from three independent experiments.Asterisks indicate significant differences 
between data distributions (Anova test). i. Area invaded by Ca
2+
 and NO waves vs. time (mean ± 
s.d.) for C26GM cells incubated or not with FFA. Asterisks indicate significant differences 
between Ca
2+ 
(blue asterisks) and NO (red asterisks) rates of wave propagation in control or FFA 
incubated cells. (Student‟s t test). ***  p ≤ 0.001. 
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Furthermore, to corroborate our findings, we tested the expression of connexins 
and function of gap junctions in resting C26GM cells. We assessed the expression 
of five different connexins, at transcription level in C26GM cells by semi-
quantitative RT-PCR. We selected Cx26, Cx30, Cx30.3, Cx40 and Cx43, because 
Cx26, Cx40 and Cx43 were reported to be present in human breast cancer, while 
Cx43 and Cx30 were detected in colon and gastrointestinal tumours, as well as 
head and neck cancers (Ozawa, Matsunaga et al. 2007; Sirnes, Bruun et al. 2012; 
Teleki, Krenacs et al. 2013) Among those tested, Cx43 resulted the most abundant 
in C26GM cells, whilst the other Cxs were poorly represented (Figure14). 
 
 
Figure14. Cx43 is highly expressed in mouse colon carcinoma C26GM cells. Total RNA was 
isolated from C26GM and qRT-PCR for content of indicated connexins. Data, reported as relative 
abundance are normalized to Cx43. GAPDH was used as positive control.  
 
Moreover, we exploited the novel Vf2.1.Cl voltage sensitive dye (Miller, Lin et 
al. 2012) to probe dynamically the extent of gap junction coupling in C26GM 
cells by a combination of single cell electrophysiology, large scale optical 
recordings and a digital phase–sensitive detector of fluorescence signals (Ceriani 
and Mammano 2013). Intercellular coupling of C26GM cells was confirmed by 
probing electrical connectivity using Vf2.1.Cl, combined with voltage low 
frequency stimulation of one cell through a patch pipette, eliciting fluorescence 
responses with the same frequency in coupled cells. The incubation with 
carbenoxolone (CBX), a known blocker of gap junctions, dramatically reduced 
the number of coupled cells thus highlighting the role of gap junction in C26GM 
intercellular communication (Figure15). 
Finally, these findings substantiate the established paradigm that gap junctions are 
instrumental for the propagation of bystander signals within tumour environment.  
 
62 
 
 
Figure15. C26GM cells are electrically coupled by gap-junctions. Intercellular coupling in 
C26GM cells was assayed by probing electrical connectivity using the phase–sensitive detector 
tecnique recently developed by prof. Mammano group (Ceriani F. et al., 2013). Cells were loaded 
with the Vf2.1.Cl voltage sensitive dye and voltage stimuli that consisted of low frequency (0.5 
Hz) sinusoidal waveforms were delivered to one cell through a patch pipette, eliciting fluorescence 
rresponses with the same frequency in coupled cells. A phase sensitive detector was used offline to 
extract the relative amplitude of the optical signal at each pixel location (x,y) within tha field of 
view. Cells not connected to the one stimulated with the patch pipette are displayed in gray (a). 
Incubation with carbenoxolone (CBX) decreases the number of coupled cells (b). 
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Discussion 
 
For a long time, radiation oncologists have reported the so-called bystander effect, 
meaning that the irradiation of a lesion might also have an impact on nearby non-
irradiated tissues. Beyond unwanted side effects of radiotherapy, bystander effect 
may also enhance the efficacy of cancer treatment. Local bystander effect can, 
infact, induce irradiated cells to release soluble mediators that exert a direct or 
indirect cytotoxic activity on non-irradiated, neighbouring cells. Additionally, 
long-range bystander response, also known as “abscopal effect”, is thought to 
reflect the elicitation of an adaptive immune response against malignant cells 
(Prise and O'Sullivan 2009; Kroemer and Zitvogel 2012; Postow, Callahan et al. 
2012). Similarly to radiotherapy, photodynamic therapy (PDT) is capable of 
triggering bystander responses in non-irradiated cells, acting as an inducer of 
immunogenic cell death, thus efficiently promoting antitumour immune response 
(Dabrowska, Gos et al. 2005; Vacchelli, Vitale et al. 2013). Although various 
mediators and pathways have been suggested to be involved in bystander response 
and death signals propagation, to date it is not known which are the key molecules 
and crucial cellular mechanisms engaged for the paucity of studies focusing on the 
three-dimensional tumour mass. Infact, much of our knowledge on bystander 
effect derives from static studies that do not necessarily reflect the natural 
dynamics of biological processes. Therefore, many outstanding questions remain: 
how do cells behave, interact with one another, and exchange information within 
the tumour microenvironment? And how do cells respond individually and 
collectively to therapeutic intervention? Notwithstanding, the development of 
high-performing instruments and procedures for imaging of live animals at 
microscopic resolution, by the so-called intravital microscopy, makes it possible 
addressing these questions. Intravital microscopy can, infact, reveal cellular 
responses over time and space and can be conducted under conditions closely 
approximating those of a natural environment (Pittet and Weissleder 2011).  
In order to image the signalling events occurring in bystander cells during 
antitumour treatment, we exploited intravital microscopy by taking advantage of 
the dorsal skinfold chamber model. This sophisticated experimental model 
provides the opportunity to examine, with high-resolution imaging, the whole 
complex cancer tissue (Baron, Welsh et al. 2011) on living tumour-bearing mice 
subjected to PDT. Notably, to visualize the molecular cross-talk supporting 
bystander response, we slightly adjusted the PDT conventional protocol (Allison 
2014), since we focused the photosensitizing light to one single cell rather than to 
a macroscopic lesion. Since NO and RNS are crucial determinants of cancer 
therapy success (Khan, Van Dyk et al. 2003), we aimed at investigating NO 
production and spreading or diffusion within the intact tumour mass. However, 
the conventional methods applied for NO tracking, such as chemiluminescence 
and spectroscopy, suffered from low spatial resolution tracking, additionally 
requiring complicated instrumentation. Moreover, the widely used fluorescent 
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probes for NO, including o-diaminonaphthalene (DAN), o-diaminofluoresceins 
(DAFs) and o-diaminocyanines (DACs), require reactions with oxidized NO 
products rather than NO itself, thus their fluorescence-response does not 
necessarily reflect real-time NO production (Lim, Xu et al. 2006). 
Notwithstanding, the use of the novel fluorescent probe CuFl, which reacts 
rapidly and specifically with NO over other potentially interfering molecules, 
allowed us to dynamically monitor in real-time NO production from bystander 
cells by intravital microscopy (Lim, Xu et al. 2006). Importantly, this study 
provides the first direct evidence of NO involvement in bystander response within 
a three-dimensional tumour mass.  
Noteworthy, the PDT-triggered NO wave investing bystander cells appeared to be 
spatially and temporally associated to generation of a very fast Ca
2+ 
wave within 
the whole tumour mass. These data, consistently with the notion that NO synthesis 
may be Ca
2+
 -dependent, at least for the constitutive NOS isoforms (McMurry, 
Chrestensen et al. 2011) supported the hypothesis that constitutive NOS activity 
might be crucial for the beneficial spread of bystander response and death signals 
propagation. Additionally, in agreement with previous reports, this study 
demonstrates that NO induces apoptotic cell death through the intrinsic apoptotic 
pathway and cytochrome c release (Snyder, Shroff et al. 2009). However, despite 
numerous studied showed the involvementof NOS2 in response to cancer therapy, 
the role of constitutive NOS has not yet well investigated. Several findings 
suggested that photosensitization of breast cancer as well as prostate cancer cells 
resulted in a rapid and prolonged upregulation of NOS2 following irradiation; in 
this case, by acting as cyto-protector, NO induces both a pro-survival and pro-
growth response, thus compromising PDT efficacy (Bhowmick and Girotti 2013). 
Conversely, other evidence demonstrated that blocking NO production by L-
NAME administration, significantly reduced the efficacy of a combinatorial 
therapy, based on IL-3-enhanced HSV-tk/GCV viral system (Yu, Hong et al. 
2013). Therefore, our data highlight the need to investigate further the role of 
constitutive NOS, primarily NOS3, in response to cancer treatment.  
Although the aforementioned notion that NO release may be dependent on 
intracellular Ca
2+ 
concentration, it is not clear whether constitutive NOS activation 
is caused by the release from either intracellular stores or Ca
2+ 
influx through 
store-operated Ca
2+
channels. It has infact been demonstrated that only the Ca
2+ 
release from internal stores might affect NO production following ATP 
stimulation (Wang, Shin et al. 1996). Conversely, other evidence suggested that 
NOS activity is more sensitive to Ca
2+
 entry through store-operated Ca
2+ 
channels 
than the release from intracellular stores (Lin, Fagan et al. 2000). Importantly, our 
data demonstrated that PDT induced bystander effect is accompanied by a NO 
wave, only partially dependent on Ca
2+
entry from the extracellular space, but 
significantly influenced by Ca
2+
release from intracellular stores. Furthermore, 
PLC inhibition did not result in the complete abrogation of Ca
2+ 
transients in 
bystander cells, suggesting that other intracellular Ca
2+ 
stores might be engaged in 
PDT-induced bystander response. Indeed, besides the well-characterized 
endoplasmic reticulum endowed with the capacity of accumulating and releasing 
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Ca
2+
, other vesicular compartments, such as mitochondria, the Golgi apparatus, 
secretory granules, lysosomes, and endocytic vesicles, are known to accumulate 
Ca
2+
 and to be capable of releasing it under some conditions (Rizzuto and Pozzan 
2006; Rizzuto, De Stefani et al. 2012). Infact, several line of evidence support the 
participation of mitochondria in Ca
2+
 homeostasis maintenance and regulation of 
apoptotic process, as they may release caspase cofactors (Pinton, Giorgi et al. 
2008). Nonetheless, increasing findings demonstrated aberrant expression of Ca
2+
 
transporters in various cancer types, (Chen, Chen et al. 2013; Leanza, Biasutto et 
al. 2013) thus adding further complexity to the understanding of Ca
2+
 signalling in 
bystander response within the tumour. Moreover, Ca
2+ 
permeable ion channels 
have emerged as important regulators of autophagy, the cellular catabolic process 
for the degradation and recycling of protein aggregates and damaged organelles, 
which participates in the maintenance of cellular homeostasis. Additionally, 
current evidence indicates that elevated autophagy is often detected in cancer cells 
in response to radiation and chemotherapy, as well asto PDT, where it contributes 
to the therapy resistance of cancers (Andrzejak, Price et al. 2011; Kondratskyi, 
Yassine et al. 2013). Conversely, chemotherapy-induced autophagy in tumour 
cells was associated with enhanced antitumour effect of combined 
immunotherapy, as a consequence of the upregulation of the mannose-6-
phosphate receptor on tumour cell surface (Ramakrishnan, Huang et al. 2012). 
Thus, unravelling the molecular and cellular networks sustained by Ca
2+
 
signalling within the tumour microenvironment might prompt the development of 
more successful combined strategy against cancer. 
The present study also points out the crucial role of gap junctions in mediating the 
bystander effect, in agreement with other reports suggesting that Cx26 as well as 
Cx43, act as key factors in mediating either gemcitabine or HSV-TK based-
therapy bystander effect, respectively (McMasters, Saylors et al. 1998; Garcia-
Rodriguez, Perez-Torras et al. 2011). Noteworthy, connexin expression in 
tumours might serve as prognostic biomarker to predict disease outcome. 
Specifically, reduced expression of Cx43 in human colorectal tumours has been 
associated with a significantly poorer clinical outcome (Sirnes, Bruun et al. 2012), 
as well as increased Cx46 positivity together with reduced Cx26 expression in 
breast cancer, was reported to improve the assessment of pathological response to 
neoadjuvant chemotherapy (Teleki, Krenacs et al. 2013). Taken together, our 
results raise the opportunity to develop novel combinatorial approaches for cancer 
therapy, aimed at enhancing intercellular communication mediated by gap 
junctions, thus amplifying bystander response. Intriguingly, the administration of 
all-trans retinoic acid (ATRA) has been demonstrated to increase gap junctional 
intercellular communication (GJIC) in a number of cancer cell types (Wang, Dai 
et al. 2013; Wu, Taylor et al. 2013), and increase the efficacy of chemotherapy in 
human hepatocellular carcinoma (Yang, Qin et al. 2014). Moreover, the 
administration of the gap junction enhancer quinoline in tumour-bearing mice was 
recently reported to increase Cx43 expression in tumour, significantly reducing 
tumour growth (Heiniger, Gakhar et al. 2010; Shishido, Delahaye et al. 2014). 
Our data indicate that, although infrequently exploited, PDT might represent an 
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excellent promising option for cancer treatment, thanks to its ability to trigger a 
powerful bystander response. Additionally, data also suggest that the use of Ca
2+
 
mobilizing agents, such as IP3, NO-donors, and gap junction enhancers could 
strikingly modulate the bystander effect of cancer therapy and their appropriate 
combinations might promote tumour eradication (Rapozzi, Della Pietra et al. 
2013). Lastly, the powerful immunostimulatory properties ascribed to PDT, such 
as macrophage activation (Song, Zhou et al. 2013) and T lymphocyte stimulation 
(Mroz, Vatansever et al. 2013), pave the way for the development of novel 
strategies to eradicate cancer by multiple attacks.  
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Abbreviations 
AlPC Aluminum Phthalocyanine Chloride 
Ca
2+
                                                                                                         Calcium ion 
CBX   Carbenoxolone 
CuFL 2-{4,5-Bis[(6-(2-ethoxy-2-oxoethoxy)-2-methylquinolin-8 
ylamino)methyl] 6-hydoxy-3-oxo-3H-xanthen-9-yl}benzoic acid FL 
Cx Connexin 
Cyt c                                                                                                    Cytochrome c
DSWC Dorsal Skinfold Window Chamber 
EGTA Ethylene Glycol-bis(beta-aminoethyl ether)-N,N,N',N'-Tetraacetic 
Acid 
FFA    Flufenamic Acid 
GJIC Gap junction intercellular communication 
GM-CSF                              Granulocyte Macrophage Colony Stimulating Factor 
IP3 Inositol 1,4,5-trisphosphate 
L-NAME                                                        L-N
ω‑nitro‑L‑Arginine Methyl Ester 
NO Nitric Oxide 
NOS       Nitric Oxide Synthase 
PDT Photodynamic Therapy 
PI Propidium Iodide 
PS   Photosensitizer 
pSIVA Polarity Sensitive Indicator of Viability and Apoptosis 
RNS    Reactive Nitrogen Species 
ROI Region Of Interest 
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Tumor progression is accompanied by an altered
myelopoiesis causing the accumulation of immu-
nosuppressive cells. Here, we showed that miR-
142-3p downregulation promoted macrophage
differentiation and determined the acquisition of
their immunosuppressive function in tumor. Tumor-
released cytokines signaling through gp130, the
common subunit of the interleukin-6 cytokine recep-
tor family, induced the LAP* isoform of C/EBPb tran-
scription factor, promoting macrophage generation.
miR-142-3p downregulated gp130 by canonical
binding to its messenger RNA (mRNA) 3’ UTR and
repressed C/EBPb LAP* by noncanonical binding
to its 5’ mRNA coding sequence. Enforced miR
expression impaired macrophage differentiation
both in vitro and in vivo. Mice constitutively ex-
pressing miR-142-3p in the bone marrow showed a
marked increase in survival following immuno-
therapy with tumor-specific T lymphocytes. By
modulating a specific miR in bone marrow pre-
cursors, we thus demonstrated the feasibility of
altering tumor-induced macrophage differentiation
as a potent tool to improve the efficacy of cancer
immunotherapy.
INTRODUCTION
Under pathological conditions, such as infections or cancer
development, a hematopoiesis subversion occurs, which leads
to the expansion of myeloid cells retaining an immature pheno-
type and sharing a propensity to inhibit T lymphocyte activation1236 Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc.(Gabrilovich et al., 2012). Mouse myeloid cells systemically
expanded in tumor-bearing hosts express the markers CD11b
and Gr-1 (Ly-6C and Ly-6G) and have been defined collectively
as myeloid-derived suppressor cells (MDSCs). CD11b+Gr-1+
cells do not possess a suppressive phenotype, which is instead
acquired in cancer hosts when they accumulate in the spleen
and within the tumor mass of tumor-bearing mice (Gallina
et al., 2006; Sica and Bronte, 2007). In addition to their immu-
noregulatory activity, CD11b+Gr-1+ cells have been found to
promote tumor angiogenesis, cell invasion, and metastasis
(Gil-Bernabe´ et al., 2012).
It is increasingly clear that CD11b+Gr-1+ cells comprise
different subsets. Granulocytic MDSCs, with high Gr-1 ex-
pression, are less immunosuppressive than monocytic- and
macrophagic-like MDSCs, which possess an intermediate
and low or negative Gr-1 expression, respectively (Dolcetti
et al., 2010).
Experimental models of autochthonous pancreatic ductal
adenocarcinoma (PDAC) formation in mouse have detailed
progressive waves of myelomonocytic cell recruitment
after initiation of the transforming program driven by the
active oncogenes Kras, with CD11b+Gr-1+ cells being among
the first to be recruited within the developing cancer lesions
(Clark et al., 2007). Moreover, recent data suggest that
Kras oncogene-dependent accrual of myelomonocytic cells is
mandatory for pancreatic intraepithelial neoplasia (PanIN)
initiation and progression. This process involves at least
two cytokines, GM-CSF and interleukin-6 (IL-6), which were
shown to be sufficient to originate immunosuppressive
CD11b+Gr-1+ cells from bone marrow (BM) precursors (Marigo
et al., 2010).
In addition, Kras oncogene-driven inflammation at the PanIN
stage critically relied on GM-CSF for both progression to
PDAC and CD11b+Gr-1+ cell recruitment within the pancreatic
stroma. Moreover, this circuit was essential to alter CD8+ cyto-
toxic T cell immunity, and only the blockade of either GM-CSF
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miR-142-3p Regulates M2 Macrophage Differentiationproduction or CD11b+Gr-1+ cell activity restored antitumor
immunity (Bayne et al., 2012; Pylayeva-Gupta et al., 2012).
Interestingly, recruited CD11b+Gr-1+ cells contribute with
transformed epithelial cells to the local production of the cyto-
kines IL-6 and IL-11 that activate the signal transducer and
activator of transcription factor 3 (STAT3). STAT3, in turn,
induces antiapoptotic and proproliferative genes, fueling tumor
initiation, promotion, and progression (Fukuda et al., 2011;
Lesina et al., 2011).
Recent studies have also unveiled a role for some transcrip-
tion factors (TFs) in regulating the myelomonocytic differentia-
tion and recruitment to either tumor site or secondary lymphoid
organs (Sonda et al., 2011). In particular, the STAT family mem-
bers STAT1 (Kusmartsev and Gabrilovich, 2005), STAT3 (Corzo
et al., 2009), and STAT6 (Munera et al., 2010) have been re-
ported as positive regulators of MDSC expansion and activation.
In addition, CCAAT/enhancer-binding protein b (C/EBPb) regu-
lates MDSC functional properties and subset distribution in
different organs (Marigo et al., 2010). Of note, STAT3 can
directly influence C/EBPb activity (Zhang et al., 2010), adding
another level of complexity to the scenario of tumor-enhanced
myelopoiesis.
In addition to TFs, an aberrant microRNA (miR) expression can
also be associated with tumor-induced myelopoiesis (Liu et al.,
2011, 2012 ; Zhang et al., 2011). MiRs are small noncoding
RNAs regulating gene expression primarily through seed-
matched sites located within the 30 untranslated regions (UTR)
of the target mRNA (Bartel, 2009). However, miRs can also
recognize sites in the 5’UTR or in the coding sequence of the
cognate mRNA, even if these bindings seem to be less effective
than those in the canonical 3’ UTRs (Fang and Rajewsky, 2011;
Tay et al., 2008).
Many biological processes, such as embryonic development,
cell differentiation, and division are influenced by the dynamically
modulated expression of specific miRs (Hatfield et al., 2005;
Miska, 2005). Hematopoiesis represents a finely tuned,multistep
process where miRs can exert a fundamental regulator role
(Baltimore et al., 2008; Chen et al., 2004; Chen and Lodish,
2005). For example, miR-17-5p, miR-20a, miR-106a, miR-150,
miR-10a, and miR-146a have been reported to regulate the
physiological differentiation ofmonocytes, B and T lymphocytes,
helper T cells, and dendritic cells (DCs), respectively (Fontana
et al., 2007; Takahashi et al., 2012 ; Turner et al., 2011 ; Zhou
et al., 2007).
Despite the increasing amount of data on the subject, the
molecular mechanisms explaining how neoplastic cells regulate
the expression and the activity of specific TFs and/or miRs in
myeloid compartment are still poorly defined. Furthermore,
reciprocal interaction between miRs and TFs and specific path-
ways controlling either granulocytic or monocytic differentiation
have not been fully elucidated. Here, we determined the ‘‘miR
signature’’ in tumor-infiltrating myeloid cells (TIMs). Among
differentially expressed miRs, we identified miR-142-3p as
critical for preventing macrophage differentiation during tumor-
induced myelopoiesis, by both canonical and non canonical
modulation of the gp130 and C/EBPb signalling. Moreover,
we demonstrated the potential therapeutic application for
miR-142-3p oligonucleotide as adjuvant tool for adoptive T cell
therapy of cancer.RESULTS
miR-142-3p Is Downregulated in Tumor-Associated
CD11b+ Cells
To identify differentially expressed miRs (DEMs) in TIMs, total
RNA was isolated from either tumor-infiltrating or normal
CD11b+ cells purified from the spleen of healthy mice and was
hybridized on to miR arrays (see Figure S1A available online).
Clustering analysis of samples, based on all considered miR
expression profiles, showed that myeloid cells isolated from
tumor-bearing mice had a distinctive miR signature compared
to control healthy spleens (Figure 1A). Among the miR repertoire,
79 were found to be differentially modulated in tumor-infiltrating
versus normal cells (Figure S1B). In particular, the array analysis
showed miR-142-3p and miR-150 were strongly downregulated
in tumor-infiltrating CD11b+ cells. This finding was further
confirmed by qRT-PCR analysis (Figure S1C).
In order to identify the putative targets of the 79 DEMs, we
performed a combined analysis of miR and gene expression
profiles of the same samples. As supported by expression
data, 238 negative correlations, mainly involving downregulated
miRs, were selected (Figure S1D). Many of the predicted target
genes are known regulatory factors of myeloid cell differentiation
and/or proliferation (Figures S1E and S1F). For example, Nras
alteration was linked to an aberrant GM-CSF signaling, causing
a chronic myelomonocytic leukemia-like phenotype (Wang
et al., 2010). Ptgs2 was associated with myeloid cell recruitment
and/or activity during tumor development (Eruslanov et al.,
2010), whereas E2f3was identified as a TF involved in monocyte
differentiation (Schmeier et al., 2009). In addition, both Dapk1
and Ccne1 expression could be regulated by C/EBPb (Gade
et al., 2008; Gutsch et al., 2011), which modulates tumor-
induced myelopoiesis (Marigo et al., 2010). We thus moved to
investigate the role of miR-142-3p and miR-150 in TIM differen-
tiation and activity during altered myelopoiesis.
miR-142-3p Directs Myeloid Cell-Commitment
In order to assess the role ofmiR-142-3p andmiR-150 inmyeloid
cell commitment, we first generated MDSCs in vitro from bone
marrow cultures, as previously described (Marigo et al., 2010).
Specific miR content was measured every day by qRT-PCR
analysis. These two miRs followed very different kinetics (Fig-
ure 1B): miR-142-3p showed a prominent downregulation in
the early phases of cell commitment, whereas miR-150 had a
linear, but delayed, decrease over time. This time-dependent
miR modulation was differently associated with BM-MDSC
generation. The enforced expression of miR-142-3p in BM
cultures determined a significant decrease of total cell numbers
(data not shown), exerting different effects on various cell sub-
sets. In fact, the expression of miR-142-3p, but not miR-150,
in BM cells mostly impaired CD11b+Gr-1lo-neg cell subset
generation (Figure 1C). The morphological analysis showed
that miR-142-3p overexpressing BM-cultures were mainly
driven towards granulocytic differentiation (Figure 1D).
Cytofluorimetric characterization and qRT-PCR analysis
confirmed that the CD11b+Gr-1lo-neg subset was mainly com-
posed of mature macrophages with enhanced expression of
markers (Figure S1G), and genes (Figure S1H), distinct from
M2-oriented, tumor-associated macrophages (GabrilovichImmunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc. 1237
A B
C D E
F
G
(legend on next page)
Immunity
miR-142-3p Regulates M2 Macrophage Differentiation
1238 Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc.
Immunity
miR-142-3p Regulates M2 Macrophage Differentiationet al., 2012; Lawrence and Natoli, 2011; Mantovani et al., 2002).
In addition, purified CD11b+Gr-1lo-neg cells secreted IL-10 but
not IL-12, analogously toM2-polarizedmacrophages (Figure 1E).
Gene-expression analysis of miR-142-3p overexpressing BM
cultures showed that miR upregulation mostly affected genes
related to M2 polarization (Figure S1I). Collectively, these data
indicated that CD11b+Gr-1lo-neg cells possessed a prevalent
M2-profile, even if the expression of M1-macrophage markers,
such as MARCO and Nos2 (Murray and Wynn, 2011), was also
detected (Figure S1G and S1H).
To characterize further miR role in myeloid cell-commitment,
we additionally stimulated BM-MDSCs expressing either control
(CTRL) or miR-142-3p oligos with M-CSF. miR-142-3p overex-
pressing cells showed a clear reduction in macrophage percent-
age and a significant increase in the granulocytes, whereas
the monocytic subset was only partially affected (Figure 1F;
Figure S1L). Collectively, these data suggest that miR-142-3p
content in BM cells regulates the transition to macrophages.
Of note, miR-142-3p-expressing BM-cells exposed to tumor-
cell conditioned medium (TCCM) showed a comparable impair-
ment in macrophage differentiation (Figure 1G).
miR-142-3p Downregulation Is Required for the
Generation and Activity of Immunosuppressive Cells
Among in vitro generated BM-MDSCs, the CD11b+Gr-1lo-neg
subset is endowedwith the highest immune-suppressive activity
(Dolcetti et al., 2010; Marigo et al., 2010). We thus wondered
whether miR-142-3p expression could control the suppressive
behavior of BM-MDSC cultures. We measured cell division in
antigen-stimulated, CFDA-SE-labeled T lymphocytes cultured
with BM-MDSCs previously transfected with either CTRL
or miR oligos. The enhanced expression of miR-142-3p, but
not miR-150, reduced the immunosuppressive activity of BM-
MDSCs, restoring CD8+ T cell proliferation (Figure 2A). A similar
decrease in the immunosuppressive activity was observed in
miR-142-3p-expressing MDSCs generated by the exposure to
TCCM (Figure S2).
We therefore asked whether forced miR downregulation in
myeloid progenitors could support macrophage generation even
in the presence of granulocytic differentiating stimuli. We isolated
BM-CD11b cells, which are capable of generating all the Gr-1
subsets after cytokine treatment (Figure 2B). We infected these
cells with a lentiviral construct (miR-142-3pT) able to ‘‘sponge’’
endogenous miR-142-3p (the infection efficiency was of 38% ±
5%). After infection, CD11b cells were treated with G-CSF toFigure 1. miR-142-3p Is Downregulated in Tumor-Recruited CD11b+ C
(A) The dendrogram shows samples classification resulting from unsupervised an
either the spleen of healthymice (navy) or from themass of the indicated tumors (b
group are shown.
(B) BM cells were cultured with GM-CSF+IL-6 to generate BM-MDSCs. Total RNA
miR-142-3p and miR-150 content was performed. Data, reported as relative qua
(C and D) BM cells from healthy mice were transfected with either CTRL (scramb
analyzed by flow cytometry and cytochemical stain to evaluate myeloid differen
expressing CD11b and Gr-1 markers (C) are reported, and May-Gru¨nwald-Giem
(E) CD11b+/Gr-1lo/neg cells were sorted from GM-CSF+IL-6 treated-BM cells and
ELISA. For comparison, cytokine levels secreted by either M1- or M2-polarized,
(F) Percentages of monocytes, macrophages, and granulocytes in BM cultures f
(G) BM cells were transfected with either CTRL or miR oligo and cultured in the
In all panels, data are expressed as mean ± SE of three independent experimendrive granulocytic differentiation. miR-142-3p downregulation
determined a significant decrease in the percentage of granulo-
cytes with a concomitant increase in the macrophage number.
The differentiation of monocytes was not affected (Figure 2C).
When cultured with antigen-activated CD8+ T cells, G-CSF-
treated CD11b cells showed a poor immunosuppressive
activity (Figure 2D). Of note, the enforced miR-142-3p downre-
gulation augmented the ability of G-CSF-treated CD11b to
block T lymphocyte proliferation (Figure 2D). Thus, miR-142-3p
downregulation in myeloid precursors represents a pivotal event
for the maturation of immunosuppressive macrophages.
IL6st Is a Direct Target of miR-142-3p, and It Is Involved
in Macrophage Commitment
In order to define the molecular mechanisms by which miR-142-
3p controls macrophage differentiation, we computationally
identified regulated genes, focusing on those involved in
monocyte-macrophage commitment. To evaluate whether miR
directly binds to these predicted targets, we set up a luciferase
reporter assay screening by using plasmids in which the firefly
luciferase open reading frame (ORF) was fused to the 3’ UTR
of these genes. miR-142-3p overexpression caused a reduction
in luciferase activity when transfected with the Il6st, Egr2, Id1,
and Pla2g6 coding plasmids, indicating these genes as direct
miR targets (Figure 3A). Mutations in the predicted seed
sequence allowed us to validate miR-142-3p interaction with
the two genes showing the strongest impairment of luciferase
activity, i.e., Il6st and Egr2. In seed-mutated mRNAs, miR-142-
3p addition did not change luciferase activity (Figure 3B).
Between these two targets,we focusedon Il6stgene, the trans-
membrane chain common to all the receptors for IL-6 cytokine
familymembers, because the activation of IL-6 pathway is known
to regulate physiological and pathological myeloid cell differenti-
ation. To verify gp130 role on tumor-altered myelopoiesis, we
injected MCA203 cells either in wild-type (WT) or in mice bearing
a conditional Il6st gene deletion in hematopoietic cells (Il6st/).
After 4 weeks, BM cells were harvested and cultured in the
presence of TCCM to evaluate myeloid cell differentiation. BM
cells from Il6st/ mice showed a clear reduction in the
percentage of the macrophages, associated to an expansion of
both the granulocytic and monocytic compartment (Figure 3C).
Intriguingly, miR overexpression induced a strong reduction in
the phosphorylated STAT3 protein level (Figure 3D), indicating
that miR-142-3p also influenced STAT3 activation, an event
downstream of the IL6st signaling.ells and Regulates Myeloid Cell Differentiation
alysis of all miR expression data obtained from CD11b+ total RNA isolated from
lue). Data from three arrays hybridizedwith pools of at least threemice per each
was isolated from either fresh or cultured BM-cells (days 1–4) and qRT-PCR for
ntity (R.Q.), are normalized to miR level in fresh BM cells.
le) or miR oligo before GM-CSF+IL-6 treatment. After 96 hours, cultures were
tiation. Representative FACS panels and the relative quantification of subsets
sa staining of cytospins is shown (D).
plated for additional 40 hours. IL-10 and IL-12p70 release was measured by
BM-derived macrophages are shown.
urther stimulated with M-CSF.
presence of TCCM. After 96 hours, cultures were analyzed by FACS.
ts. **p < 0.01; ***p < 0.001. See also Figure S1.
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Figure 2. miR-142-3p Regulates Immune-Suppressive Activity of TIMs
(A) CFDA-SE-labeled CD8+ T cells from pmel-1 mice were stimulated with the specific antigen in the presence of BM-MDSCs expressing either CTRL or miR
oligos. CD8+ T cell proliferation was evaluated as CFDA-SE dilution relative to lymphocyte cultures stimulated in the absence of BM-MDSCs (MLPC).
(B) BM CD11b+ and CD11b cells of healthy mice were treated for 4 days with GM-CSF+IL6 before evaluating CD11b/Gr-1 distribution.
(C) BM-CD11b cells were infected with either CTRL or miR-142-3p capturing (miR-142-3pT) lentiviruses and then cultured in the presence of G-CSF. Per-
centages of granulocytes, monocytes, and macrophages are reported.
(D) CD8+ T lymphocytes were antigen-stimulated and cultured for 3 days in the presence of CD11b BM cells generated as in (B) and (C). Histograms represent
the quantification of CD8+ T cell-proliferation evaluated as CFDA-SE dilution relative to control MLPC.
In all panels, data are expressed as mean ± SE from three independent experiments. *p < 0.05;**p < 0.01; ***p < 0.001. See also Figure S2.
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A reported link exists between Stat3 and Cebpb (Zhang et al.,
2010), which regulates the differentiation of immunosuppressive
TIMs (Marigo et al., 2010). We therefore tested whether Cebpb
could be controlled by miR-142-3p. Cebpb mRNA encodes
three isoforms, with different molecular weight and transcription
activity: two activating proteins, LAP* and LAP, and an inhibitory
isoform, LIP. We evaluated C/EBPb isoform amounts in miR
overexpressing NIH-3T3 cells, and we observed a significant
downregulation exclusively in LAP* (Figure 4A).
During cell differentiation, the activating/inhibitory isoform
ratio dynamically changes to guarantee a specific gene-
transcription pattern (Smink et al., 2009). We detected a sig-
nificant variation in isoform ratio, mainly due to downregulation
of the LAP*, in miR-142-3p overexpressing BM-MDSCs
(Figure 4B). Intriguingly, BM cells driven to granulocytic differen-
tiation treatment showed a strong decrease in LAP* content,1240 Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc.whereas macrophage differentiation caused LAP* upregulation
(Figure 4C).
To determine whether C/EBPb isoform ratio was altered by
miR-142-3p through STAT3 activity modulation, we treated BM
cells with GM-CSF and IL-6 in the presence of JSI-124, a specific
STAT-3 phosphorylation inhibitor. As previously reported
(Nefedova et al., 2005), the addition of the inhibitor promoted a
strong DC maturation and a reduction in the macrophage
number (Figure S3). JSI-124-treated BM cells showed a strong
LAP* decrease (Figure 4D), an overall response similar to miR-
142-3p enforced expression (Figure 4B), suggesting a direct
link between STAT3 activation and C/EBPb isoform-ratio
modulation.
We additionally ablated gp130 expression in NIH-3T3 cells by
small hairpin RNA (shRNA) (Figure 4E). In the absence of gp130,
we found a significant decrease of both LAP* and LIP expression
(Figure 4F), suggesting that, in addition to gp130 modulation,
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Figure 3. A Direct Target of miR-142-3p, IL6st, Is Involved in Macrophage Commitment
(A and B) HEK293T cells were cotransfected with a plasmid carrying the luciferase ORF fused to WT 3’UTR of the indicated genes and with either CTRL or miR-
142-3p oligos (A). Experiments were additionally performed with a plasmid mutated in the seed sequence of 3’UTR (B). The firefly activity was normalized to the
Renilla activity and the normalized value of CTRL-transfected cells was set as 100.
(C) WT (CTRL) or Il6st/ mice were injected with MCA203 cells. After 4 weeks, BM cells were harvested and further cultured with TCCM. Cultures were
analyzed by flow cytometry. Percentages of granulocytes, monocytes, and macrophages are reported. Data from n= 6 mice per group (from two independent
experiments).
(D) Immunoblot analysis (WB) of STAT3 phosphorylation in miR-142-3p-over-expressing NIH-3T3 cells and the related signal quantification (ratio between
phosphorylated STAT3 (pSTAT3)/nonphosphorylated STAT3). Protein levels were normalized to a-actin signal. The normalized STAT3 ratio in CTRL-transfected
cells was set as 1.
In all panels, data are expressed as mean ± SE from three (or five for luciferase assays) independent experiments. *p <0.05;**p < 0.01; ***p < 0.001.
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mechanisms.
miR-142-3p Directly Regulates the C/EBPb Isoform
Ratio and Is Negatively Regulated by LAP*
Wedetected a significant LAP* downregulation even in HEK293T
cells coexpressing miR-142-3p and Cebpb coding sequence
domain (CDS) (Figure 5A). By using RNAHybrid 2.2 algorithm, a
putative miR-142-3p binding site was identified in the Cebpb
CDS (Figure 5B). Of note, this binding site spans the second
start codon, where a loop structure can be created, regulating
the reciprocal isoform expression (Baldwin et al., 2004). Wespeculated that miR binding, by either modifying or interfering
with the loop generation, could control C/EBPb isoform transla-
tion (Figure 5B).
To validate the hypothesis of a direct miR binding, we trans-
fected HEK293T cells with a plasmid carrying the Cebpb CDS
in frame with the luciferase ORF. The addition of miR-142-3p
significantly reduced the luciferase activity (Figure S4A).
Coherently, miR overexpression did not impact the luciferase
activity in cells expressing a mutated CDS (Figure S4A). Results
were validated by protein blot analysis (compare Figures 5A
and 5C). These data unveiled a direct miR-142-3p-Cebpb
interaction.Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc. 1241
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Figure 4. LAP* C/EBPb Expression Is Controlled by miR-142-3p
(A and B)WBof C/EBPb isoform expression in the nuclear fraction (NF) of NIH-3T3 cells (A) or BM-MDSCs (B) expressing either CTRL ormiR-142-3p oligo and the
related signal quantification were reported. Protein levels were normalized to nucleoporin-62 (Np62) signal. The normalized C/EBPb value in CTRL-transfected
cells was set as 100. A.U., arbitrary units.
(C) WB of C/EBPb isoform expression in the NF of BM-cells cultured for 96 hours in the presence of different cytokines (GM-CSF/IL-6, G-CSF or M-CSF) and the
related signal quantification were reported.
(D) BM cells were treated for 4 days with GM-CSF+IL-6 and 0.5 mMJSI-124 or DMSO vehicle were added 24 hours before culture harvesting. C/EBPb expression
was analyzed by WB.
(E) Il6stwas ablated in NIH-3T3 cells by transfecting different shRNAs expressing puromycin resistance. After 4 weeks of antibiotic selection, IL-6 expressionwas
analyzed in whole-cell extract by WB. Silencing efficiency: sh A = 85% sh C = 10%.
(F) WB for C/EBPb isoform expression in the NF of Il6st-silenced NIH-3T3 cells and the relative signal quantification were reported.
In all panels, data are expressed as mean ± SE of three independent experiments. *p < 0.05 **p < 0.01 ***p < 0.001. See also Figure S3.
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miR-142-3p Regulates M2 Macrophage DifferentiationA TF-miR feedback loop is frequently reported, thus we asked
whether C/EBPb could in turn regulate miR-142-3p expression.
A plasmid coding a region of 1,250 bp upstream of the pri-
miR-142-3p sequence (named Walk 1) fused to the luciferase
ORF was generated. This region contains the miR promoter
and nine computationally identified C/EBPb binding sites. In
addition, two shorter constructs (Walk 2 andWalk 3; Figure S4B)
were considered. Moreover, to further dissect the role of each
isoform in miR regulation, Cebpb sequence was modified to
generate a LAP*-coding construct (Figures S4C and S4D). No
miR-142-3p promoter activation was observed when cells
were cotransfected with miR promoter plasmids and LAP*
coding construct (Figure 5D). On the other hand, a clear incre-1242 Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc.ment in luciferase activity was detected by transfecting cells
with a LIP-coding plasmid. The reduction in miR promoter activ-
ity linearly correlated with the binding site number (Figure 5D).
To evaluate the impact of C/EBPb isoform ratio on miR
promoter activity, we cotransfected HEK293T with different
concentrations of LAP*- and LIP-coding plasmids. We found
that an increased ratio caused a linear promoter activity reduc-
tion (Figure 5E), whereas a higher promoter activity was
observed when the ratio decreased (Figure 5F).
In summary, we hypothesize that during tumor-induced
myelopoiesis a mini-circuit is activated by tumor-released IL-6
family cytokines. Their binding to the IL-6 subunit determines
both a STAT3-mediated and a direct C/EBPb isoform ratio
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Figure 5. miR-142-3p Directly Regulates the C/EBPb Isoform Ratio and Is Negatively Regulated by LAP*
(A) Signal quantification of C/EBPb isoform expression by WB in the NF of HEK293T cells transfected with mouse C/EBPb CDS and either CTRL or miR-142-3p
oligo.
(B) Computationally predictedmiR-142-3p binding site in the C/EBPbCDS (left) and the hypothesized impact ofmiR binding on AUG recognition (right). Blue/grey
arrow = active/not active start codons, respectively.
(C) Signal quantification of C/EBPb expression by WB in HEK293T cells transfected with a plasmid coding a mutated C/EBPb CDS and with either CTRL or
miR-142-3p oligos.
(D) Luciferase assay in HEK293T cells transfected with constructs expressing three putative miR-142-3p promoter sequences (Walk 1, 2, and 3), and
plasmids expressing either the LIP or the LAP* isoforms. Luciferase activity was normalized to the Renilla luciferase activity and the normalized value of
pcDNA3.1-trasfected cells was set as 1.
(E and F) HEK293T cells were transfected with the Walk 1 plasmid and constructs expressing either the LIP and the LAP* isoforms in different ratios. Luciferase
activity was normalized to the Renilla luciferase activity and the normalized value of LAP*/LIP-transfected cells (LAP*/LIP ratio = 1) (E) or pcDNA3.1-trasfected
cells (F) was set as 100.
In all panels, data are expressed as mean ± SE of four independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S4.
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Figure 6. miR-142-3p Overexpression Alters Tumor Microenvironment
(A–G)Myeloid infiltrate analysis in the BM, blood, spleen, and tumormass of miR-overexpressing chimeras. FACS analyses were performed on Ly5.2+/mOrange+
cells at day 5 or 10 (except for tumor infiltrate, analyzed only at day 10) following MCA203 injection. Absolute numbers (3106) of granulocytes, monocytes,
macrophages, DCs (CD11c+/I-A/I-E+), and hematopoietic precursors (Sca-1+/c-kit+) are reported.
Data are reported as mean ± SE from n = 6 mice per group, two cumulated experiments. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S5.
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miR-142-3p Regulates M2 Macrophage Differentiationvariation. In particular, this ratio increases as a result of the in-
duction of the LAP* protein, driving macrophage differentiation.
In this scenario, miR-142-3p modulation plays a key role: miR
downregulation, due to the LAP* increase, induces IL6st upregu-
lation, thus sustaining its downstream pathway. Moreover,
miR-142-3p downregulation determines, in a feedback loop,
LAP* expression increment, further promoting myeloid cell dif-
ferentiation towards immunosuppressive macrophages.
miR-142-3p Overexpression Alters Tumor
Microenvironment
We then address whether miR-142-3p overexpression in vivo
could alter tumor microenvironment. We transplanted Ly5.2+
CD11b BM cells infected with a miR-142-3p-coding lentiviral
construct in g-irradiated, Ly5.1+ recipient mice. Infected cells,
identified by the mOrange2 reporter protein, had a constant
miR content, as determined in qRT-PCR (about 1.97 ± 0.261244 Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc.compared to control cells). Three weeks after transplantation,
mice were injected with MCA203 tumor cells, and we evaluated
myeloid cell distribution in tumor mass and lymphoid organs at
two different time points (Figure S5A).
At day 5, miR overexpressing mice showed a strong reduction
in macrophage-monocyte subsets, a modest decrease in gran-
ulocytes, but a remarkable drop in the percentage of immature
precursors. Moreover, an increase in BM-DCs was evidenced
(Figure 6A). A similar drive in myeloid maturation was already
reported in Cebpb/ mice (Marigo et al., 2010), further high-
lighting the link between this TF and miR-142-3p.
An analogous scenario was still evident at day 10 in BM,
with the exception of an increase in the precursor numbers
(Figure 6B). Whereas minor differences were found among
circulating and splenic cells at day 5 (Figures 6C–6E), a clear in-
crease in the monocyte percentage and a concomitant signifi-
cant reduction of the macrophage number was evidenced in
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Figure 7. Enforced miR-142-3p Expression Favors Antitumor Immune Response leading to Tumor Growth Control
(A) Schedule for ACT protocol in CTRL or miR-142-3p-expressing chimeras.
(B) Survival analysis of tumor-bearing chimeras. Mantel-Haenszel statistics: LV-CTRL+mTERT CTLs versus LV-miR-142-3p+mTERT CTLs, p = 0.007; LV-miR-
142-3p+mTERT CTLs versus LV-miR-142-3p, p = 0.017; LV-miR-142-3p+mTERT CTLs versus MCA203, p = 0.042. All other comparisons were not significant.
n = 12 LV-CTRL+mTERT CTLs; n = 10 LV-miR-142-3p; n = 8 LV-miR-142-3p+mTERT CTLs and MCA203, two cumulated experiments.
(C) ACT was performed in MCA203 tumor-bearing mice previously transplanted with BM cells expressing either CTRL or miR-142-3p oligo. Tumor growth and
survival analysis are reported. Mice were euthanized when the tumor area reached 200 mm2. Mantel-Haenszel statistics: LV-miR-142-3p+mTERT CTLs versus
MCA203, p = 0.00007; LV-CTRL+mTERT CTLs versus MCA203, p = 0.667; LV-miR-142-3p+mTERT CTLs versus LV-CTRL+mTERT CTLs, p = 0.00001. Data are
reported as mean ± SE from n = 10/12 mice per group.
See also Figure S6.
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miR-142-3p Regulates M2 Macrophage Differentiationthe blood and the spleen of miR overexpressing mice at day 10
(Figures 6D–6F), recapitulating the in vitro block in monocyte-
macrophage transition.
Tumor dimension allowed us to analyze tumor infiltrate only at
the latest time point. We detected a similar decrease in the
percentage of macrophages and an associated expansion of
DC numbers (Figure 6G), suggesting that in vivo miR overex-
pression was able to change the ratio of macrophage: DC to
favor the DC expansion.
Enforced miR-142-3p Expression Favors Antitumor
Immune Response leading to Tumor Growth Control
The macrophage subversion and coincident DC expansion
might create a more favorable microenvironment for antitumorT lymphocyte recruitment and activity. Thus, the preconditioning
of BM cell differentiation by miR-142-3p expression could be
an innovative strategy to improve the efficacy of cancer immu-
notherapy. To address this possibility, we generated stable
miR-142-3p expressing chimeras and subjected them to
adoptive cell therapy (ACT) with mouse telomerase (mTERT)
antigen-specific T lymphocytes (CTLs) (Figure 7A). Six weeks
after BM transplantation, a similar chimerism and BM recon-
stitution between the control and miR-overexpressing mice
were found (Figures S6A and S6B).
After tumor injection, mice survival was monitored. CTRL-
lentivirus chimeras receiving ACT and miR overexpressing-
lentivirus chimeras without ACT died within 55 days after tumor
injection, with a time course indistinguishable from nonchimeric,Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc. 1245
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miR-142-3p Regulates M2 Macrophage Differentiationtumor-bearing mice (Figure 7B). In contrast, miR overexpressing
mice receiving ACT showed a prolonged survival, with 50% of
them surviving till the end of the observation period (Figure 7B).
We next addressed the potential therapeutic application of
miR-142-3p overexpression. MCA203 tumor-bearing, Ly5.1+
mice were treated with a low dose of 5-fluoracil to induce a
partial myelodepletion and then injected with syngenic Ly5.2+
BM cells previously transfected with either CTRL or miR-142-
3p oligo (Figure S6C). Two weeks after transplantation, a similar
percentage of Ly5.2+ cells in all mice groups was found
(Table S6D). After adoptive transfer of either mTERT or b-GAL
specific (as T lymphocytes recognizing an irrelevant antigen)
CTLs, mice survival was monitored. We found that the
miR-142-3p expression in conjunction with tumor-specific
CTLs administration was able to delay tumor growth and signif-
icantly increase mice survival (Figure 7C).
DISCUSSION
Starting from the early steps of cancerogenesis, tumor cells
modify surrounding environment to evade host immune
response (Bayne et al., 2012; Pylayeva-Gupta et al., 2012).
Moreover, the recruitment to tumor mass and secondary
lymphoid organs of myeloid cells with immunosuppressive
activity is a prominent feature of tumor progression (Gabrilovich
et al., 2012; Ostrand-Rosenberg et al., 2012; Sica and Bronte,
2007). Immature DCs, macrophages, and MDSCs are expanded
and recruited by tumor- and host-released factors (Gabrilovich
et al., 2012; Sica andMantovani, 2012; Viola et al., 2012). Among
various factors, GM-CSF, IL-6, and M-CSF have been clearly
associated with the induction of immunosuppressive programs
in TIMs (Bayne et al., 2012; Bronte et al., 1999; Hume and
MacDonald, 2012; Marigo et al., 2010; Pylayeva-Gupta et al.,
2012), but the molecular mechanisms underlying the altered
myelopoiesis in cancer remain to be fully elucidated.
During late stages of tumor progression, TAMs acquire a
prevalent M2-like phenotype characterized by low IL-12 and
high IL-10 expression. In contrast to M1-type macrophages,
TAMs have poor antitumoral activity but they rather promote
tissue remodeling and angiogenesis, favoring metastatic
dissemination (Sica and Bronte, 2007; Sica and Mantovani,
2012). However, this dualistic vision is challenged by findings
indicating that different functional states can be present among
TAMs of the same tumor microenvironment (Movahedi et al.,
2010; Torroella-Kouri et al., 2009). In numerous solid cancers,
high presence of tumor-recruited macrophages is tightly corre-
lated to poor prognosis (Qian and Pollard, 2010).
Macrophages are extremely plastic cells, and both epigenetic
changes and noncoding RNAs can contribute to their polariza-
tion. For example, miR-155 can target human IL-13Ra1 subunit,
thus decreasing a set of M2 genes in human macrophages
(Martinez-Nunez et al., 2011). We report here that miR-142-3p
controls the generation of M2-type, immunoregulatory macro-
phages during cancer-promoted myelopoiesis, both in vitro
and in vivo, by conventional binding to 3’ UTR and unconven-
tional binding to CDS of target genes in the IL-6 cytokine-family
signaling cascade. Recent studies addressing miR role as
regulator of myeloid cell differentiation and accumulation
have mainly considered the granulocytic subset of MDSCs1246 Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc.(Liu et al., 2011, 2012; Zhang et al., 2011). In particular, miR-
17-5p and miR-20a reduced the expression of STAT3 and
modulated the suppressive activity of granulocytic CD11b+
Ly6G+ cells (Zhang et al., 2011). In another report, high levels
of miR-494 were reported to control the nonimmunological
activity of MDSCs. (Liu et al., 2012).
To identify miR regulating the function and the generation
of tumor-recruited myeloid cells, we characterized their full
‘‘miRNome,’’ following purification of CD11b+ cells from five
different transplantable tumors, in two genetic mouse back-
grounds. The choice of evaluating a broad myeloid population
sharing the CD11b marker was determined by the rationale
that tumors often induce a global alteration in myeloid differenti-
ation, resulting in extensive changes in myeloid cell subset
distribution and multiple blocks in differentiation towards the
myeloid mature stages (Gabrilovich et al., 2012). Isolating and
comparing specific cell subsets might thus not allow to pinpoint
miRs responsible for the altered myeloid differentiation program
and, indeed, our data highlight the enrichments in pathways
related to myeloid differentiation.
Block of macrophage differentiation due to miR-142-3p-
enforced expression impaired tumor growth in vivo, but only
when coupled with the adoptive transfer of tumor-specific
CTLs. These results suggest that miR-142-3p mainly impacts
on the regulation of the immunological activity of TAMs. More-
over, in many tissues, the decreased macrophage number was
associated to increased granulocyte and DC differentiation.
Because DCs and monocytes derive from the same hematopoi-
etic precursor cells, we hypothesize that miR-142-3p upregula-
tion is also necessary to drive myeloid differentiation towards a
full DC maturation, by reducing macrophage generation. In this
regard, it is known that the interplay between IL-6 and M-CSF
can drive macrophage differentiation and/or polarization pre-
venting DC maturation from monocytes. In particular, IL-6 upre-
gulates the expression of a functional MCSF-receptor (M-CSFR)
on monocytes, allowing these cells to utilize the M-CSF pro-
duced in autocrine fashion (Chomarat et al., 2000). Analogously,
IL-6 family cytokines, such as LIF and IL-6, can control TAM
generation and M2-polarization through the M-CSFR pathway.
In the tumor microenvironment, where increased LIF and IL-6
levels are found, monocytes consume M-CSF through an
augmented M-CSFR-dependent internalization, and this event
is linked to the skewing towards M2-type macrophages (Duluc
et al., 2007). Our data indicate that miR-142-3p modulates
macrophage differentiation through the alteration of IL-6 ex-
pression and signaling. Moreover, we demonstrated a double
impact of miR-142-3p on the IL-6 signaling pathway. In fact,
miR-142-3p directly regulated gp130, but, more interestingly, it
also modulated the downstream signaling element, C/EBPb. In
this case, we showed that miR overexpression determined a
prominent reduction of the full-length isoform LAP* by binding
to a noncanonical site located in the CDS.
miR-142-3p activity in the regulation of myeloid differentiation
has been recently addressed (Chen et al., 2008; Wang et al.,
2010). The study of Wang and collaborators reported that
miR-142-3p (and miR-29a) level increased during induced
maturation of both monocytes and granulocytes. Additionally,
miR enforced expression is able to overcome the differentiation
block, which is a specific feature of the AML samples. Thus, the
Immunity
miR-142-3p Regulates M2 Macrophage Differentiationrole of miR downregulation in maintaining cells in an undif-
ferentiated phase was advocated. However, this study did not
address whether a block in the monocyte-macrophage transi-
tion was consequent to miR-142-3p-enforced expression in
CD34+ cells. In our model, miR-142-3p overexpression did not
induce myeloid differentiation but, on the contrary, impaired
macrophage differentiation. This apparent discrepancy is likely
due to the different models analyzed and to the stimuli used.
In addition, we unveiled a reciprocal C/EBPb-miR-142-3p
interaction and defined a feedback loop, which explains how
this miR is downregulated in TIMs. Intriguingly, this mini-circuit
is regulated by an unanticipated activity of LAP* and LIP iso-
forms. Contrary to the expectations, in fact, we found that
LAP* acted as an inhibitory regulator of miR activity. However,
increasing evidence shows that the ‘‘dogma,’’ which defines
LAP* as an activating and LIP as an inhibitory TF, should be
revised. In fact, LIP can also positively regulate the transcription
of some genes, whereas LAP* can act as an inhibitor of gene
transcription (Luedde et al., 2004).
Thinking about possible therapeutic translation of our findings,
we also validated miR-142-3p expression modulation as adju-
vant in ACT against cancer. Transfer of tumor-antigen-specific
T lymphocytes is a promising anticancer strategy, but it is
mandatory to create an optimal environment to allow T lympho-
cyte recruitment to tumor mass and unleash their full effector
functions. This was previously achieved by the conditional ge-
netic ablation of Cebpb gene (Marigo et al., 2010), a strategy
that is difficult to transfer to the clinic given the pleiotropic activity
of this TF. We demonstrated here that the use of an oligo to
enforce miR-142-3p expression could be a feasible option to
modify tumor environment and favor antitumor immunity. We
are currently exploring the possibility to target miR-142-3p to
myeloid cells by the use of nanoparticles and dendrimers.
EXPERIMENTAL PROCEDURES
General Note
All mice were maintained under SPF conditions in the animal facility of the
Istituto Oncologico Veneto, and experiments were performed according to
state guidelines and approved by the local ethics committee. C57BL/6 and
BALB/c mice were purchased from Harlan (Milan, Italy). Transgenic mice
and tumor cell lines were described in the Supplemental Information.
Mouse recombinant GM-CSF, G-CSF, IL-6, and M-CSF were purchased
from Peprotech. Db-restricted hgp10025–33 were synthesized by JPT (Berlin,
Germany).
Cell Isolation
CD11b+ and CD11b cells were isolated by using magnetic microbeads con-
jugated with monoclonal rat anti-mouse-human CD11b antibody. Separations
were performed by Miltenyi Biotec kits and MidiMacs LS or LD columns,
respectively (Miltenyi Biotec, Germany).
Flow Cytometry
Antibodies, described in Supplemental Information, and matched isotypes
were purchased from eBiosciences. Fluorescence acquisition was performed
with FACSCaliburTM (Becton and Dickinson) and analyzed with FlowJo
software (Treestar).
Bone Marrow Cultures
BMcells were obtained as previously described (Marigo et al., 2010). To obtain
BM-MDSCs, we plated 1.2 3 106 cells into 6-well plates in medium supple-
mented with either cytokines or 25% v/v TCCM and maintained at 37C in a5% CO2-humidified atmosphere for 4 days. TCCM was obtained by culturing
subconfluent tumor cells in medium with 3% serum for 48 hr. Supernatants
were then collected, aliquoted, and kept at 80C until use.
BM Transfection
Fresh BM cells were transfected with either 100 nM of miR-142-3p mimic
or scramble CTRL oligo (IDT), by using the transfection agent GeneSilencer
(Genlantis) according to manufacturer’s instructions. After 5 hours, cytokines
or TCCM were added.
In Vitro CFDA-SE Labeling and Proliferation Assay
Mixed-leukocyte peptide cultures (MLPC) were set up as described in Supple-
mental Information.
qRT-PCR
Total RNA was extracted from cells by using Trizol reagent (Life Technologies).
Taqman probes were used for the detection of miRs (Applied Biosystems), as
described by the manufacturer, by using small nuclear RNA sno292 as endog-
enous control. For mRNA-level analysis, cDNA was generated by using
reverse transcriptase SuperScript II and poly dT primers (Invitrogen). Real-
time PCR was performed by using SYBR Green Master Mix (Invitrogen) and
the ABI 7900HT fast real-time PCR System (Applied Biosystems). Primers
are described in the Supplemental Information. S18 was used as endogenous
control. Relative quantification of miRNA and mRNA expression was per-
formed by using the DDCT method.
Enzyme-Linked Immunosorbent Assay
ELISA for murine IL-12p70 and IL-10 was performed with R&D kits, following
manufacturer’s instructions.
Immunoblot Analysis
Nuclear cell extracts were obtained from 3 3 106 cells by using the Pierce
NE-PER nuclear reagents (Pierce Biotechnology) in presence of protease in-
hibitors (Calbiochem). The following antibodies were used: C/EBPb (1:1,000,
Santa Cruz), gp130 (1:1,000, eBiosciences), p-STAT-3 Tyr705 (1:1,000, Cell
Signaling), STAT3 (1:1,000, Santa Cruz), Nucleoporin p62 (1:1,000, BD), and
a-Actin (1:5,000, Sigma). Secondary HRP-conjugated Abs were obtained
from GE Healthcare Life Sciences. Immunoblots were analyzed by ECL
(Pierce Biotecnology). Signal quantification was performed by using ImageJ
Software.
Transduction of Hematopoietic Progenitor-Enriched CD11b– Cells
and Transplantation Procedure
We transduced 33 106 BM-CD11b cells with mock, miR-142-3p expressing
or miR-142-3p sponge lentiviral vector stocks, produced as described in
Supplemental Information, at a multiplicity of infection (MOI) of 75 for 18
hour. For in vitro experiments, CD11b-transduced cells were cultured in
G-CSF-containing medium for 4 days. Transduction of CD11b and stable
chimera generation were obtained as previously described (Montini et al.,
2006).
Adoptive T Cell Transfer Protocol
Eight weeks after transplantation, chimera mice were injected s.c. with
MCA203 fibrosarcoma cells and ACT was performed as previously described
(Ugel et al., 2010).
Luciferase Reporter Assay
HEK293T cells were cultured to 80% confluence in 24-well plates and trans-
fected as described in Supplemental Information.
Statistics
All results are expressed asmean ± SE. Student’s t test was used to determine
p values. Kaplan-Meier survival analysis was performed for the comparison
of survival curves. Statistical significance was defined as p < 0.05. In figures,
asterisks were used as follows: * p%0.05; ** p%0.01; *** p%0.001.Immunity 38, 1236–1249, June 27, 2013 ª2013 Elsevier Inc. 1247
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Phosphatidylinositol phosphate kinase type 1γ (PIPKIγ) is a key en-
zyme in the generation of phosphatidylinositol 4,5-bisphosphate [PI
(4,5)P2] and is expressed at high levels in the nervous system. Homo-
zygous knockout mice lacking this enzyme die postnatally within
24 h,whereas PIPKIγ+/− siblings breed normally and have no reported
phenotype. Here we show that adult PIPKIγ+/− mice have dramati-
cally elevated hearing thresholds for high-frequency sounds. During
the ﬁrst postnatal week we observed a reduction of ATP-dependent
Ca2+ signaling activity in cochlear nonsensory cells. Because Ca2+
signaling under these conditions depends on inositol-1,4,5-trisphos-
phate generation from phospholipase C (PLC)-dependent hydrolysis
of PI(4,5)P2,we conclude that (i) PIPKIγ is primarily responsible for the
synthesis of the receptor-regulated PLC-sensitive PI(4,5)P2 pool in the
cell syncytia that supports auditory hair cells; (ii) spatially graded
impairment of this signaling pathway in cochlear nonsensory cells
causes a selective alteration in the acquisition of hearing in PIPKIγ+/−
mice. This mousemodel also suggests that PIPKIγmay determine the
level of gap junction contribution to cochlear development.
connexins | deafness | phosphoinositides | Ca2+ oscillations | NF-κB
Cell stimulation with a variety of agents triggers signaling cas-cades that involve PI(4,5)P2, a minor glycerophospholipid of
the inner leaﬂet of the plasmamembrane. PI(4,5)P2 contributes to
these processes by being converted into second messengers, by
controlling the activity of PI(4,5)P2-binding proteins, or by acting
as the substrate of PI(3,4,5)P3 kinase (1). Phospholipase C (PLC)-
dependent hydrolysis of PI(4,5)P2 generates the secondmessenger
molecules diacylglycerol and IP3; the latter binds to IP3 receptors
(IP3R) to activate Ca
2+ efﬂux from the endoplasmic reticulum,
raising the cytosolic free Ca2+ concentration ([Ca2+]i) (2).
Most plasma membrane PI(4,5)P2 is generated by phosphory-
lation of PI(4)P at the D-5 position of the inositol ring, a reaction
catalyzed by type I PI(4)P 5-kinases (PIPKI) (1). Distinct genes
encode the three PIPKI isoforms, named α, β, and γ (note that
nomenclature for the murine and human isoforms of PIPKIα and
PIPKIβ were previously inconsistent; in this article, the murine
nomenclature is used); the three isoforms localize within different
compartments and play speciﬁc roles in individual cell types, be-
cause one isoform cannot compensate for the loss of another (3,
4). Of the three isoforms, PIPKIγ is the one expressed at highest
concentration in the nervous system (5) in platelets and mega-
karyocytes (6).
Knockout mice have been generated for all three isoforms of
PIPKI. PIPKIα−/− mice develop normally but show increased
degranulation and cytokine production by mast cells activated via
the Fcε receptor (7). PIPKIβ−/− mice have a normal phenotype
except for decreased fertility; however, platelets from these mice
show diminished PI(4,5)P2 production, PLC activation, and IP3
production after thrombin treatment (6). PIPKIγ−/− mice, in
which exons 2–6 of the PIPKIγ gene (Pip5k1c) that encodemost of
the catalytic region were deleted by homologous recombination,
present decreased levels of PI(4,5)P2 in the nervous system (5).
Whereas PIPKIγ+/− mice breed normally and have no obvious
phenotype, all PIPKIγ−/−mice are recognizable soon after birth by
their impaired motility, and they die postnatally within 24 h. The
inability of these mice to feed after birth strongly suggested the
occurrence ofmajor neurological defects. Indeed, cortical neurons
in primary cultures of from PIPKIγ−/− mice revealed defects in
synaptic transmission that may result, at least in part, from an
impairment of synaptic vesicle trafﬁc (5). Note that another
PIPKIγ knockout mouse generated by random insertional muta-
genesis exhibits embryonic lethality at midgestation (8); the reason
for this discrepancy is not known.
Here we report that PIPKIγ deﬁciency in mice results in
a sizeable and spatially graded down-regulation of IP3R Ca
2+
signaling along the sensory epithelium of the cochlea (inner ear)
during a crucial postnatal period that precedes acquisition of
hearing, which inmice occurs around postnatal day 12 (P12, where
P0 indicates day of birth). This reduction of Ca2+ signaling cor-
relates with the appearance of a speciﬁc deafness phenotype in
adult PIPKIγ+/− mice, characterized by normal sensitivity to low-
frequency sounds but a dramatic reduction of the sensitivity to
frequencies in excess of 20 kHz. These data are discussed in terms
of presentmodels of inner ear development and sound perception.
Results
Hearing relies on a sensitive mechanoelectrical transduction
process in the cochlea of the inner ear, in which the organ of Corti
encompasses highly specialized sensory hair cells that are em-
bedded in a matrix of supporting and epithelial cells, henceforth
designated as cochlear nonsensory cells. The functional maturation
of the cochlea relies not only on the differentiation of hair cells
and the formation of coordinately polarized hair bundles, but also
on the formation of nonsensory cell networks, which form vast
functional syncytia coupling transfer of ions, signaling molecules
and nutrients through gap junction channels (9). Our recent work
has linked alterations of IP3R Ca
2+ signaling in nonsensory cells of
the developing cochlea to impaired hearing acquisition in mouse
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models of human hereditary deafness (10). On the basis of the
primary role played by PIPKIγ in IP3 signaling, although no phe-
notype has been described in PIPKIγ+/− mice, we would predict
that a reduction of PI(4,5)P2 levels may affect the development of
hearing capability. Accordingly, it seemed of potentially great in-
terest to investigate the hearing performances of transgenic mice
with PIPKIγ deﬁciency.
Hearing Loss in PIPKIγ+/− Mice. Initially, we examined hearing in
adult PIPKIγ+/− mice by recording auditory brainstem responses
(ABRs), which are electrical signals evoked from the brainstem by
the presentation of sound stimuli (Fig. 1). We assessed ABR
thresholds in (n = 6) PIPKIγ+/− mice and (n = 4) WT siblings and
found similar values for click and tone burst stimuli at 8, 14, and 20
kHz.However, thresholdswhere signiﬁcantly elevated inPIPKIγ+/−
mice compared withWTanimals, bymore than 12 and 33 dB sound
pressure level (SPL), respectively, at 26 kHz (P= 0.003) and 32 kHz
(P = 0.0002). These results demonstrate that PIPKIγ deﬁciency
ensues in a unique phenotype of hearing loss at high sound fre-
quencies, which aremapped onto the basal 50%of the length of the
mouse cochlea (11) (Fig. 1B). Note that the structure of ABR
waveforms, when identiﬁable, was well preserved at all frequencies
(Fig. 1A). This behavior suggests normal general functioning of the
nervous system and in particular of the neural elements contrib-
uting to the generation of synchronized discharges along the au-
ditory nerve and brainstem pathway; and this is also consistent with
the lack of an overt neurologic phenotype in these heterozygous
mice. Confocal microscopy in adult PIPKIγ+/− mice revealed nei-
ther hair cell loss nor morphological abnormalities in spiral gan-
glion neurons and organ of Corti, which appeared normally
innervated (SI Appendix, Fig. S1). In particular, the density of nerve
ﬁbers in tangential sections of the osseous spiral lamina (expressed
as number of ﬁbers per mm2) was (1.6 ± 0.2) × 105 in WT and
(1.6 ± 0.4) × 105 in PIPKIγ+/− mice.
PIPKIγ Deﬁciency Impairs Intercellular Ca2+ Waves and Intracellular
[Ca2+]i Oscillations Evoked by ATP in the Postnatal Cochlea. For these
experiments, we used organotypic cultures of P0–P5 cochlear tis-
sue (SI Appendix, Fig. S2) prepared according to standard proto-
cols, because this preparation preserves the architecture and
functional relationships among the cells observed in vivo (12).
Cultures comprised the lesser epithelial ridge (LER), which is
thought to give rise to the outer hair cells and lateral nonsensory
cells, and the adjacent greater epithelial ridge (GER), which gives
rise to the inner hair cells and medial nonsensory cells (13). After
overnight incubation in vitro, we loaded cochlear cultures with the
Ca2+ indicator fura-2 and performed ratiometric imaging of the
cytosolic free Ca2+ concentration ([Ca2+]i) at room temperature
(22−24 °C).
We and others have previously demonstrated that the binding of
extracellular ATP toG protein-coupled P2Y2 and P2Y4 receptors,
expressed on the endolymphatic surface of the developing sensory
epithelium, activates PLC-dependent generation of IP3, which in
turn triggers a regenerative Ca2+ wave that propagates for hun-
dreds of micrometers from the site of stimulation (14–18). Using
previously developed image processing algorithms (16, 17), we
examined Ca2+ wave propagation elicited by a puff of ATP (4 μM,
50ms) in cultures from (n = 3)WT, (n= 5) PIPKIγ+/−, and (n= 3)
PIPKIγ−/− mice (Fig. 2 A and B). Data analysis revealed a signiﬁ-
cant reduction of the propagation index in LER cells of PIPKIγ+/−
(P= 0.003) and PIPKIγ−/− (P= 0.001) cultures comparedwithWT
cultures; the reduction was more pronounced in PIPKIγ−/− cul-
tures, and differences between these and PIPKIγ+/− cultures were
statistically signiﬁcant (P = 0.011) (Fig. 2C). Thus, only quantita-
tive and not qualitative differences were observed, related to this
parameter, between the heterozygous and homozygous animals.
In addition, because of the postnatal lethality of PIPKIγ−/− mice
(5), not only could we analyze only P0 tissues, but later alterations
in cochlea physiology were prevented. Clearly complete loss of
PIPKIγmay be particularly toxic for the whole organisms, whereas
the reduction in the gene dosage in the heterozygote may be more
informative of some key feature and speciﬁc of the enzymes for
cochlear functions. Therefore, we concentrated exclusively on
PIPKIγ+/− mice.
Intercellular Ca2+ waves are often accompanied by a trail of
[Ca2+]i oscillations, which can also be reliably evoked by the ap-
plication of extracellular ATP at nanomolar levels (16–18). When
stimulated by prolonged application of ATP (200 nM), nonsensory
LER cells in cultures from P5 WT mice developed [Ca2+]i oscil-
lations that persisted for periods in excess of 10 min (Fig. 2 D and
E, Left). By contrast, [Ca2+]i oscillations in LER cells from age-
matched PIPKIγ+/− mice ceased almost abruptly after variable
time intervals that rarely exceeded 5 min (Fig. 2 D and E, Right).
Speciﬁcally, the duration of Ca2+ oscillation bursts evoked by
application of 200 nM ATP in the LER of PIPKIγ+/− cultures
were 169 ± 37 s in the apical turn, 244 ± 40 s in the middle turn,
and 171 ± 38 s in the basal turn (m = 100 cells in each of n = 3
cultures for each turn and each genotype).
Next, we constructed ATP dose–response functions by plotting
the maximal fura-2 ratio change (ΔRmax) vs. [ATP] in LER cells
from P5 mice (Fig. 3; each data point is the average ofm = 15 cells
in n = 3 cultures). In the apical turn, the dose–response of WT and
PIPKIγ+/− cultures superimposed almost perfectly, with similar
half-maximal effective concentration: EC50= 93± 4 nM inWT and
EC50 = 101 ± 9 nM in PIPKIγ+/− cultures. In the middle turn, the
EC50 shifted signiﬁcantly from 96± 5 nM ofWT to 353± 13 nM of
PIPKIγ+/− cultures (P = 2 × 10−4). In the basal turn, the shift was
even more dramatic: from 72 ± 4 nM of WT to 448 ± 18 nM of
PIPKIγ+/− cultures (P = 5 × 10−4). Quantitative real-time PCR
(qPCR) analysis of cochlear ducts explanted from (n= 4) PIPKIγ+/−
mice at P5 showed the expected reduction of PIPKIγ mRNA level
compared with (n = 4) age-matched WT controls (Fig. 3B). The
reduction in the basal turn was signiﬁcantly more pronounced than
in the middle and apical turn (P < 0.05), in accord with the ATP
dose–response analysis (Fig. 3A).
The question thus arises as to whether PIPKIγ reduction also
affects the amplitude of the [Ca2+]i oscillations evoked by ATP in
the LER (Fig. 4). Averaged waveforms had similar amplitudes in
apical turn ofWT and PIPKIγ+/− cultures; by contrast, amplitudes
in middle and basal turn PIPKIγ+/− cultures were reduced by 24%
and 22% compared withWT controls (Fig. 4, Left; each waveform
was obtained in LER cells by averaging more than 1,500 peak-
aligned [Ca2+]i oscillations within 3 min from the onset of a 200-
nM ATP application). Accordingly, distributions of [Ca2+]i oscil-
lation amplitudes in WT and PIPKIγ+/− LER cultures (Fig. 4,
Fig. 1. Hearing loss in adult PIPKIγ+/− mice. (A) Representative ABR wave-
forms evoked by a 32-kHz tone burst in a WT mouse (blue) and a PIPKIγ+/−
mouse (magenta); numbers indicate stimulus intensity in dB sound pressure
level (SPL). (B) Average hearing thresholds (left ordinates) of wave IV ABR
for clicks and tone bursts of 8, 14, 20, 26, and 32 kHz in WT mice (blue) and
PIPKIγ+/− mice (magenta) between P27 and P50; black asterisks indicate sig-
niﬁcant differences (ANOVA); error bars, SD. The black dotted curve (right
ordinates) is a portion of the mouse position vs. frequency map d = 156.5 −
82.5 · log10(f), where d is the normalized distance along the coiling axis of the
cochlea from its base, in percent, and f is the frequency in kHz (11); dashed
lines delimit the portion of the map where hearing loss in PIPKIγ+/− mice is
noticeable; Apical (A), Middle (M), and Basal (B) refer to the three segments of
the cochlear duct length shown schematically (Inset) (SI Appendix, Fig. S2).
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Right) overlapped in the apical turn but were shifted toward sig-
niﬁcantly lower values in middle and basal turns (P = 2.2 × 10−16).
PIPKIγ Deﬁciency Impairs Spontaneous [Ca2+]i Transients in the
Postnatal Cochlea. Spontaneous [Ca2+]i oscillations in LER cells
are rarely observed while working with cochlear organotypic
cultures at room temperature, but their frequency is drastically
increased upon blockade of ectoATPases (17). Conversely,
spontaneous [Ca2+]i transients were always observed in the GER
(Fig. 5A). These spontaneous events have been attributed by us
and other investigators to spontaneous release of ATP (19, 20)
through connexin hemichannels (21). Not only have we con-
ﬁrmed these data in these GER preparations (sensitivity to ATP
receptor antagonists and to connexin hemichannel inhibitors),
but we could also show that focal UV photolysis of a caged in-
tracellular IP3 precursor in the GER evokes [Ca
2+]i transients
similar to the spontaneous ones (Movie S1). In addition, and
similarly to [Ca2+]i oscillations induced by exogenous ATP in
LER cells, (i) the spontaneous [Ca2+]i transients showed no sign
of fatigue in recordings lasting 15 min or more in the GER of
(n = 3) WT cultures (SI Appendix, Fig. S3A, Left); (ii) the spon-
taneous [Ca2+]i transients in the GER ceased within 5 min in (n =
3) WT cultures after addition of 200 nM thapsigargin (SI Ap-
pendix, Fig. S3A, Right) a noncompetitive inhibitor of the Ca2+-
ATPase (SERCA) that causes the complete and irreversible
depletion of Ca2+ from the endoplasmic reticulum; (iii) the PLC
inhibitor U73122 (2.5 μM) signiﬁcantly (P = 0.001) and re-
versibly reduced the frequency of spontaneous [Ca2+]i transients
in the GER (n = 3; SI Appendix, Fig. S3B, Left); and (iv) the
spontaneous [Ca2+]i transients in the GER were also drastically
reduced by the potent (although not completely speciﬁc) IP3R
antagonist 2-aminoethoxydiphenyl borate (2-APB, 100 μM; n =
3; SI Appendix, Fig. S3B, Right). Altogether, the results of these
and previously published experiments (17, 21) indicate that ATP-
evoked [Ca2+]i oscillations in the LER and spontaneous [Ca
2+]i
transients in the GER are generated by similar mechanisms [i.e.,
ATP activation of P2Y receptors (by exogenous addition of ATP
in the LER or local ATP release through connexin hemichannels
in the GER), followed by IP3 generation and Ca
2+ release from
the endoplasmic reticulum].
The prediction can thus be made that PIPKIγ deﬁciency should
also affect the pattern of spontaneous events in GER cells. We
thus examined the frequency of spontaneous [Ca2+]i transients in
each cochlear turn by counting all events within the portion of the
GER in the ﬁeld view while imaging cultures obtained from P5
WTmice (n= 4) and age-matched PIPKIγ+/− siblings (n= 4) (Fig.
5B). Even considering the different areas of the GER regions
along the coiling axis of the cochlea (SI Appendix, SI Materials and
Methods), the 1.85-fold lower mean frequency in the basal turn
with respect to the apical turn reﬂects a genuine reduction of
spontaneous Ca2+ signaling activity in the different GER regions
of WT cultures (Fig. 5B, Left). We then performed the same
analysis in GER cells from PIPKIγ+/− cultures (Fig. 5B, Right). In
Fig. 2. ATP-evoked Ca2+ signaling in the LER of cochlear organotypic cul-
tures from postnatal WT and PIPKIγ+/− mice. (A) Samples of a representative
false-color image sequence showing fura-2 ﬂuorescence ratio changes (ΔR),
encoded as shown by the color scale bar, recorded in a WT culture after
delivery of a brief puff (50 ms) of ATP (4 μM) through a glass micropipette
(white asterisk); time in seconds from puff offset is shown in the lower right
corner of the corresponding frame. (Scale bar, 100 μm.) (B) Waveforms of
Ca2+ responses obtained by averaging signals within the nine color-matched
regions of interest shown over individual cells at increasing distance from
micropipette opening in A. (C) propagation index, deﬁned as the maximal
area invaded by the intercellular Ca2+ wave divided by the area directly
stimulated by the puff (pooled data); an index of 1 indicates no propagation;
black asterisks indicate signiﬁcant differences (ANOVA); error bars, SD. (D)
Sample traces of Ca2+ responses obtained by averaging fura-2 ratio signals
within 15 randomly selected cells in representative apical turn cultures from
P5 WT and PIPKIγ+/− mice during sustained application of extracellular ATP
(200 nm, gray bars). (E) Frequency histograms of ATP-evoked [Ca2+]i oscil-
lations (events) in cultures from P5 WT and PIPKIγ+/− mice (pooled data); in
each graph, the solid black line (right ordinates) is the time integral of the
corresponding frequency histogram and, as such, it tracks the mean number
of events in the cell population from the onset of the ATP application.
Fig. 3. ATP dose–response curves in the LER of organotypic cultures (A) and
qPCR analysis of PIPKIγmRNA level in the sensory epithelium (B) from P5 WT
and PIPKIγ+/− cochleae (pooled data). Lines through data in A are least-
square ﬁts with the sum of two scaled logistic functions. Black asterisks in B
indicate signiﬁcant differences (ANOVA); error bars, SD.
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the apical turn, we found similar mean frequencies of occurrence
(39 ± 4 events per minute in WT vs. 38 ± 11 events per minute in
PIPKIγ+/− cultures). Differences become discernible, although
not statistically signiﬁcant, in the middle turn (32 ± 7 events per
minute in WT vs. 25 ± 8 events per minute in PIPKIγ+/− cultures;
P = 0.32). They were evident (ﬁvefold reduction) and highly sig-
niﬁcant in the basal turn (21 ± 2 events per minute inWT vs. 4 ± 1
events per minute in PIPKIγ+/− cultures; P = 2 × 10−4), in accord
with the more pronounced reduction of PIPKIγ mRNA level in
this turn (Fig. 3B).
As far as amplitudes of spontaneous [Ca2+]i transients are
concerned (Fig. 6), akin to what we noticed in LER cells, aver-
aged waveforms had similar amplitudes in apical turn GER of
WT and PIPKIγ+/− cultures; by contrast, amplitudes in middle
and basal turn GER of PIPKIγ+/− cultures were reduced by 21%
and 33% compared with WT controls (Fig. 6, Left; waveforms
were obtained by averaging 448, 385, and 389 peak-aligned [Ca2+]i
transients in WT cultures, 557, 392, and 62 transients in PIPKIγ+/−
cultures from the apical, middle, and basal turn, respectively).
Accordingly, amplitude distributions of spontaneous [Ca2+]i tran-
sients in the GER of PIPKIγ+/− cultures overlapped with WT
distributions in the apical turn but were shifted toward signiﬁ-
cantly lower values (P < 5.0 × 10−5) both in middle and basal
turns (Fig. 6, Right). [Ca2+]i oscillations induced by exogenous
ATP were not investigated in GER cells, because they super-
impose to spontaneous events.
To summarize, both the amplitude and frequency of spontane-
ous [Ca2+]i transients were drastically reduced in the basal turn and
hardly affected in the apical turn of the GER. This correlates with
the reduced sensitivity to ATP and the more marked reduction in
the level of PIPKIγ in the basal region, suggesting that this
enzyme is critical for producing the PI(4,5)P2 pool responsible
for IP3 generation in cochlear nonsensory cells.
PIPKIγ Deﬁciency Causes Down-Regulation of Connexin Transcripts in
the Postnatal Cochlea. In nonexcitable cells, such as cochlear
nonsensory cells, [Ca2+]i controls the dynamics of gene expression
through the activation of multiple transcription factors (22, 23). A
widely held hypothesis is that information is encodedmainly by the
frequency of [Ca2+]i oscillations (22); however, a possible role of
amplitudes and duration in signal transduction has been discussed
(24, 25). It has also been argued that amplitude modulation and
frequency modulation differentially regulate distinct targets (26).
Our prior work with cochlear organotypic cultures had noted
that [Ca2+]i oscillations in nonsensory cells participate in the co-
ordinated regulation of connexin26 (Cx26) and connexin30 (Cx30)
expression through the nuclear factor-κ light chain enhancer of
activated B cells (NF-κB) (27), a thoroughly investigated Ca2+-
dependent transcription factor (22, 23, 28). These are the only
connexins expressed in the organ of Corti nonsensory cells (29), and
they are essential for the cell-to-cell propagation ofCa2+ signals (14,
17, 18). Here we analyzed samples from (n = 8) P5 PIPKIγ+/−mice
and compared mRNA levels of both connexins with the corre-
sponding cochlear turn in (n = 8) age-matched WT controls. The
residual level of Cx26 mRNA was 75% ± 7% in the apical turn,
Fig. 4. Amplitudes of [Ca2+]i oscillations evoked by 200 nM ATP in the LER
of organotypic cochlear cultures from P5 WT and PIPKIγ+/− mice (pooled
data). Left: Average waveforms; Right: amplitude distributions (for box plot
symbolism; see, e.g., http://en.wikipedia.org/wiki/Box_plot); black asterisks
indicate signiﬁcant differences between data distributions (Mann−Whitney
U test; SI Appendix, SI Materials and Methods).
Fig. 5. Spontaneous [Ca2+]i transients in the GER of WT and PIPKIγ+/−
postnatal cochlear cultures. (A) Left: representative false-color image of
fura-2 ﬂuorescence ratio changes (ΔR), encoded as shown by the color scale
bar, obtained as maximal projection rendering of all frames recorded in
a basal turn culture from a WT P5 mouse imaged for 4 min at eight frames
per second; 20 regions of interests are shown superimposed on different
Ca2+ hot spots. (Scale bar, 100 μm.) Right: Fura-2 traces generated as pixel
averages from the 20 color-matched regions of interests shown at Left. (B)
Frequency histograms of spontaneous [Ca2+]i transients (events) in cultures
from P5 WT and PIPKIγ+/− mice (pooled data); in each graph, the solid black
line (right ordinates) is the time integral of the corresponding frequency
histogram and, as such, it tracks the mean number of events in the cell
population from the onset of the recording.
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65% ± 7% in the middle, and 65% ± 6% in the basal turn. The
corresponding ﬁgures for Cx30 mRNA were 70% ± 5%, 79% ±
5%, and 67% ± 4% in the apical, middle, and basal turn, re-
spectively. Thus, impaired IP3R Ca
2+ signaling in cochlear non-
sensory cells due to PIPKIγ deﬁciency causes signiﬁcant down-
regulation of both connexin transcripts (P < 0.005), whereas our
prior work determined that deletion of either Cx26 or Cx30 impairs
IP3R Ca
2+ signaling in cochlear nonsensory cells (17, 27). A
seemingly logical conclusion is that IP3R Ca
2+ signaling establishes
a tight feedback loop between channel function and transcript levels
of Cx26 and Cx30 in the developing cochlea.
To corroborate this conclusion, we analyzed also Cx30+/− and
Cx30−/−mice. Note that normal auditory thresholds were reported
for adult Cx30+/− mice (30), whereas both Cx30−/− mice (21, 30)
and mice with targeted ablation of Cx26 in the inner ear (31, 32)
are profoundly deaf at all tested frequencies. We also showed that
whole-cochlea samples from postnatal Cx30−/− mice have only
∼8% residual Cx26 mRNA (27). Here we found signiﬁcantly re-
duced levels (P < 0.001) of Cx26 (58% ± 8%) and Cx30 (54% ±
9%) in the cochlea of (n= 4) P5 Cx30+/−mice compared with (n=
4) age-matched WT controls. The frequencies of occurrence of
spontaneous [Ca2+]i transients in GER cells of cochlear organo-
typic cultures from (n = 4) P5 Cx30+/−mice were indistinguishable
from those of (n= 4)WT controls; by contrast, frequencies in (n =
4) Cx30−/− cultures were signiﬁcantly reduced (P < 0.001) to levels
resembling those of (n = 4) basal turn PIPKIγ+/− cultures (SI Ap-
pendix, Fig. S4). Finally, amplitudes of these spontaneous [Ca2+]i
transients were reduced in the middle and basal turn of Cx30+/−
cultures (P < 0.005) and in all turns of Cx30−/− cultures (P < 0.001)
(SI Appendix, Fig. S5).
To consolidate these ﬁndings we exploited the previously dem-
onstrated capability of ﬂufenamic acid, a connexin hemichannel
blocker, to reversibly suppress both intercellular Ca2+ waves (17)
and spontaneous [Ca2+]i transients (21). In this study, we used
a canalostomy approach for drug delivery to the inner ear via the
posterior semicircular canal of WT mouse pups aged P4 or P5
(Movie S2). Four weeks after this single-shot injection, we tested
hearing by recording ABRs and determined that auditory thresh-
olds in (n = 25) mice injected with artiﬁcial endolymph (vehicle)
were indistinguishable from those of (n= 12) noninjected controls;
in contrast, thresholds in (n = 4) mice that had received ﬂufenamic
acid (250 μM) were signiﬁcantly elevated (P < 0.05) by more than
15 dB SPL at all tested frequencies (SI Appendix, Fig. S6).
Discussion
This study reveals a unique hearing loss phenotype in adult
PIPKIγ+/− mice at sound frequencies in excess of 20 kHz (Fig. 1)
and demonstrates a key role of PIPKIγ in the inner ear and its
essential function for the acquisition of hearing. It has been hy-
pothesized that different enzymes contribute to the local control of
PI(4,5)P2 synthesis and conﬁnement, thus generating distinct pools
of PI(4,5)P2 in the plasma membrane, each controlling speciﬁc
functions (1). On the basis of studies in platelets it has been sug-
gested that PIPKIα and PIP5KIβ contribute to the rapid synthesis
of the PI(4,5)P2 pool required for IP3 and diacylglycerol generation
upon agonist stimulation, whereas the PI(4,5)P2 pool synthesized
by PIP5KIγ does not play a major role in this process (6). At odds
with this conclusion, inhibition of PIPKIγ expression in HeLa cells
by RNA interference, although marginally reducing the total cel-
lular PI(4,5)P2 level, dramatically reduces IP3 formation after his-
tamine stimulation (33). The present data concur with the results in
HeLa cells, demonstrating that Ca2+ signaling is selectively affected
in nonsensory cells of PIPKIγ+/− and PIPKIγ−/− cochlear tissue.
Taken together, the simplest interpretation of the data pre-
sented in Figs. 2 and 3 is that reduction in gene dosage of PIPKIγ
in the heterozygote causes a corresponding reduction in PI(4,5)
P2 levels in nonsensory cells of the developing cochlea. Conse-
quently, PLC-mediated PI(4,5)P2 hydrolysis in PIPKIγ+/− cul-
tures more rapidly depletes a speciﬁc pool of PI(4,5)P2 that is
necessary for ATP-dependent intercellular Ca2+ wave propaga-
tion and maintenance of [Ca2+]i oscillations in nonsensory LER
cells. The apparent decrease in afﬁnity for ATP in the medial
and basal turn (Fig. 3A) most likely depends on the more marked
reduction in PIPKIγ in these locations (Fig. 3B). Thus, below
a critical enzyme level, PI(4,5)P2 becomes the limiting factor,
and optimal levels of IP3 can only be produced when a larger
number of P2 receptors are engaged by the ligand. This con-
clusion is also consistent with the reduced amplitudes of [Ca2+]i
oscillations evoked by 200 nM ATP (Fig. 4), which is a nearly
saturating concentration in all cochlear turns of WT cultures, but
submaximal for medial and basal turn PIPKIγ+/− cultures (Fig.
3A). Most relevant from a functional point of view, the hearing
loss detected by our ABR measurements in adult PIPKIγ+/−
mice maps precisely to this basal portion of the cochlea (Fig. 1),
in a region comprising part of the middle and the whole basal
turn where we detected the most pronounced Ca2+ signaling
alterations (Figs. 3–6).
To summarize, the results presented here demonstrate that
cochlear nonsensory cells of the LER and the GER share the same
PLC- and IP3R-dependent signal transduction cascade activated by
ATP (SI Appendix, Fig. S3) and suggest that reduction in PIPKIγ
gene dosage in the heterozygote causes a corresponding reduction
in the critical pool of PI(4,5)P2 necessary for normal Ca
2+ sig-
naling. We can speculate that the lack of spontaneous oscillations
in LER cells in these experimental conditions (unlike those of
GER) is due to (i) more efﬁcient ATP hydrolysis by ectoATPases;
(ii) reduced number and/or decreased opening probability of Cx
hemichannel; or (iii) a combination of these mechanisms.
PIPKIγ reduction affects not only Ca2+ signaling directly (by
reducing the precursor of IP3) but also the expression of another
key component of Ca2+ signaling, the channel-forming proteins
Cx26 and Cx30. Indeed, we have shown previously that genetic
manipulation of these connexins strongly affects Ca2+ signal
generation and propagation (17, 21, 27). The present results
single out Cx26 and Cx30 as both targets and effectors of Ca2+
signaling in the developing cochlea. As for the pathogenesis of
Fig. 6. Amplitudes of spontaneous [Ca2+]i transients in the GER of cochlear
organotypic cultures from P5 WT and PIPKIγ+/− mice (pooled data). Left:
Average waveforms; Right: amplitude distributions; black asterisks indicate
signiﬁcant differences between data distributions (Mann−Whitney U test).
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deafness, our comparative analysis of PIPKIγ+/− and Cx30+/−
postnatal cultures (SI Appendix, Figs. S4 and S5) indicates that
down-regulation of Cx26 and Cx30 mRNA level, by as much as
∼50%, is insufﬁcient per se to cause hearing loss. Instead, hearing
acquisition is disrupted when Ca2+ signaling in cochlear non-
sensory cells falls below a critical threshold. In Cx30−/− postnatal
cultures the criticality is imparted by the uniform deletion of
Cx30 and the drastic reduction of the residual Cx26 in the sensory
epithelium. Indeed, in all turns of the Cx30−/− postnatal cochlea,
IP3R Ca
2+ signaling in nonsensory cells is reduced to levels
comparable to or lower than those of basal turn PIPKIγ+/− co-
chlea. As predicted, adult Cx30−/− mice are doomed to deafness
at all frequencies (21, 30). In PIPKIγ+/− mice, the criticality is
imparted by the apparent decrease in afﬁnity for ATP only in the
medial and basal turn, and the hearing defect is limited to the
sound frequencies mapping in this region of the coiled sensory
epithelium (Fig. 1). The importance of connexin hemichannel
functionality in the critical period of hearing acquisition is further
supported by the results with the connexin hemichannel inhibitor
ﬂufenamic acid (SI Appendix, Fig. S6), which suppresses Ca2+
signaling in nonsensory cells of cochlear cultures (17, 21) and
causes hearing loss at all tested frequencies when delivered via
canalostomy to the inner ear of mouse pups.
The severe hearing loss of Cx30−/− mice (30) and of mice with
targeted ablation of Cx26 in the inner ear (31, 32) is associated
with substantial cell death affecting hair cells and supporting cells.
By contrast, we did not detect morphological abnormalities in the
inner ear of adult PIPKIγ+/− mice, in which hair cells, spiral
ganglion neurons and nerve ﬁber counts were indistinguishable
from WT controls (SI Appendix, Fig. S1). Indeed, an overall
normal functioning of the neural elements that contribute to the
generation of synchronized discharges along the auditory nerve
and brainstem pathway is required to account for the shape of
PIPKIγ+/− ABR waveforms (Fig. 1A); and this is also consistent
with the lack of an overt neurologic phenotype in these hetero-
zygous mice, which behave and breed normally. Evidently, com-
plete lack of one of these two connexins, combined with the
regulation mechanisms that govern their coordinated expression
(27), impacts on viability of inner ear cells more than impairment
of Ca2+ signaling due to reduction of PIPKIγ gene dosage. Fur-
ther understanding how the Ca2+ signaling defects reported here
link to hearing loss in these different mouse models may prove
crucial to unravel how hearing acquisition proceeds under normal
circumstances, as well as to decipher the pathogenic processes
underlying human hereditary deafness forms and, eventually, to
test prospective therapies.
Materials and Methods
Statistical Analysis. Means are quoted ± SD, and P values are indicated by
letter P. Unless otherwise stated, statistical comparisons of means were
made by one-way ANOVA in conjunction with the Tukey range test.
Animal Handling. Animal handling was approved by the Ethics Committee of
Padua University (Comitato Etico di Ateneo per la Sperimentazione Animale;
Project 54/2009, Protocol 51731).
ABR Recordings.ABRs were used to assess hearing threshold of all mice strains
used in this study.
Quantitative PCR. mRNA was extracted from freshly isolated P5 whole co-
chleae or from apical, middle, and basal turn, using the RNAeasy kit (Qiagen).
Ca2+ Imaging. Signals were measured as fura-2 emission ratio changes,
ΔR=RðtÞ−Rð0Þ, where t is time, RðtÞ is emission intensity excited at 360 nm
divided by the intensity excited at 380 nm, and Rð0Þ indicates baseline ratio.
Immunohistochemistry and Confocal Imaging. Cochlear tissues were prepared
according to standard protocols and analyzed using a confocal microscope
(TCS SP5; Leica) equipped with an oil immersion objective (either 40× HCX PL
APO 1.25 N.A.; Leica).
Further details are provided in SI Appendix, SI Materials and Methods.
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